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Abbreviations 
 
5meC  5-methyl cytosine 
Arg, R  arginine 
BrdU  5-bromo-2-deoxyuridine 
BrUTP  5-bromouridine-5-triphosphate 
cAMP   3‟,5‟-cyclic adenosine monophosphate 
Cdk  cyclin dependent kinase 
ChIP  chromatin immuno-precipitation 
CPE  cytoplasmic polyadenylation element  
CPEB  cytoplasmic polyadenylation element binding protein 
Cys  cystein 
DAPI  4,6-diamidino-2-phenylindole 
dm  double mutant 
Dnmt  DNA methyl transferase 
Dpc  day post coitum 
DSB  double-stranded break  
dsRNA  double-stranded RNA 
DUB  de-ubiquitintating emzyme 
E  embryonic day 
ES  embryonic stem 
GO  gene ontology 
GV  germinal vesicle oocyte 
GVBD  Germinal vesicle breakdown 
H2AK119ub1 histone H2A lysine 119 mono-ubiquitination 
H3K27me3 histone H3 lysine 27 tri-methylation 
HAT  histone acetyl transferase 
HCP  high-CpG content  
HDAC  histone deacetylase 
HMTase histone methyl transferase 
Hox  homeobox 
HP1  heterochromatin protein 1 
Hpf  hours post fertilization 
ICM  inner cell mass 
ICR  imprinting control region 
IF  immunofluorescent 
IVF  in vitro fertilization 
KMTase lysine methyltransferase 
KO  knockout   
LCP  low CpG-content 
Lys, K  lysine 
mat  maternal 
ME  meridional division followed by equatorial division 
me1/me2/me3 mono-/di-/tri-methylation 
MEF  mouse embryonic fibroblast 
MET/MZT maternal to embryonic transition; maternal to zygotic transition 
M-I/M-II  metaphase-I/metaphase-II oocyte 
miRNA  micro RNA 
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MSCI  Meiotic Sex Chromosome Inactivation 
MSUC  Meiotic Silencing of Unsynapsed Chromatin 
MZT  maternal to zygotic transition  
ncRNA  non-coding RNA 
NPC  neural progenitor cell 
NSN  non-surrounding nucleolus oocyte 
PB  polar body 
P-body  Processing body 
PcG  Polycomb group 
PCH  pericentric heterochromatin 
PCR  polymerase chain reaction 
PN  pronucleus 
PRC  Polycomb repressive complex 
PRE  Polycomb response element 
pre-RC   pre-replication complex  
pri-miRNA  primary microRNA 
Prm  protamine 
PRMTase arginine methyltransferases  
PTM   post-translational modification 
Rb  retinoblastoma 
RC  replication coupled  
RI  replication independent  
RISC   RNA-induced silencing complex  
RNAi  RNA interference 
RNAP  RNA polymerase 
RT-PCR reverse transcriptase PCR 
SC  synaptonemal complex  
Ser, S  serine 
SET  Suppressor of variegation, Enhancer of Zeste, Trithorax 
SN  surrounding nucleolus oocyte 
TC  transcription coupled  
TCR  transcription requiring complex 
TE  trophectoderm 
TG   trophoblast giant  
Thr  threonine 
TP  transition protein 
TrxG  Trithorax group 
TS  trophoblast stem 
TSA  trichostatin A 
TSS  transcription start site 
XIC  X-inactivation center 
Xist  X-inactivation specific transcript 
ZGA  zygotic genome activation 
ZP  zona pellucid 
γH2AX   histone variant H2AX phosphorylated at serine residue 139  
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1. Summary 
 
Mammalian development begins at fertilization, when two highly specialized gametes, sperm and oocyte 
fuse to form a zygote. It is well established that early development of the embryo is driven by factors that 
are inherited from the oocyte. A complex maternal program, consisting of mRNAs, proteins and chromatin 
modifications is prepared in the oocyte that bears the intimate potential to execute events that will 
ultimately lead to the formation of a totipotent embryo. The components of this maternal program and the 
players involved in establishing it are poorly characterized. 
Polycomb group proteins (PcG) are evolutionarily conserved chromatin–modifying factors that maintain 
cellular identity during many rounds of cell division by transcriptionally repressing developmental regulator 
genes that are inappropriate for the given cell lineage. Lack of Polycomb function has been shown to 
result in de-repression of differentiation specific factors in embryonic stem (ES) cells and interfere with 
proper differentiation. Similarly in vivo, embryonic deficiency for some core PcG members in the mouse 
results in embryonic lethality around gastrulation. PcG proteins are known to function in at least two major 
complexes, termed Polycomb Repressive Complex 1 (PRC1) and 2 (PRC2). Silencing is thought to be in 
part a consequence of the ubiquitin ligase activity of the PRC1 complex towards histone H2A, inhibiting 
productive transcriptional elongation of genes. Previous data from our laboratory indicated that PcG 
proteins were present in the oocyte and transmitted to the embryo. 
The aim of this PhD project is to address the role of the Polycomb silencing pathway, focusing on the 
PRC1 complex, during oogenesis and early embryonic development. 
We show that embryos lacking the maternal contribution of Rnf2 (Ring1b) -the main catalytic subunit of 
PRC1- and its paralog Rnf1 (Ring1) fail to develop beyond the 2-cell stage. Expression profiling of fully 
grown oocytes revealed de-repression of numerous developmental regulator genes, most of which are 
established Polycomb targets in other cellular systems. We show however, that these differentiation-
specific transcripts are only translated after fertilization, resulting in the inappropriate presence of 
differentiation factors during the otherwise totipotent stage of early embryogenesis. Additionally, maternal 
pro-nuclear transfer experiments between control and maternal Rnf1/Rnf2 double mutant zygotes 
revealed that the developmental block is not only due to inappropriate cytoplasmic factors, but also to a 
defective chromatin setup inherited from the PRC1 deficient oocyte.  
Our findings demonstrate that PRC1-mediated silencing during oocyte growth is an essential component 
in the preparation of the maternal to embryonic transition program required for proper initiation of 
embryonic development. 
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2. Introduction 
 
At the onset of mammalian development a totipotent embryo is formed by the union of sperm and oocyte. 
Development of an organism involves carefully regulated differentiation processes during which the 
totipotent cells of the early embryo give rise to many distinct cell types of the adult body. During this 
phase, developmental potential of the differentiating cells is gradually decreasing and specificity towards 
a single terminal fate is acquired. The character of a differentiated cell is defined by its constituent 
proteins, which are the result of specific patterns of gene expression. Specific gene expression programs 
on one hand need to be stable enough to maintain cell identity but also need to be flexible to allow 
changes if change in developmental potential is required, for example during differentiation of embryonic 
cells. This balance of stability versus plasticity presents an inherent regulatory challenge for developing 
organisms. 
Cell type specific gene expression programs need to be executed on the same genomic DNA template. 
Crucial determinants of gene expression patterns are DNA-binding transcription factors that choose 
genes for transcriptional activation or repression by recognizing the sequence of DNA bases in their 
promoter regions. However if transcription factors alone were responsible for the regulation of gene 
expression then the gene expression pattern of a differentiated nucleus would be completely reversible 
upon exposure to a different set of factors. As reproductive cloning of animals by transferring somatic 
nuclei to an enucleated oocyte is successful only with low efficiency, the “transcription factor only” model 
seems to be incorrect and suggests that other components like chromatin structure plays an important 
role in regulating gene expression. 
Over the past few decades the rapidly evolving field of epigenetics explored the molecular mechanisms 
which shape or modify chromatin structure and thereby present an opportunity for regulating DNA-
templated events such as transcription, replication and repair which then contribute to the maintenance or 
the establishment of new cell type specific gene expression programs. 
 
 
2.1. Epigenetics and heritability 
 
In 1942 a developmental biologist C.H. Waddington, who was interested in how gene expression patterns 
are modified during development, coined the word epigenetic which he described as “the causal 
interaction of genes and their products, which bring the phenotype into being” (Waddington, 1942). 
To date a more narrow definition has become more widely accepted among molecular biologists, where 
epigenetics refers to mitotically and/or meiotically heritable changes in gene function that cannot be 
explained by changes in the DNA sequence. Of note, there is still considerable disagreement about what 
falls under this definition. Strictly, to be epigenetic, a phenomenon has to be inherited through rounds of 
10 
 
cell division without relying on the initial trigger (Ptashne, 2007). Due to the inherent difficulty to 
distinguish between sequence-independent self-propagation of epigenetic states and a re-establishment 
after cell division mediated by sequence-dependent recruitment of enzymatic activities, most chromatin 
modifications are termed epigenetic without the knowledge of the molecular mechanisms that mediate 
propagation (Bird, 2007). 
Many examples of mitotic heritability of epigenetic information have been documented where epigenetic 
marks are passed on to daughter cells to “remember” active or repressive transcriptional states. Recent 
years have even yielded the first clues about the molecular mechanism involved in propagation of certain 
epigenetic modifications (Margueron et al., 2009). 
Much less is known about meiotic or essentially transgenerational heritability of epigenetic information. A 
certain epigenetic state is inherited by the embryo from the maternal oocyte and the paternal 
spermatozoon which then after fertilization is in part reset to suit the needs of embryonic development. 
This change of epigenetic marks correlates with the establishment of totipotency in the early embryo and 
is essential for allowing new gene expression programs to be established that will drive cellular 
differentiation. However, evidence mostly based on DNA methylation studies, that epigenetic information 
is not completely erased and can be inherited from parent to offspring comes from several observations 
(Ashe and Whitelaw, 2007; Blewitt et al., 2004; Chandler and Stam, 2004; Chong and Whitelaw, 2004). 
One of the best understood examples of trans-generational inheritance of epigenetic information is the 
case of genomic imprinting. Genomic imprinting is a phenomenon in mammals where a gene is 
expressed only from one allele, either coming from the mother of from the father (Reik et al., 1987). This 
differential expression is dependent on DNA methylation at imprinting control regions (ICRs), which are 
located within or outside the differentially expressed loci. Depending on their methylation status, ICRs 
either enhance or repress expression of neigbouring genes. Sex specific DNA methylation patterns are 
established on ICRs during male and female germ cell development and are brought to the embryo by the 
gametes. There are so far around 80 genes identified that undergo genomic imprinting. Most ICRs are 
methylated at the maternal allele and only three on the paternal one (Feil, 2009). Proper DNA methylation 
of ICRs in sperm and oocyte are necessary for the successful development of the embryo. Oocytes 
lacking maternal imprints give raise to embryos that die in utero. Males with impaired DNA methylation, 
including on paternal ICRs, are infertile, thus its effect on the embryo cannot be determined (Bourc'his et 
al., 2001; Kaneda et al., 2004). Nonetheless, embryos carrying two maternal genomes (parthenogenetic 
or gynogenetic) die in utero, showing that the paternal genome is necessary for the development (Surani 
and Barton, 1983). Further, bi-maternal embryos constructed by combining a haploid genome of a fully 
grown oocyte, which contains maternal imprints, and a haploid genome of an „imprint free‟ non-growing 
oocyte in which two out of three paternally methylated ICRs were deleted (mimicking paternal repression 
of the ICR), developed into viable and fertile females (Kawahara et al., 2007). These results indicate that 
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correct maternal imprints and at least two out of three correct paternal imprints are crucial for normal 
development. 
Trans-generational epigenetic inheritance has also been demonstrated using the agouti viable yellow 
(A
vy
) mouse model (Bultman et al., 1992; Morgan et al., 1999). The Agouti (A) locus is responsible for the 
production of yellow hair pigment. In wild type animals, the pigment is produced only during a short period 
of the hair growth resulting in a light brown (agouti) coat color (Bultman et al., 1992). In the A
vy 
line, an 
IAP retrotransposon has integrated upstream of the agouti promoter and the LTR of the IAP element took 
over the control of A
vy
 expression. The IAP element can be silenced by DNA methylation, allowing normal 
expression of agouti locus under the endogenous promoter, therefore resulting in agouti fur color or it can 
be un-methylated, resulting in a constitutively active yellow gene and therefore a yellow coat color. A
vy
 
mice display a wide range of coat colors, depending on the DNA methylation state of the IAP element 
inherited from the mother which is thought to be incompletely cleared in the embryo (Morgan et al., 1999). 
However, this modification was shown to be entirely erased from the A
vy
 locus immediately post 
fertilization (Blewitt et al., 2006). Recently, a number of epigenetic factors have been identified that 
influence the expression of A
vy 
and show trans-generational effects, supporting novel mechanisms other 
than DNA methylation to be involved in transmission across early embryonic development (Blewitt et al., 
2006; Chong et al., 2007). 
Further examples of maternal and even paternal transgenerational inheritance of epigenetic information is 
reviewed in Chong and Whitelaw, 2004 (Chong and Whitelaw, 2004). 
Taken together, concrete functional evidence for the transgenerational inheritance of epigenetic 
information is very limited and apart from imprinting, is mostly dependent on observations of transgenes 
or genes under the control of inserted retrotransposons. Moreover, majority of these phenomena are 
related to the inheritance of DNA methylation. Importantly, we and others have shown that histones along 
with post translational modifications are passed through the female (Puschendorf et al., 2008) and even 
the male germline (Brykczynska, in press.; Hammoud et al., 2009) to the embryo, thus are attractive 
candidates for transgenerational epigenetic inheritance. (Discussed later, in chapters 2.7.1.4. and 
2.7.3.1.) 
 
2.2. Epigenetics and plasticity 
 
The original view of epigenetic modification stability, even of the “most stable” modifications, such as 
histone methylation and DNA methylation has been changed over the past decades. Since the 
groundbreaking discovery of the first histone demethylase (Shi et al., 2004) numerous others have been 
identified (Agger et al., 2008). Although still the relatively most stable epigenetic modification known, DNA 
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methylation is also known to be removed at certain developmental stages and recently the elongator 
complex and enzymes involved in DNA repair processes have been proposed to be involved in this 
process (Bhutani et al., 2010; Okada et al., 2010; Popp et al., 2010). 
During mammalian development two waves of epigenetic (re-)programming are known to take place. One 
right after fertilization where some of the inherited gametic epigenetic marks are reset in order to execute 
the embryonic transcription program and the other during primordial germ cell development were even 
DNA methylation from imprints is erased followed by a sex specific re-establishment. Both of these 
epigenetic re-programming events are known to be essential for proper development (Dean et al., 2003; 
Reik et al., 2001).  
Dynamics of epigenetic marks has also been demonstrated by studies examining genome-wide changes 
of different modifications during cellular differentiation (Mikkelsen et al., 2007; Mohn et al., 2008). The 
current view is that epigenetic mechanisms can confer robustness to steady state gene expression and 
thereby stabilize cell identity; however, upon external stimuli that induce differentiation, they can impact 
on changes in gene expression patterns and thereby direct further developmental potential.  
 
2.3. Chromatin 
 
Chromatin is the basic organizational form of DNA in the eukaryotic nucleus. The repeat unit of chromatin 
is the core nucleosome in which 147 base pairs of DNA are wrapped around the histone octamer that 
consists of two molecules each of the core histones H2A, H2B, H3 and H4 (Kornberg, 1974). Between 
these nucleosome cores is a variable length of DNA that is bound by the linker histone H1. The 
interaction between histone H1 molecules helps mediating the assembly of the nucleosomal array into a 
chromatin fiber, which then is further folded into a higher order structure. Eukaryotic genomes are 
ubiquitously packaged into chromatin; however, cells need to spatially and temporally regulate specific 
loci independently of bulk chromatin (O'Malley et al., 1977; Weisbrod, 1982). In order to achieve the high 
level of control required to co-ordinate nuclear processes such as DNA replication, repair and 
transcription, cells have developed a variety of means to locally and specifically modulate chromatin 
structure defining accessibility of transcription factors and RNA polymerase to promoter elements (Li et 
al., 2007). While nucleosomes have long been viewed as stable entities, today considerable evidence 
exists supporting their dynamic nature, capable of being altered in their composition and structure. This 
can involve the incorporation of histone variants, covalent modification of histones and non-covalent 
remodeling by ATP-dependent remodeling enzymes.  
Whilst histones are remarkably conserved throughout evolution, several variant forms have been 
identified that are characterized by specific expression and localization patterns, allowing specialized 
13 
 
regulation of chromatin dynamics at certain loci compared to the bulk of chromatin that is occupied by 
canonical histones (Talbert and Henikoff, 2010). 
Since they were discovered in the mid 1960‟s we know of over 60 residues on histones that are subject to 
post-translational modifications (PTMs), including acetylation and methylation of lysines (Lys) and 
arginines (Arg), phosphorylation of serines (Ser) and threonines (Thr), ubiquitination and sumoylation of 
lysines, as well as ribosylation (Kouzarides, 2007). Some modifications have been shown to be correlated 
with gene silencing; others seem to be correlated with gene expression. 
At first, these chromatin modifications and the overall chromatin structure were thought to be stable and 
simply providing a structural scaffold. However, the discoveries that the yeast transcriptional co-activator 
Gcn5 bears histone acetylation activity (Brownell et al., 1996), while the co-repressor Rpd3 mediates 
histone deacetlyation (Taunton et al., 1996) for the first time directly linked transcriptional regulation to 
PTMs. A few years later Suv39h, a previously identified transcriptional regulator and suppressor of 
variegation in Drosophila (Tschiersch et al., 1994) and its yeast homolog Clr4 were shown to specifically 
methylate lysine 9 at histone H3 (H3K9) (Rea et al., 2000). This subsequently led to a change of 
paradigms towards a regulatory role of chromatin and PTMs of histones in DNA templated processes. 
Ultimately, the discovery of histone demethylases indicated that PTMs are much more dynamic than 
previously anticipated (Shi et al., 2004). 
The fact that most of the early PTMs found were concentrated within the tail extensions that protrude from 
the nucleosome core lead to two main theories regarding the regulatory mechanism of histone 
modifications. One theory suggests that they may affect electrostatic interactions between the histone 
tails and DNA to “loosen” chromatin structure. Later it was proposed that combinations of these 
modifications may create binding epitopes which recruit other proteins, leading to the “histone code” 
hypothesis
 
(Strahl and Allis, 2000).  
Although many of these PTMs are considered to be epigenetic and are thought to be inherited during 
mitotic cell divisions, so far the propagation mechanisms are unknown for most of these modifications. 
ATP-dependent chromatin remodeling enzymes convey alterations to DNA accessibility by mediating  a 
variety of reactions such as sliding nucleosomes along DNA (Whitehouse et al., 1999), disrupting histone-
DNA contacts to the extent of destabilizing the H2A/H2B dimer (Bruno et al., 2003; Kassabov et al., 
2003), introducing a histone variant into nucleosomes (Mizuguchi et al., 2004) and generating negative 
superhelical torsion in DNA and chromatin (Havas et al., 2000). 
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2.4. Histone variants 
 
In most organisms, there are multiple copies of the histone genes encoding for the major histone proteins. 
These genes are highly similar in sequence, code for the bulk of the cellular histones, are expressed in a 
tightly regulated manner during the cell cycle with the histones deposited onto DNA in a process that is 
strictly coupled to DNA replication.  
While histones are among the slowest evolving proteins known, there are non-allelic variants of the major 
histones that can have significant differences in the primary sequence. The similarity between the major 
histone subtypes and the variants on amino acid level can range from almost no differences to extremely 
divergent changes. Some variants have distinct biophysical characteristics that are thought to alter the 
properties of nucleosomes, while others localize to specific regions of the genome. The variants are 
usually present as single-copy genes (also called orphan genes) that are not restricted in their expression 
to the S-phase but are expressed throughout the cell cycle and can also be incorporated outside of S-
phase. Unlike the major subtypes, variant genes contain introns and the transcripts are often 
polyadenylated. These features are thought to be important in the post-transcriptional regulation of these 
proteins (Old and Woodland, 1984). Some variants exchange with the pre-existing histones during 
development and differentiation, and are therefore referred to as replacement histones (Bosch and Suau, 
1995; Grove and Zweidler, 1984; Wunsch et al., 1991). These observations have led to the suggestion 
that the histone variants have specialized functions regulating chromatin dynamics. Interestingly, this 
diversification of histone function is restricted to H2A and H3, with H2B and H4 being mostly invariant. 
Assembly factors and functions are not identified yet for all variants. 
 
2.4.1. H2A replacements 
 
Among core histones, H2A has the largest number of variants identified, among them H2AX, H2AZ, 
macroH2A and H2A-Bbd (H2A-bar-body-deficient) (Ausio and Abbott, 2002; Fernandez-Capetillo et al., 
2004; Redon et al., 2002). 
The H2A.Z variant has been linked to both transcriptional repression and activation, localizing to silent or 
active chromatin in various organisms (Draker and Cheung, 2009). First in yeast (Rusche et al., 2003) 
and later in mammalian cells (Rangasamy et al., 2004) H2AZ was also postulated to participate in the 
establishment or maintenance of the boundary between heterochromatin and euchromatin. 
H2AX is a histone variant in mammals, while in other species, like in budding yeast it is the main histone 
H2A. In both cases H2AX has a unique extended C-terminus compared to the canonical H2A. The 
Ser139 in this C-terminal region is phosphorylated in response to DNA double-stranded breaks (DSBs), 
implicating the involvement of this histone in the early steps of response to DNA damage (Rogakou et al., 
1998). 
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MacroH2A and H2A-Bbd are vertebrate specific variants, MacroH2A localizing predominantly to the 
inactive X-chromosome (Costanzi and Pehrson, 1998), while H2A-Bbd localizes to the active X-
chromosome and autosomes (Chadwick and Willard, 2001). 
 
2.4.2. H3 variants 
.  
Most studies concerning histone variants have focused on variants of H3. In mammals, there are two 
canonical forms of H3: H3.1 and H3.2 as well as three other H3 variants: H3.3, a testis specific H3 variant 
(H3t) and centromeric H3 variants (CENP-A).  
The H3 variant CenH3 (in mouse/human termed CENP-A, in Drosophila Cid) exclusively localizes to 
centromeres and is essential for proper centromer functioning and chromosome segregation (Black and 
Bassett, 2008). CenH3s form a highly divergent family of histone H3 variants that are characterized by an 
H3-like histone fold domain and a variable N-terminus tail. (Dalal et al., 2007). 
In the mouse 13 canonical histone genes are present in the genome, encoding the two major H3 histones 
H3.1 and H3.2, which only differ in one amino acid located at position 96: Cys in H3.1 and Ser in H3.2. 
Cysteins are rarely used amino acids in nature and can form disulfide bonds under oxidative conditions 
which are known to be involved in dimerization of proteins. All H3 proteins contain a conserved Cys at 
position 110 (Luger et al., 1997), but the additional Cys 96 in H3.1 was speculated to confer further 
chromatin compaction and gene silencing roles for this histone version through forming disulfide bridges 
with other H3s or proteins containing Cys. Deposition of H3.1 and H3.2 was also suggested to involve 
different proteins, which could lead to specific targeting of these variants to different genomic loci (Hake 
and Allis, 2006). Another notion that H3.1 and H3.2 could have different functions was shown by mass-
spectrometry analysis of histone H3s which revealed that the PTMs occurring on the two canonical H3s 
are different: H3.2 is enriched in repressive marks (H3K27me2/3) while H3.1 contains PTMs of active 
(H3K14 acetylation) and inactive chromatin (H3K9me2) (Garcia et al., 2008; Hake et al., 2006; McKittrick 
et al., 2004). The functional importance however for having two different replicative histones is unclear. 
The H3.3 variant is present in all eukaryotes and is among the most conserved proteins (Malik and 
Henikoff, 2003). Five or four amino acids are different between H3.3 and H3.1 or H3.2, respectively 
(Graves et al., 1985). The differences in amino acid sequence amongst H3.1/2 and H3.3, albeit 
surprisingly small, lead to different pathways of incorporation into the chromatin (Ahmad and Henikoff, 
2002a; Ahmad and Henikoff, 2002b). In somatic cells, it is well established that the canonical variants 
H3.1 and H3.2 are synthesized only during S-phase and deposited into the chromatin through a 
Replication Coupled (RC) pathway (Polo and Almouzni, 2006).  
In mammals two H3.3 genes (H3.3A and H3.3B) encode for the same protein, but the transcripts only 
differ in their untranslated regions (Frank et al., 2003). The fact that expression of H3.3 genes is not 
linked to S-phase (Replication Independent (RI)) has been known for a long time (Wu et al., 1982). This 
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observation led to the so-called neutral-replacement idea, in which the function of H3.3 is to replace H3 
whenever nucleosome assembly takes place independently of S phase.  
As a generalal rule, H3 is deposited as H3-H4 tetramers (Akey and Luger, 2003). The activities 
responsible for loading H3.1 or H3.3 have been characterized (Tagami et al., 2004); the complexes 
responsible for H3.1 or H3.3 deposition include several common subunits (eg ASF-1), as well as unique 
histone chaperones. The canonical H3.1 is deposited by a complex containing ASF-1 and the entire CAF-
1 complex, whereas the H3.3 deposition complex contains ASF-1, the smallest subunit of the CAF-1 
complex (p48) and a specific histone chaperone HIRA (Ray-Gallet et al., 2002; Tagami et al., 2004). 
CAF-1 can interact with PCNA and promote subsequent deposition of H3.1-H4 heterodimers to sites of 
DNA synthesis, allowing for the assembly of new nucleosomes at the replication fork (Shibahara and 
Stillman, 1999). Amino acids 87-90 in H3.3 have been shown to be important for the RI deposition into 
chromatin, suggesting that this region serves as a chaperone recognition site where HIRA binds H3.3 and 
CAF-1 to H3.1. It is not known whether H3.2 binds to a different chaperone and whether the Ser at 
position 96 plays a role in this (Ahmad and Henikoff, 2002b; Tagami et al., 2004). 
An example supporting the neutral-replacement model of H3.3 comes from differentiated cells which have 
exited the cell cycle. In the absence of S-phase and RC histone gene expression, differentiating cells 
have abundant H3.3 transcripts, while canonical transcripts are not detected (Krimer et al., 1993; 
Pantazis and Bonner, 1984). Another example in line with the neutral-replacement model describes H3.3 
deposition during DNA repair at sites of heterochromatin in human cells after treatment with HDAC 
inhibitors (Zhang et al., 2007).  
The observation that H3.3 deposition is not homogenous throughout the genome, but is enriched at highly 
transcribed regions, has led to the model of H3.3 being a marker of active chromatin. As the RNAP 
complex passes through a transcribed gene, it displaces nucleosomes, creating a situation were 
nucleosomes need to be re-deposited in a RI manner (Li et al., 2007; Schwabish and Struhl, 2004). 
Therefore H3.3 is deposited in a transcription coupled manner (TC). For example incorporation of H3.3 at 
large transcription units on the Drosophila polytene chromosomes has been described, linking H3.3 to 
transcriptional elongation (Schwartz and Ahmad, 2005). Studies of high resolution mapping of H3.3 
distribution by ChIP analysis have also found this variant enriched at sites of active transcription (Mito et 
al., 2005; Wirbelauer et al., 2005). Finally, others found H3.3 enrichment at regulatory elements of active, 
but also inactive genes (Jin and Felsenfeld, 2006; Mito et al., 2005; Nakayama et al., 2007). These last 
two observations link H3.3 deposition yet to another phenomenon: H3.3 marking sites of rapid histone 
turnover at regulatory elements. Whether H3.3 would have any role in facilitating accessibility of 
regulatory factors to bind to their elements or this is a mere consequence of high nucleosome turnover at 
these regions is not clear. On a side note, the TC and chromatin remodeling associated roles for H3.3 
discussed so far do not interfere per se with the neutral-replacement model, as these processes are not 
limited to the S-phase of the cell cycle. 
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Correlating with its appearance at transcriptionally active site, mass spectrometry studies showed that 
H3.3 harbors PTMs associated with active chromatin (hyperacetylation and dimethylation of K36 and 
K79) (Hake et al., 2006; McKittrick et al., 2004). Remarkably, a study by Loyola et al. showed that H3.3 
histones already carry a distinct set of PTMs before they are deposited into the nucleosome, impacting its 
final PTM composition in chromatin (Loyola et al., 2006).  
A study in Xenopus has put forward the potential role of H3.3 in epigenetic memory. By transferring a 
somatic cell nucleus into a Xenopus oocyte, authors demonstrated the inheritance of an active chromatin 
state of a gene, whose activity correlates with the presence of H3.3 harboring H3K4 methylation. This 
epigenetic memory persisted throughout numerous rounds of cell division in the absence of transcription, 
supporting the model that H3.3 is transmitted through cell generations, rather than always being re-
established by re-occurring transcription (Ng and Gurdon, 2008). Unfortunately, this study did not address 
whether this memory was simply due to K4 methylation on any H3 or K4 methylation specifically on H3.3, 
although the importance of K4 methylation specifically of H3.3 has since been demonstrated in a different 
system  (see below) (Hodl and Basler, 2009). 
Besides its neutral-replacement and epigenetic roles discussed above, several recent studies pointed out 
that the function of H3.3 in RI chromatin remodeling processes is unique to the germline (Ooi and 
Henikoff, 2007). For example, an interesting study highlighted the importance of H3.3 in Drosophila 
germline (Hodl and Basler, 2009). Deletion of the two fly H3.3 genes did not affect somatic tissues of the 
animal, but caused sterility. The major fraction of active H3K4 methylation is harbored by the H3.3 
variant. Surprisingly, in contrast to the germ line, somatic cells did not seem to mind loss of H3.3 or loss 
of bulk K4 methylation levels. Fertility however, could not be rescued by H3.2, even when engineered to 
be expressed outside of S-phase, or by an H3.3 mutant containing an Ala instead of a Lys at position 4. 
These results imply that K4 methylation specifically on H3.3 is essential for proper germ line function in 
the fly.  
The laboratory of Peter De Boer with collaborative help from us has demonstrated a role for H3.3 during 
Meiotic Sex Chromosome Inactivation taking place in the male germ line. This will be discussed in the 
Results section (van der Heijden et al., 2007).  
The function of H3.3 in male pronucleus formation in the zygote will be mentioned later in the context of 
early embryonic development. 
Recently, a novel function for H3.3 was identified at telomeres of mouse ES cells. Localization of H3.3 at 
interphase telomeres and enrichment of Ser31-phosphorylated H3.3 (H3.3S31P) at metaphase telomeres 
was shown in pluripotent mouse ES cells. Upon differentiation, telomeric H3.3S31P signal decreased, 
accompanied by an increase of heterochromatic repressive marks and decreased micrococcal nuclease 
sensitivity at the telomeres. RNAi-depletion of H3.3 induced a telomere-dysfunction phenotype, providing 
evidence for a role of H3.3 in the regulation of telomere chromatin integrity in ES cells (Wong et al., 
2009). Surprisingly, two studies have recently shown that this H3.3 localization at telomeres is HIRA 
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independent, but is instead dependent on the SWI2/SNF2 chromatin remodeling protein ARTX (alpha 
thalassemia / mental retardation syndrome X-linked) (Goldberg et al., 2010).  
. 
 
2.5. Epigenetic modifications 
 
Epigenetic modifications serve as an extension of the genetic information encoded by the genome. These 
modifications mark genomic regions and act as heritable and stable instructions for defining chromatin 
organization and structure that dictate transcriptional states. In mammals, DNA methylation and the 
modification of histones account for the major epigenetic alterations (Berger, 2002). 
 
      2.5.1.     DNA methylation 
 
Methylation is the only physiological post-synthetic modification of DNA able to modify DNA function and 
consists in the introduction of methyl groups on cytosines mainly at the CpG dinucleotides of the 
mammalian genome.  DNA methyltransferases (Dnmts) like Dnmt1 and Dnmt3a/Dnmt3b are differentially 
responsible for establishing and maintaining methyl-CpG patterns. This epigenetic modification introduces 
a fifth base into DNA, the 5-methyl-cytosine (5mC). It is well-known that 5mCs are distributed in a non-
random fashion in genomic DNA. The distribution is characterized by the presence of methylated 
cytosines on the bulk of DNA (98% of the vertebrate genome) while the unmethylated ones are mainly 
located within particular regions termed CpG islands (1-2% of the genome) (Suzuki and Bird, 2008). CpG 
islands are found in the promoter regions of genes and the methylation of these CpG islands correlates 
with silencing of the gene (Bird, 2002). While methylation may directly interfere with the binding of some 
transcription factors, indirect repression by proteins that specifically recognize methylated CpGs is 
currently believed to be responsible for the majority of methylation dependent silencing. A family of 
proteins which all share a common methyl-CpG-binding domain have been identified as capable of 
reading the methylation pattern.  
DNA can be demethylated passively via blocking maintenance during DNA replication and thereby 
avoiding methylation of the newly synthesized DNA strand. Alternatively it has been proposed that DNA 
methylation can be removed actively via specific enzymes.  While in plants, active demethylation occurs 
widely and is carried out by 5meC glycosylases such as Demeter and Demeter-like proteins (Gehring et 
al., 2009a; Gehring et al., 2009b; Hsieh et al., 2009) existence active demethylation in mammals is highly 
controversial. There are two stages during mammalian development where the occurrence of DNA 
demethylation is highly suspected: first in the pre-implantation embryo and later during primordial germ 
cell (PGC) development (Reik, 2007). Very recently a number of studies identified factors involved in DNA 
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demethylation events. A study by Popp et al. claims to have identified the cytidine deaminases AID as the 
enzyme responsible for DNA demethylation during PGC development (Popp et al., 2010). AID-dependent 
DNA de-methylation has also been demonstrated in the context of somatic cell nucleus re-programming 
to a pluripotent state (Bhutani et al., 2010). Another group showed involvement of the elongator complex 
in active paternal genome de-methylation in the zygote (Okada et al., 2010). DNA demethylation in the 
context of early embryonic development will be discussed in more detail later.  
 
2.5.2. Histone acetylation 
 
Lysines are the major source of the net positive charge of histone octamers and therefore crucial for 
binding the negatively charged phosphate backbone of DNA.  For transcription, replication or DNA repair 
it is important that histone-DNA interactions can be modified in order to facilitate passage of polymerases. 
All four core histones bear lysine residues which are subject to acetylation and deacetylation by specific 
histone acetyltransferases (HAT) and deacetylases (HDAC) (Kouzarides, 2007).  Generally, acetylated 
lysines on histones H2B, H3 and H4 are highly correlated with actively transcribed regions (Pokholok et 
al., 2005; Schubeler et al., 2004; Wang et al., 2008). This is thought to be due to neutralization of the 
positive charge of lysines upon acetylation, which lowers the electrostatic interactions with the negatively 
charged phosphate backbone of DNA and consequently weakens the DNA-histone interaction. Indeed, 
acetylation increases DNA accessibility, destabilizes nucleosomes and leads to an increase of non-
histone protein binding to DNA in vitro (Lee et al., 1993; Vettese-Dadey et al., 1996; Wolffe and Hayes, 
1999). Many proteins however, in chromatin-associated complexes contain highly conserved 
Bromodomains which specifically bind to acetylated lysines, indicating that there might be more specific 
regulatory potential to acetylation than previously anticipated (Taverna et al., 2007).  
 
 
2.5.3. Histone methylation 
 
There are two types of histone methylation, targeting either arginine (R) or lysine (K) residues. Adding to the 
complexity is the fact that each K residue can accept one, two or even three methyl groups (abbreviated 
me1, me2, and me3), and an R can be either mono- or di-methylated (Sims et al., 2003). It is possible that 
methylation induces alterations in chromatin structure, either condensing or relaxing it. However, a methyl 
group is relatively small and in contrast to acetylation, does not neutralize the charge of a K or R residue, so 
it is unlikely that methylation per se will significantly alter chromatin structure. It is more likely that it creates 
binding sites for regulatory proteins. Unlike DNA methylation, histone methylation can represent active as 
well as repressive states depending on the modified residue (Barski et al., 2007; Pokholok et al., 2005; 
Saunders et al., 2006; Schubeler et al., 2004). 
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Arginine methylation is performed by protein arginine methyltransferases (PRMTs) and is antagonized by 
PADI4 (Klose et al., 2006a; Zhang and Reinberg, 2001). Lysine methylation is carried out by specific lysine 
methyltransferases (KMTases or HMTases), that all but one (Dot1) contain the catalytically active “SET” 
domain. This domain is named after the three evolutionary conserved founding members Suv39h, 
Enhancer of Zeste and Trithorax. All three play major roles in chromatin formation and gene expression 
among the species. 
Numerous proteins have been discovered that bind to different methylated lysine marks, thereby reading 
the modification pattern and translating it into a biological meaning. Several protein domains have been 
found to specifically recognize methylated lysines, such as Tudor domains, chromodomains, PHD-finger 
domains and WD40 domains. Each domain has characteristic affinities for different lysines and 
methylation states which further depend on other domains of the respective protein and its interaction 
partners (Margueron et al., 2009; Martin and Zhang, 2005; Taverna et al., 2007). 
For a long time, histone methylation – unlike all other histone modifications – was considered a 
permanent mark. The discovery of enzymes capable of demethylating histones however has proven 
histone methylation a dynamic modification as well (Bannister and Kouzarides, 2005). Lysine methylation 
can be removed by two distinct classes of histone demethylases (HDMs): the LSD1 enzyme and the JmjC 
protein family (Klose et al., 2006a). 
 
Chromatin immunoprecipitation experiments have revealed that active genes are methylated at lysine 4 of 
histone H3 (H3K4), H3K36 and H3K79 (Barski et al., 2007; Pokholok et al., 2005; Saunders et al., 2006; 
Schubeler et al., 2004). These modifications are thus thought to have a role in transcription.  This is 
supported by data from yeast indicating that Set1 and Set2, which methylate H3K4 and H3K36, directly 
interact with factors bound to the RNA polymerase II (RNAPII) complex (Krogan et al., 2003a; Krogan et 
al., 2003b). Genetic evidence also predicts a recruitment of Dot1 (a H3K79 HMTase) to chromatin via 
elongating RNAPII (van Leeuwen et al., 2002). H3K4me peaks around the transcription start site and is 
gradually diminished further 3‟. H3K36me and H3K79me display a broader distribution within the gene 
body, starting just downstream of the H3K4me peak (Bell et al., 2007; Wirbelauer et al., 2005). Consistent 
with a role for H3K36me in transcription, data from yeast show that H3K36me prevents cryptic initiation 
via recruiting a histone deacetlyase to the body of genes, which presumably leads to a less accessible 
chromatin structure (Carrozza et al., 2005). H3K4 methylation has been implicated in transcriptional 
activation pathways since many chromatin remodeling and co-activator complexes bear a module which 
specifically recognizes H3K4me2/3. For example a PHD-domain in the NURF chromatin remodeling 
complex specifically recognizes H3K4me3 and might facilitate transcriptional activation via opening the 
chromatin structure around H3K4me2/3 modified promoters (Wysocka et al., 2006). 
More recent data from mammalian systems indicates that in contrast to invertebrates H3K4me2/3 are not 
exclusively marking actively transcribed regions (Bernstein et al., 2006; Guenther et al., 2007; Mikkelsen 
et al., 2007; Roh et al., 2006; Weber et al., 2007). Interestingly, these loci are CpG-rich sequences and 
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many bear low but detectable levels of RNAPII and acetylated histone H3 (Guenther et al., 2007; Roh et 
al., 2006). Moreover, virtually all CpG-rich promoters reside in chromatin carrying H3K4 di-/tri-methylation 
independent of transcriptional activity. This is in sharp contrast to CpG-poor promoters. These promoters 
are only H3K4 methylated when transcribed, which is reminiscent of the situation in invertebrates such as 
fly and yeast (Pokholok et al., 2005; Schubeler et al., 2004). 
 
Inactive loci display a different set of methylation marks mainly consisting of methylation of H3K9, H4K20, 
and H3K27. These will be discussed in the next part on the basis of which silencing pathway they 
participate in. 
 
2.6. Silencing mechanisms 
 
  2.6.1.    Constitutive heterochromatin formation  
 
Constitutive heterochromatin has been historically defined as chromosomal regions that remain 
condensed throughout the cell cycle. The proper formation of heterochromatin is very important for gene 
regulation as well as maintaining genome stability. A classical example of constitutive heterochromatin is 
formed on satellite repeats around the centromeres, termed pericentric heterochromatin (PCH).  
RNA interference (RNAi) and histone methylation have been shown to play central roles in constitutive 
heterochromatin formation in fission yeast, where long double stranded RNA molecules, transcribed from 
underlying tandem satellite repeats, are thought to be processed by the RNAi machinery into small 
interfering RNAs that subsequently target other HTMases to repeats (Grewal and Elgin, 2007).  
Although mammals do not possess the RNA-dependent RNA polymerase activity to produce dsRNA, 
evidence is accumulating that an RNAi(-like) pathway is functioning at mammalian heterochromatin too. 
(Chen et al., 2008; Fukagawa et al., 2004; Kanellopoulou et al., 2005) 
Constitutive heterochromatin is enriched in tri-methylated H3K9 (H3K9me3), which in mammals is mediated 
by the Suv39h1 and Suv39h2 enzymes (Peters et al., 2001). H3K9me3 creates a binding site for the 
heterochromatin protein 1 (HP1) (Bannister et al., 2001; Lachner et al., 2001). Although H3K9me3 is 
required for heterochromatin targeting of HP1 (Lachner et al., 2001), it does not seem to be sufficient. In 
mammalian cells, HP1 localization to heterochromatic foci requires a structural RNA of unknown identity 
(Maison and Almouzni, 2004) In mammals, HP1 interacts with the DNA methyl transferases Dnmt1 and 
Dnmt3a/b (Fuks et al., 2003), directing DNA methylation to satellite repeats (Lehnertz et al., 2003). 
Moreover, additional repressive histone methylation at H4K20 is mediated by the recruitment of the Suv4-
20h HMTase (Schotta et al., 2004). Taken together, mammalian heterochromatin is marked by a number of 
characteristic chromatin modifications establishing a transcriptionally repressed state. Loss of Suv39h-
mediated chromatin modification leads to an increase in satellite transcription from PCH (Lehnertz et al., 
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2003). Importantly, in Suv39h-deficient mice chromosome segregation is perturbed, indicating that proper 
marking of PCH is essential to ensure correct chromosome segregation and genome stability (Peters et al., 
2001). 
 
2.6.2. Non-coding RNA and domain wide gene silencing 
 
Perhaps the best studied phenomenon of non-coding RNA (ncRNA) mediated silencing is X-chromosome 
inactivation in female mammals required for dosage compensation. X-chromosome inactivation begins 
with the synthesis of the Xist (X-inactivation specific transcript) non-coding RNA from the XIC (X-
inactivation center) locus. The expression and spreading of Xist RNA along the X chromosome triggers a 
cascade of events leading to the inactivated state and ultimately to the formation of facultative 
heterochromatin.  
Facultative heterochromatin, in contrast to constitutive heterochromatin does not stay condensed 
throughout the cell cycle and development, but can change its chromatin state in response to 
developmental signals. H3K4 hypomethylation, H3K9me2, H3K27me3 (set by PRC2 and then bound by 
PRC1, see later) (de Napoles et al., 2004), H4K20me1 hypermethylation, macroH2A histone variant 
incorporation and DNA methylation are characteristic marks of the inactivated X-chromosome (Okamoto 
et al., 2004; Peters and Schubeler, 2005). 
Another well known example of silencing involving ncRNAs - along with DNA methylation and histone 
modifications - is genomic imprinting. Most mammalian imprinted genes are found in clusters that also 
contain large imprinted ncRNAs. In most cases, expression of the ncRNA correlates with repression of 
the protein-coding genes in the opposite strand (in cis). So far, two of the three tested imprinted long 
ncRNAs (Airn in the Igf2r locus and Kcnqot1 in the Kcnq1 locus) have been shown to be required for the 
imprinted expression of the whole cluster (Koerner et al., 2009).  
 
2.6.3. H3K9 mediated gene silencing  
 
One example of gene silencing is conferred by the methylation of H3K9. Several distinct SET domain 
containing HMTases are known to methylate mono-, di-, and tri-methyl H3K9: G9a and Glp1 confer mono- 
and di-methylation, Eset mediates di- and tri-methylation while the Suv39h HMTs direct tri-methylation. It is 
well known that the H3K9me2 and me3 marks serve as binding sites for HP1. Binding of HP1 is however 
alleviated during mitosis by phosphorylation at the adjacent Ser10. HP1 in turn recruits Dnmts, which 
methylate DNA and drive the formation of heterochromatin, either at genes or repetitive sequences (Fischle 
et al., 2003; Fuks, 2005; Snowden et al., 2002). 
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2.6.4. Polycomb-mediated silencing 
 
At the core of development lies the specialization of cells that make up an organism. Upon specialization 
different cells acquire different programs of gene expression. During the growth of an organism, these 
specialized states need to be maintained and the particular configurations of gene expression transmitted to 
daughter cells in the cell lineage. This requirement, referred to as „transcriptional memory‟ or „cellular 
memory‟ is fulfilled in part by the antagonistic functions of Polycomb group (PcG) and Trithorax group 
(TrxG) proteins (Dellino et al., 2004; Klymenko and Muller, 2004; Ringrose and Paro, 2001). Both groups of 
proteins are involved in maintaining the spatial patterns of homeotic box (Hox) gene expression, which are 
established early in embryonic development (Deschamps et al., 1999). In general, PcG proteins are 
transcriptional repressors that maintain the repressed state and TrxG proteins are transcriptional activators 
that counteract the repressed state. PcG and TrxG proteins function in large multiprotein complexes which 
harbor different intrinsic histone methyltransferase or ubiquitin ligase activities, which suggests that PcG 
and TrxG proteins participate in cellular memory through methylation or ubiquitination of core histones 
(Ringrose and Paro, 2004). 
 
2.6.4.1.  Polycomb repressive complex 1 and 2 
 
PcG proteins can be separated biochemically and functionally into at least two major multiprotein 
complexes termed Polycomb repressive complexes (PRCs). In Drosophila Polycomb Repressive Complex 
1 (PRC1) is composed of the chromodomain containing protein Polycomb (Pc), Polyhomeotic (Ph), 
Posterior Sex Combs (Psc) and the dRing protein which contains a Ring finger-motif, a characteristic of 
ubiquitin ligases. In mouse, depending on cell type, several redundant homologues exist for each core 
component: Pc- Cbx2, 4, 6, 7, 8; Ph- Rae28, Mph2; Psc- Bmi1, Mel18, Mblr and dRing- Rnf1 (Ring1a), Rnf2 
(Ring1b). The Polycomb repressive complex 2 (PRC2) is comprised of the SET domain containing HMT 
Enhancer-of-zeste (E(Z)) (mammalian homologs Ezh2 and Ezh1), different isoforms of the WD-repeat 
protein Extra sex combs (Esc) (mammalian Eed (embryonic ectoderm development)), the Zn-finger protein 
suppressor-of-zeste-12 (Su(Z)12) (mammalian Suz12) and another WD-repeat protein Nurf55 (mammalian 
RpAp48/46) (Lund and van Lohuizen, 2004) (Figure 1).  
The signature of the PRC2 complex is tri-methylation of lysine 27 on histone H3 (H3K27me3) (Figure 1), 
carried out by the cathalytic subunit E(Z). In Drosophila, loss of E(Z) or ESC results in loss of mono-, di- and 
trimethylation of H3K27, suggesting that a complex containing these subunits are the only source for K27 
HMTase activity. In mammals, loss of E(Z) homolog Ezh2 reduces only di- and tri-methylation, indicating a 
different complex responsible for mono-methylation. The mono-methylating complex was shown to contain 
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the other mammalian E(Z) homolog Ezh1 (Shen et al., 2008) and it still requires Eed, as deletion of this 
subunit eliminates all three layers of K27 methylation (Montgomery et al., 2005).  
 
 
 
Figure 1. Main mammalian Polycomb complexes and a model for Polycomb-mediated targeting and 
silencing. 
 
Recent studies have identified distinct functions for the PRC2 complex containing Ezh1 in contrast to PRC2 
with Ezh2 (Margueron et al., 2008). While Ezh2 is highly expressed in during embryonic development and 
in proliferating cells, Ezh1 is mostly present in non-proliferating adult tissues (Bracken et al., 2003). Ezh2 
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containing PRC2 (Ezh2-PRC2) was shown to have robust H3K27me3 HMTase activity, while the HMTase 
activity of Ezh1-PRC2 was weak. Additionally, the study by Margueron et al. claims that the Ezh1-PRC2 
complex can compact polynucleosomes, unlike Ezh2-PRC2. Ezh1-PRC2 was shown to be able to repress 
transcription from chromatinized templates in vitro, while Ezh2-PRC2 could not (Margueron et al., 2008). 
They propose that Ezh2-PRC2 mediates repression through a catalytic mechanism, whereas Ezh1-PRC2 
functions in a non-catalytic fashion. However, it is more conceivable that Ezh1-PRC2, albeit with a weaker 
HMTase activity, functions together with Ezh2-PRC2 in tri-methylating H3K27 at target genes (Shen et al., 
2008). Ezh1 occupies a subset of Ezh2 target genes in ES cells, and residual H3K27me3 at these genes in 
Ezh2-/- cells only disappears upon knockdown of Ezh1 (Shen et al., 2008).  
The composition of the PRC2 complex can be further complicated by the presence of different Eed 
isoforms. Alternative transcription start sites can yield 4 different isoforms of Eed. The PRC2 complex which 
contains the two shortest isoforms of Eed methylates H3K27, while the complex containing the longest Eed 
isoform confers histone methylation at H1K26 (Kuzmichev et al., 2004). The potential role of H1K26 
methylation in Polycomb-mediated silencing is not known. 
An additional variation of PRC2 is achieved by binding of the PcG protein Polycomb-like (PCL in 
Drosophila, PHF1 in mammals), which alters the properties of PRC2. Intriguingly, PRC2-PCL is found 
specifically at PcG target genes (Tie et al., 2003) and in the absence of PLC function H3K27me3, but not 
H3K27me2 is lost (Nekrasov et al., 2007; Sarma et al., 2008). This may be a very important component in 
targeting PRC2-mediated silencing, as H3K27me2 is a wide-spread mark, not correlating with the more 
restricted domains of H3K27me3 at silenced Polycomb target genes. 
Numerous studies have accumulated genetic and biochemical evidence that PRC1 proteins are at the heart 
of Polycomb-mediated silencing (Francis and Kingston, 2001; Levine et al., 2004; Muller and Verrijzer, 
2009; Schuettengruber et al., 2007; Schwartz and Pirrotta, 2007). PRC1-mediated ubiquitination of histone 
H2A at lysine 119 (H2AK119Ub) (Figure 1) is one of the most abundant ubiquitinated nuclear proteins and 
is required for Polycomb-mediated silencing (Jason et al., 2002). The RING finger containing protein Rnf2 
(Ring1b) was identified as the main catalytic subunit of PRC1, whose enzymatic activity was greatly 
enhanced by Bmi1 (Buchwald et al., 2006; Cao et al., 2005; Wang et al., 2004a). Rnf2 does seem to be the 
major H2A ubiquitin ligase in vivo, as loss of Rnf2 dramatically decreases global H2AK119Ub levels and de-
represses Polycomb target genes in cells (Stock et al., 2007; van der Stoop et al., 2008). However, Rnf1 
(Ring1a), a paralog of Rnf2 in mammals can substitute for Rnf2 in vitro (Buchwald et al., 2006). 
Consistently, in the absence of Rnf2, Rnf1 can still mediate H2AK119Ub at the inactive X chromosome in 
fibroblasts and during ES cell differentiation (de Napoles et al., 2004; Leeb and Wutz, 2007), arguing for 
functional redundant roles of these proteins in certain biological contexts. An additional observation 
supporting functional redundancy comes from a study of Rnf1/2 double knockout (KO) ES cells (Endoh et 
al., 2008). In Rnf1/2 double KO ES cells over twice as many genes were de-repressed then in Rnf2 single 
KO cells. The overlap between the two groups of de-repressed genes was significant, but the level of de-
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repression was always higher in Rnf1/2 double mutant cells. This suggests that Rnf1 can even compensate 
to a certain extent at genes, as full de-repression is only achieved when both proteins are lost (Endoh et al., 
2008).  
As for PRC2, there is great diversity among PRC1 complexes as well. This diversity is in part due to the 
existence of multiple paralogs of each PcG gene, creating various possible combinations of core subunits. 
Additionally, binding to the core complex are a variety of non-core Polycomb proteins, including Rybp, Mblr, 
NSPc1, Smcl2 and L(3)Mbt. 
A recent study in Drosophila identified the dRAF complex, containing dRing and Psc with an additional 
lysine demethylase Kdm2 (Lagarou et al., 2008). Interestingly, Kdm2 has H3K36me2 de-methylase activity, 
but it also stimulates the ubiquitin ligase activity of dRing and Psc. More strikingly, reconstituted complexes 
containing dRing, Psc and the two other PRC1 core subunits Pc and Ph did not increase ubiquitin ligase 
activity of dRing and Psc alone, while addition of Kdm2 instead of the original PRC1 subunits increased 
enzymatic activity. Moreover depletion of Kdm2 revealed that this component, along with dRing and Psc is 
also responsible for global H2AUb in Drosophila cells (Lagarou et al., 2008). This study therefore suggests 
that in flies the primary source for H2AUb is dRAF rather than PRC1. Whether an analogous situation exists 
in mammals, remains to be addressed, although the previously identified Rnf1 and Rnf2 containing complex 
Bcor shares similarities with the fly dRAF (Gearhart et al., 2006; Sanchez et al., 2007).   
Another model organism, Caenorhabditis elegans provides further evidence of evolutionary conservation of 
the components of PRC1 that are the most central to ubiquitination. Based on homology it is clear that 
PRC2 members are present in the worm, however PRC1 was thought to be absent, as obvious homologs 
were not identified (Bender et al., 2004). Recently however, two proteins with distant homology to Rnf2 and 
Bmi1 have been shown to catalyze H2AUb in the worm (Karakuzu et al., 2009).  
Taken together, the emerging picture is that PRC1 and PRC2 come in a variety of flavors. Thus, different 
target genes, different tissues or different developmental stages may involve differentially composed 
Polycomb complexes that confer distinct functionalities. 
 
2.6.4.2.  Targeting of Polycomb complexes 
 
An important question of the Polycomb-field is how the complexes are recruited to their target genes, as 
PcG proteins do not possess DNA sequence specific binding properties.  
In Drosophila it has been known for a long time that PcG proteins are targeted to specific regulatory 
elements called Polycomb response elements (PREs). PREs are not easily recognizable, as they are not a 
binding site for a single transcription factor, but rather a collection of different combinations of transcription 
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binding sites, defined as an “element” (Ringrose and Paro, 2007). The recruitment of PcG proteins to these 
elements is thought to be mediated by trans-acting factors that recognize PREs and recruit PcG proteins by 
direct or indirect interactions. One such factor Pho (mammalian Yy1) -in complex with Sfmbt forms the Pho-
repressive complex - has been shown to co-occupy most PREs with PRC1 and PRC2 components in 
Drosophila embryos (Klymenko et al., 2006; Kwong et al., 2008; Oktaba et al., 2008). Other DNA binding 
proteins such as Zeste, GAGA factor (GAF), Pipsqueak and Dorsal switch protein1 (DSP-1), have also 
been implicated in PcG recruitment, although contributions of these factors to Polycomb silencing are not 
fully understood (Muller and Kassis, 2006; Ringrose and Paro, 2007).  
Despite mapping thousands of Polycomb binding sites in mammalian cells, no PRE motif has been 
identified to date (Boyer et al., 2006; Bracken et al., 2006; Lee et al., 2006) (Figure 1). Partially explaining 
this is the fact that in mammals PcG proteins bind to a much broader domain at target genes, in contrast to 
Drosophila, where PcG proteins localize in a well recognizable peak (Boyer et al., 2006; Ku et al., 2008; Lee 
et al., 2006). It seems that in mammals an even more complex system is responsible for targeting PcG 
proteins, involving many more combinations of recruiting factors. A good candidate for a recruiter is the Yy1 
protein, a homolog of the fly PHO (Thomas and Seto, 1999) (Figure 1). Indeed, knockdown of Yy1 disables 
Ezh2 binding and removes H3K27me3 from target genes in mouse myoblasts (Caretti et al., 2004). 
However, only limited regions are co-occupied by Yy1 and PRC2 in ES cells (Squazzo et al., 2006), 
suggesting that Yy1 is not a general factor at all PcG binding sites. It has been proposed that in ES cells the 
core transcription factors Oct4, Nanog and Sox2 might be involved in PcG recruitment, as these factors co-
occupy a subset of PcG target genes in human ES cells (Boyer et al., 2006; Lee et al., 2006) (Figure 1). A 
functional link has been proposed by showing reduced PRC1 levels in ES cells on Oct4 knockdown (Endoh 
et al., 2008). As loss of Oct4 induces differentiation, changes in PRC1 occupancy may be a mere 
secondary effect. Another study carried out genome-wide mapping of PRC1 and PRC2 subunits at high 
resolution in ES cells. As a result they found a very significant overlap among PRC2 and CpG islands or CG 
rich regions, suggesting that CpG-binding proteins also contribute to PcG recruitment (Ku et al., 2008).  
Long non-coding RNAs (ncRNAs) have also been implicated in PcG targeting (Figure 1). Three well 
studied cases involve production of ncRNAs: Hox gene silencing, X chromosome inactivation and imprinting 
(Mercer et al., 2009). Interestingly, all three scenarios also involve accumulation of H3K27me3, raising the 
possible link between ncRNAs and PcG proteins. A recent study identified ncRNAs transcribed from human 
Hox loci, for example Hotair from the HoxC locus. Interestingly Hotair is required to repress expression form 
the HoxD locus in trans through recruiting PRC2, as loss of Hotair RNA results in eviction of H3K27me3 
from the HoxD locus (Rinn et al., 2007). How Hotair exactly recruits PRC2 and whether the interaction is 
direct remains to be addressed. 
X inactivation and imprinting involve ncRNAs that act in cis. The key ncRNA in X inactivation is Xist, which 
contains a repetitive element called repA. This repA motif has been shown to bind PRC2, implying a 
recruitment option to the inactive X chromosome (Zhao et al., 2008a). The paternally imprinted Kcnq1 locus 
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Gene repression by PcG proteins has been proposed to involve changes in chromatin remodeling and/or by 
interfering with the transcriptional machinery. Reconstructed or purified fly and human PRC1 can bind and 
compact nucleosomal arrays in vitro, thereby making them refractory to SWI/SNF-class remodelers, which 
could otherwise move nucleosomes out of the way and allow binding of e.g. transcription factors (Francis et 
al., 2004; Francis et al., 2001; King et al., 2002; Shao et al., 1999). PRC1 and SWI/SNF remodeler binding 
seems to be competitive, as remodelers can remove bound PcG proteins from endogenous target genes 
(Kia et al., 2008). However, there is no strong evidence to support PcG induced chromatin compaction in 
vivo (Schwartz and Pirrotta, 2007). 
 Another option for exerting repression is by blocking transcription. PRC1 does not seem to block 
transcription initiation or steps before that, as several studies have shown that transcription factors or the 
transcription machinery and PRC1 proteins can bind at target genes at the same time in both fly and 
mammalian cells (Breiling et al., 2001; Dellino et al., 2004; Papp and Muller, 2006; Saurin et al., 2001; 
Stock et al., 2007).  
Several studies have proposed that PRC1 blocks transcription elongation. Many genes in mouse ES cells 
are termed bivalent because they possess the active H3K4me3 mark and the repressive H3K27me3 mark 
at the same time (Azuara et al., 2006; Bernstein et al., 2006) (Figure 1). These bivalent genes are 
expressed at very low levels. Searching for RNAPII on promoters of these PcG target genes revealed that 
they are bound by a special poised form of RNAPII, which is phosphorylated at Ser 5 (Stock et al., 2007) 
(Figure 1). Depleting H2AK119Ub by deletion of Rnf2 and Rnf1 in ES cells releases the poised state of 
RNAPII and leads to gene de-repression (Stock et al., 2007). These results suggest that PRC1 mediated 
H2AK119Ub achieves repression by holding RNAPII in check. Recent work in fly also finds paused RNAPII 
at two classical Polycomb target genes, Ultrabithorax and AbdominalB, although a direct role for PcG 
proteins in generating or maintaining this paused RNAPII was not addressed (Chopra et al., 2009). Of note, 
the previously discussed chromatin compaction function might also contribute to stalling the polymerase on 
Polycomb target genes. 
Overall, mechanisms of PcG-mediated silencing still hold many unknowns and will be an exciting field for 
new discoveries. 
 
2.6.4.4.  PRC1-PRC2 dependence or independence in targeting and silencing? 
 
The “classical” sequence of Polycomb complex recruitment described above stems from the affinity of the 
chromodomains of Cbx proteins for H3K27me3 (Fischle et al., 2003; Min et al., 2003) and studies in 
Drosophila (Cao et al., 2002; Wang et al., 2004b) and mammalian cells (Boyer et al., 2006; Cao et al., 
2005), where disruption of PRC2 leads to the loss of PRC1 from chromatin targets. Moreover, 
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is also known to transcribe a long ncRNA, Kcnq1ot1 that is essential for imprinted silencing. PRC2 has also 
been shown to be required for imprinted silencing at this locus. Physical interaction between Kcnq1ot1 and 
PRC2 has been demonstrated as well as the requirement of Kcnq1ot1 for PRC2 targeting (Pandey et al., 
2008; Terranova et al., 2008). NcRNAs are wide-spread in the mammalian genome, therefore the possibility 
is there for a more general Polycomb-targeting via this mechanism. 
Very recently a number of studies demonstrated the involvement of the Jumonji family member Jarid2 in 
recruiting PRC2 to target genes (Li et al.; Pasini et al.; Peng et al., 2009; Shen et al., 2009) (Figure 1). 
Jarid2 was sufficient to target PcG proteins to a heterologous promoter and inhibiting of Jarid2 expression 
resulted in altered PcG protein binding and H3K27me3 levels at target genes. The DNA-binding ARID 
domain of Jarid2 was shown to be required for Polycomb-targeting. Previous studies have shown that the 
AIRD domain of Jarid2 can bind to diverse DNA sequences (Kim et al., 2003b). It was suggested that the 
broader specificity of Jarid2 binding to DNA could be narrowed by other transcription factors to achieve 
specific PRC2 targeting to genes (Pasini et al.). 
Although the listed examples are promising, further work is clearly needed to fully unravel PcG targeting 
mechanisms in mammalian cells. 
 
2.6.4.3.  Mechanism of Polycomb-mediated silencing 
 
The classical model for PcG mediated silencing involves recruitment of PRC2 to target genes, setting 
H3K27me3 and thereby creating an anchorage point for Cbx proteins (Figure 1). These latter proteins bind 
to H3K27me3 via their chromodomains and recruit other PRC1 complex members that establish silencing 
(Cao et al., 2002; Wang et al., 2004b). It has been proposed that histone H2A ubiquitination plays an 
important role in PRC mediated silencing. The PRC1 component Rnf2 protein was identified as an E3 
ubiquitin ligase, monoubiquitinating lysine 119 on histone H2A (H2AK119Ub) (Wang et al., 2004a).  
Depletion of dRing, the Drosophila homolog of Rnf1/2 by RNAi in cell culture resulted in loss of 
ubiquitinated H2A and caused de-repression of the Ubx homeotic box gene, a well known target of PRC 
mediated silencing. Moreover, a single amino acid substitution in the catalytic RING finger domain that 
abolishes ubiquitin ligase activity in vitro, behaves as a loss of function allele for dRing in vivo (Wang et al., 
2004a). These findings indicated that ubiquitination of H2AK119 plays a central role in the PRC mediated 
silencing pathway. Since then, numerous other studies have supplied evidence highlighting the important 
role of Rnf2-, Rnf1- or Bmi1-dependent H2AK119Ub in repression (de Napoles et al., 2004; Endoh et al., 
2008; Kallin et al., 2009; Leeb et al., 2010; Stock et al., 2007; van der Stoop et al., 2008). Although key to 
Polycomb-mediated silencing, the precise molecular mechanism of repression mediated by PRC1 is only 
poorly understood.  
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overlapping genomic distribution of PRC1, PRC2 members and H3K27me3 suggests concerted actions 
of these complexes (Boyer et al., 2006; Ku et al., 2008).  
Two recent studies have further addressed the role of H3K27me3 in PRC1 targeting, importantly, by 
altering the modification level but not the PRC2 complex itself. Either by knocking down a H3K27 de-
methylase (Utx) (Lee et al., 2007) or by constructing a viral HMTase capable of mediating H3K27me3 
(Mujtaba et al., 2008), authors showed increased H3K27me3 levels at targeted Hox genes. In both cases 
increasing H3K27me3 levels corresponded with increasing PRC1 levels, thus providing further evidence of 
inter-dependency of the two complexes.                                                                                                                                                                                          
An increasing number of observations however, demonstrate PRC2 independent recruitment of PRC1, 
contradicting the generality of the classical model of PcG recruitment. In flies, PRC1 specifically peaks at 
PREs, while H3K27me3 comprises a broader domain (Schwartz et al., 2006). Physical interaction of the 
recruitment factor Pho and PRC1 has been described in Drosophila, alleviating the need for PRC2-
mediated targeting (Mohd-Sarip et al., 2006). 
In mammals both random and imprinted X inactivation initiate normally in Eed-deficient embryos that have 
no detectable level of H3K27me3 (Kalantry and Magnuson, 2006). Xist expression at an autosomal locus 
recruits Rnf2 and establishes long-term silencing in Eed knockout ES cells (Schoeftner et al., 2006). The 
PRC1 complex is recruited to paternal pericentric heterochromatin in zygotes generated by Ezh2 mutant 
gametes that (paternally) lack detectable H3K27me3 (Puschendorf et al., 2008). In Ezh2 mutant embryos, 
Rnf2 is recruited to the silenced allele of the Kcnq1 locus, although in theory PRC2 function may still be 
partially rescued by redundancy of Ezh1 (Terranova et al., 2008). During differentiation of Suz12 deficient 
ES cells, two PRC1 members (Bmi1 and Cbx8) are recruited to most of the target genes they occupy in wild 
type ES cells (Pasini et al., 2007).  
A recent study analyzed PRC1 (Rnf2)/PRC2 (Eed) double mutant ES cells (Leeb et al., 2010). They 
identified a group of genes that are redundantly repressed by both complexes (only de-repressed when 
both are gone) and a distinct group of genes where loss of either complex is already sufficient for de-
repression (for example Hox genes). However, their analysis is not satisfying, lacking a clear overview of 
genes and levels of de-repression in single (Rnf2 or Eed) and double (Rnf2/Eed) mutant ES cells. Their 
data indicate that in most cases loss of either PRC from a target gene already results in a certain level of 
de-repression, while the loss of the second PRC adds to this de-repression.  
Genome-wide ChIP analysis of PRC1 (Rnf2) and PRC2 (Ezh2, Suz12) occupancy in mouse ES cells 
showed many genomic sites which accumulate PRC2, but not PRC1 (Ku et al., 2008). This however, may 
simply be due to the different efficiencies of antibodies used for PRC1 and PRC2 components.  
In summary, only few cases confirm that PRC1 can be targeted to chromatin in a PRC2-independent 
manner. In general, PRC1 and PRC2 seem to act through cooperatively to silence target genes. 
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2.6.4.5. Role in pluripotency, differentiation and development 
 
Polycomb during development 
 
Mice deficient for any core PRC2 member are not viable and die during early post-implantation stages 
displaying severe developmental and proliferative defects (Faust et al., 1995; O'Carroll et al., 2001; Pasini 
et al., 2004). This demonstrates that Polycomb function is essential for proper embryonic development.  
Deletion of several PRC1 members leads to homeotic transformations (Akasaka et al., 1996; Core et al., 
1997; del Mar Lorente et al., 2000; van der Lugt et al., 1994). The most severe phenotype, resulting in 
embryonic lethality, is observed for Rnf2 deficiency (Voncken et al., 2003). Deletion of Rnf2 results in 
gastrulation arrest and cell cycle inhibition. In contrast, mice deficient for the homologous Rnf1 are viable 
and fertile with only minor homeotic transformations (del Mar Lorente et al., 2000). With respect to the 
differences in the severity of these phenotypes (del Mar Lorente et al., 2000; Voncken et al., 2003) it is 
interesting that global H2A ubiquitination levels are drastically reduced in Rnf2 but not in Rnf1 mutant ES 
cells (de Napoles et al., 2004). Mutations in other PRC1 members yield relatively mild phenotypes, 
possibly due to the functional redundancy of the different mouse PRC1 homologs.  
 
Polycomb in stemmness and differentiation 
 
Pluripotent embryonic stem cells have the unique ability to self-renew and to differentiate into all cell types 
of the embryo and adult organism. During differentiation, gene expression patterns are gradually specified 
and restricted along with the developmental potential of the cell, ultimately resulting in commitment to a 
specific fate. Developmental stage specific transcription factors are known to orchestrate gene expression 
patterns, which become heritable through acquiring epigenetic modifications, providing cellular memory of 
lineage restriction. Polycomb proteins have emerged as important regulators of stemness and 
differentiation.  
This role of Polycomb is best illustrated by various PcG-knockout ES cells. Although different knockouts 
have slightly different phenotypes, there are common trends. Core components of PRC2 (Ezh2, Eed and 
Suz12) and the main catalytic subunit of PRC1 (Rnf2) are not required for stem cell proliferation and 
maintenance, although they do stabilize self-renewal (Chamberlain et al., 2008; Leeb and Wutz, 2007; 
Pasini et al., 2007; Shen et al., 2008; van der Stoop et al., 2008). PcG mutant ES cells are prone to 
spontaneous differentiation. Expression of pluripotency factors such as Oct4 are maintained in mutant ES 
cells, but differentiation specific genes are activated. Upon in vitro induced differentiation, mutant cells are 
unable to give rise to the full range of cell types in in vitro differentiation assays, accompanied by failure to 
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repress pluripotency genes as well as failure to activate appropriate differentiation markers (Chamberlain 
et al., 2008; Leeb and Wutz, 2007; Pasini et al., 2007; Shen et al., 2008; van der Stoop et al., 2008). 
Although slightly more severe, this phenotype resembles that of ES cells double deficient for a PRC1 
(Rnf2) and a PRC2 (Eed) complex member (Leeb et al., 2010). The only exception known so far are ES 
cells double deficient for Rnf1 and Rnf2, which seize proliferation upon PRC1 loss (Endoh et al., 2008). 
We can draw two interesting conclusions from these studies: first, in ES cells Rnf1 is capable to 
compensate in part for the loss of Rnf2 and to maintain stem cell self-renewal; second, there seems to be 
a discrepancy between the need for PRC1 and PRC2 for ES cell maintenance. This result points to a 
surprising importance-hierarchy among PRC1 and PRC2 for silencing. However, this could be simply due 
to different culture conditions, as pointed out in Leeb et al. 2010.  
Interestingly many reports demonstrate that PRC1 proteins have an essential role in maintenance of 
more differentiated cell types as multipotent adult stem cells. For example, Bmi1 is required for 
maintenance of self-renewing hematopoietic stem cells (Park et al., 2003), neuronal stem cell proliferation 
(Molofsky et al., 2003) and mammary stem cell maintenance (Liu et al., 2006). Bmi1 homozygous null 
mice can survive to adulthood, but show progressive postnatal growth retardation and the loss of 
hematopoietic and neural stem cells (Bruggeman et al., 2005). In addition, Ph1 (Rae28), a PRC1 member 
that interacts directly with Bmi1 is also required for sustaining activity of hematopoietic stem cells (Kim et 
al., 2004; Valk-Lingbeek et al., 2004). While inactivation of Rnf2 in embryonic neural stem cells affects 
self-renewal and results in precocious neuronal but not glial differentiation (Roman-Trufero et al., 2009), 
deletion of Rnf2 in adult stem cells or progenitor cells of the hematopoietic system results in proliferation, 
rather than differentiation defects (Cales et al., 2008). 
Genome-wide mapping studies of Polycomb protein occupancy in mouse and human ES cells have shown 
that PcG complexes are predominantly bound at genes that encode key developmental regulator factors 
that control diverse developmental pathways (Boyer et al., 2006; Lee et al., 2006). Most of these factors are 
expressed at very low levels or not at all in ES cells. However, upon differentiation a discrete set of these 
genes become activated, pointing out an intimate involvement of Polycomb proteins in the dynamic 
regulation of stem cell identity and cell fate determination. 
Further studies have shown that many PcG targets in ES cells are broadly covered with H3K27me3, but 
surprisingly also harbor H3K4me3, an active mark, and RNAPII Ser5-phospho at the transcription start site 
(Bernstein et al., 2006; Mikkelsen et al., 2007; Pan et al., 2007; Stock et al., 2007; Zhao et al., 2007) 
(Figure 1). Such regions marked by dual histone modifications were termed bivalent domains. By mapping 
histone modifications and determining gene expression during the course of differentiation, the current 
hypothesis is that bivalent domains poise genes for subsequent activation (accompanied by the loss of the 
H3K27me3 mark) or permanent repression (accompanied by the loss of the H3K4me3 mark) (Mikkelsen et 
al., 2007). Permanent repression of genes in some cases also involves additional silencing mechanisms, 
like H3K9me or DNAme that may contribute to locking in the silenced state (Feldman et al., 2006; Mohn et 
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al., 2008). Bivalent domains are not unique to ES cells as initially thought but are also found in differentiated 
cells, like NPCs, MEFs and T cells (Mikkelsen et al., 2007; Mohn et al., 2008; Roh et al., 2006). However, 
the number of genes marked by bivalency in differentiated cells is much lower compared to ES cells, 
suggesting that the resolution of these domains is closely related to the commitment of cells. With 
progressive commitment, lineage choices become increasingly limited by the resolution of 'poised' promoter 
states into either “on” or “off” states (Pietersen and van Lohuizen, 2008).  
Interestingly, bivalent domains in ES cells were found to correlate with the presence of CpG-rich promoters 
(High-CpG content promoters; HCP) (Mikkelsen et al., 2007; Mohn et al., 2008) (Figure 1). In general, 
genes with HCP and bivalent marks were found to mainly include key developmental transcription factors, 
morphogens, and cell surface markers, while genes bearing HCP and H3K4me3 marks generally have 
„housekeeping‟ functions, including replication and basic metabolism. On the other hand, genes with low-
CpG content promoters (LCP) are associated with tissue-specific genes (Mikkelsen et al., 2007). To 
illustrate the Polycomb-bivalency-CpG richness connection in numbers: a study by van der Stoop el al. 
2008 showed that Rnf2 in ES cells almost exclusively associated (93% of Rnf2 targets) with and regulated 
(94% of Rnf2 targets) transcription of genes with HCPs. Moreover, 99% of Rnf2 targets carried bivalent 
chromatin marks (van der Stoop et al., 2008). 
Taken together, apart from the known role of heritable silencing mediated by Polycomb proteins, a new, 
more plastic role has emerged for Polycomb-mediated regulation, providing means for a more flexible 
regulation of developmental transcription factors during differentiation. 
Coordinated transcription factor networks have emerged as master regulatory mechanisms of stem cell 
pluripotency and differentiation. Pluripotency factors Oct4, Sox2 and Nanog function in combinatorial 
complexes to activate the expression of genes promoting stemness and repress differentiation inducing 
factors (Boyer et al., 2005). They are also known to form a core regulatory feedback circuit, in which all 
three factors regulate their own, as well as each other‟s expression to sustain precise levels of pluripotency 
factors required for ES cell maintenance (Catena et al., 2004; Kuroda et al., 2005; Okumura-Nakanishi et 
al., 2005; Rodda et al., 2005). Initiation of differentiation requires interruption of this positive feedback loop 
by differentiation factors, for e.g. Gata6. Given the crucial role of PcG proteins in stem cells, it was obvious 
that Polycomb-pluripotency network relationships had to be examined. First reports demonstrated that 
PRC2 members co-occupy a significant subset of genes targeted by the (repressive function of the) core 
pluripotency network in human ES cells (Boyer et al., 2006; Lee et al., 2006). Additionally, it has now been 
shown that there is a functional link between these regulatory mechanisms (Endoh et al., 2008) (PRC1 and 
PRC2 occupancy is reduced at target genes upon loss of Oct4, while Oct4 binding does not change 
significantly upon loss of PRC1. Furthermore, molecular links between PRC1 and Oct4 have been shown, 
all pointing towards Polycomb silencing functioning downstream of the core pluripotency circuitry (Endoh et 
al., 2008).  
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2.6.4.6.  Polycomb proteins in cell cycle regulation and DNA damage response, a highly 
dynamic role? 
 
Beyond the role in stable maintenance of repressive chromatin during development, Polycomb proteins 
have long been implicated in playing a role in cell proliferation. For example Drosophila E(Z) mutants 
display a small disc phenotype with no discernible mitotic figures (Phillips and Shearn, 1990). Mutations in 
PH, PC and PSC display segregation defects caused by the formation of anaphase bridges during syncytial 
embryonic mitoses (O'Dor et al., 2006). Examples in mammalian systems include cell cycle arrest 
generated by Rnf2 knockdown in U2OS cells (Wang et al., 2004a), and proliferation halt of ES cells where 
both Rnf1 and Rnf2 were deleted (Endoh et al., 2008). Unfortunately, in both studies the cell cycle block 
was not characterized.  
An essential requirement for regulating the cell cycle is flexibility of the system; even more flexible than the 
previously discussed plasticity that developmental progression requires. Surprisingly, studies on mobilities 
of PRC1 proteins in Drosophila and mammalian cells using photobleach recovery showed exactly such a 
dynamic behavior, challenging the previous view of Polycomb protein always being in static association with 
chromatin. In U2OS cells two Bmi1 populations were identified based on their mobilities: a highly mobile 
one and one that is immobile (Hernandez-Munoz et al., 2005). In ES cells the rates of exchange for over 
85% of Cbx proteins were orders of magnitude faster than the mean exchange rates of core histones. The 
mobility of PcG proteins decreased and the immobile population grew during differentiation of ES cells and 
also during Drosophila development (Ficz et al., 2005; Meshorer et al., 2006; Ren et al., 2008). The 
significance of these two populations remains to be determined, although it is intriguing to speculate that the 
immobile population may be the one relatively stably repressing developmental gene promoters, while the 
mobile portion may be involved in completely different functions, such as cell cycle regulation. 
Although several Polycomb mutants show cell cycle defects it remains unclear how Polycomb complexes 
control cell cycle progression. In theory there are different possibilities to achieve this: 1) by direct silencing 
of cell cycle genes, 2) by indirect control of cell cycle genes through de-repression of Polycomb-targets, 3) 
by having a role in proper chromatin setup that is required for cell cycle progression or even 4) by directly 
modifying cell cycle factors and thereby altering their properties. Below I have listed examples supporting 
each possibility. 
In a bioinformatic search of PREs in Drosophila, authors pointed out a number of potential Polycomb 
targets involved in cell cycle control (Ringrose et al., 2003). Functional evidence for this prediction first 
came from identifying Cyclin A as a bona fide PcG target in the fly (Martinez et al., 2006), followed by the 
first study reporting genome-wide binding profiles of PcG proteins in developing Drosophila, which also 
identified cell cycle genes directly regulated by Polycomb (Oktaba et al., 2008).  
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In mammals, the tumor suppressor Ink4a/Arf locus has been identified as a target of PRC. The Ink4a/Arf 
locus encodes two proteins, p16 and p19 by use of alternative reading frames. p16 and p19 are important 
players in the retinoblastoma (Rb) and p53 pathways, respectively and their activation results in growth 
arrest, senescence or apoptosis. Bmi1 has been shown to negatively regulate the Ink4a/Arf locus, thereby 
repressing the p16 and p19 mediated senescence pathways, promoting stem cell self-renewal and 
maintaining of multipotency (Molofsky et al., 2005). Disruption of the Ink4a/Arf locus in Bmi1-/- stem cells 
partially restores self-renewal capacity, indicating that inappropriate activation of the locus negatively 
influences stem cell fate (Jacobs et al., 1999a; Lowe and Sherr, 2003; Sharpless and DePinho, 1999). 
Since then, the Ink4a/Arf locus was shown to be also targeted by a number of other PcG proteins, including 
Cbx4, Cbx7, Cbx8, Mel18, Rnf2, Ezh2 and Suz12 (Bracken et al., 2007; Dietrich et al., 2007; Gil et al., 
2004; Jacobs et al., 1999a; Voncken et al., 2003). Cbx7 was shown to extend the life span of human and 
mouse cells by bypassing replicative senescence through down regulation of the Ink4a/Arf locus (Gil et al., 
2004). Similarly, ectopic expression of Cbx8 leads to repression of the Ink4a/Arf locus and immortalization 
of mouse embryonic fibroblasts (Dietrich et al., 2007). Another cell cycle inhibitor, Cdkn1c (p57, Kip2) has 
also been shown to be a direct target of PRC2 (Yang et al., 2009) and the paternally imprinted allele to be 
expressed upon the loss of Eed (Mager et al., 2003), Ezh2 or Rnf2 (Terranova et al., 2008).  
Taken together, Polycomb proteins can directly regulate the expression of positive or negative (like 
checkpoint components) regulators of the cell cycle. 
Well established Polycomb targets like Hox genes have previously been shown to be involved in cell 
proliferation control (Core et al., 1997; Sauvageau et al., 1994; Sordino et al., 1995). In mice for example, 
Hoxa1 mutants have cell growth defects (Dolle et al., 1993) and Hoxd3 has been suggested to regulate 
proliferation roles of precursor cells (Condie and Capecchi, 1993). In humans, Hoxb4 expression is involved 
in hematopoetic stem cell proliferation (Antonchuk et al., 2002). Finally, misregulation of some Hox genes 
leads to alterations in lymphocyte proliferation (Perkins et al., 1990; Sauvageau et al., 1994). Thus cell 
cycle defects in PcG mutants may be an indirect consequence of changes in Hox gene activities. 
An observation suggesting a chromatin-based role in cell cycle regulation comes indirectly from the study of 
de-ubiquitintating emzymes (DUBs) (Discussed in more detail in chapter 2.6.4.9.). Disturbing the dynamics 
of H2AUb leads to chromosome condensation and mitotic defects in HeLa cells (Joo et al., 2007), although 
direct PRC1 involvement in setting this Ub marks has not been demonstrated. 
Finally, an interesting study reports that PRC1 can directly ubiquitinate the cell cycle regulator Geminin and 
therefore target it for ubiquitin-proteosome-mediated degradation (Ohtsubo et al., 2008). Geminin is a 
central component in controlling DNA replication licensing by binding to and antagonizing the replication 
initiation factor Cdt1 (Melixetian and Helin, 2004; Pitulescu et al., 2005). Loss of Geminin permits re-
licensing of replication initiation complexes and leads to endoreplication in higher eukaryotes (Melixetian 
and Helin, 2004; Tachibana et al., 2005; Zhu and Dutta, 2006a), while overexpression of Geminin causes 
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cells to accumulate in G1-phase, possibly because of induction of a licensing checkpoint (Shreeram et al., 
2002). In PRC1 member Phc1 knockout embryos hematopoetic stem cell activities were eliminated, 
presumably due to the accumulation of Geminin and subsequent cell cycle arrest (Ohtsubo et al., 2008).  
A very recently published report set out to dissect the mitotic defect of Polycomb mutant Drosophila 
embryos (Beck et al., 2010). Time-lapse imaging of PH mutant embryos showed that the absence of PcG 
proteins was actually accelerating S-phase by abrogating the DNA damage checkpoint, which then 
reflected in aberrant mitosis. Additionally Ring1b in the context of PRC1 has been shown to mediate 
ubiquitination of H2A in response to DNA damage, probably to facilitate chromatin relaxation or to mediate 
transcription pausing during repair (Bergink et al., 2006).   
 
2.6.4.7. Propagation of Polycomb-mediated marks  
 
A feature of chromatin based epigenetics is that chromatin structure can be modified either to allow or to 
inhibit transcription, and that these regulatory features of chromatin structure are propagated throughout 
the cell cycle. Recent studies on Polycomb proteins have begun to unravel the mechanisms by which 
Polycomb-memory is inherited through DNA replication. 
The H3K27me3 mark is a good candidate for transmission of regulatory information, as parental histones 
with this mark are segregated into daughter chromatin during replication. PRC2 was show to be able to 
bind H3K27me3 in vitro, moreover when targeted to a reporter gene, it was able to establish H3K27me3, 
recruit PRC1 and initiate gene silencing (Hansen et al., 2008). Importantly, all these features were 
maintained at the reporter gene even after the targeted version of PRC2 was no longer expressed. This 
suggests that stable epigenetic silencing was established by transient PRC2 recruitment. Recently, the 
WD40 domain of Eed was shown to selectively bind to H3K27me3 by virtue of an aromatic cage and this 
interaction stimulated HMTase activity of the PRC2 complex by an allosteric mechanism (Margueron et 
al., 2009). These studies support a model where replication segregates H3K27me3 marked nucleosomes 
into daughter chromosomes where it interacts with PRC2, which in turn directs methylation of newly 
deposited histones, maintaining high levels of histone methylation at Polycomb target sites. 
Replicating chromatinised templates in a cell free system revealed that PRC1 complexes stay associated 
with chromatin throughout S-phase, although no further data on mechanisms for propagation is available 
(Francis et al., 2009).   
Chromosome condensation and mitosis may present further problems for transmission of epigenetic 
information. While chromatin is stably H3K27me3-modified during mitosis (Puschendorf et al., 2008), 
ubiquitination of H2A needs to be removed at the onset of mitosis to allow cell cycle progression (Joo et 
al., 2007). How is then the repressive memory mediated by H2AUb remembered? One possibility is that 
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the PRC1 complex stays anchored to condensed mitotic chromatin and re-ubiquitinates its target sites in 
anaphase (Joo et al., 2007). Indeed, PRC1 members are known to stay chromatin-bound during M-phase 
(Buchenau et al., 1998; Messmer et al., 1992; Puschendorf et al., 2008), however re-ubiquitination by 
these proteins has not been directly shown. 
 
2.6.4.8.  Other complexes containing PRC1 members 
 
Some PRC1 members, such as Rnf1 and Rnf2 have been found to interact with other repressive 
complexes other than PRC1. Immuno-affinity purification of E26F interacting proteins identified Rnf1 and 
Rnf2 together with L3mbtl2, Yaf2, Dp1, Mga, Max, Eu-HMTase1/Glp1 and G9a (Ogawa et al., 2002). The 
two last proteins are H3K9 HMTases, which may contribute to silencing of E2F6 target genes. Similarly, 
Rnf1 and Rnf2 associate with the Bcl6 co-repressor (Bcor), Nspc1, LSD1/Aof2 and Fbxl10/Jhdm1B 
(Gearhart et al., 2006; Sanchez et al., 2007). Bcor target genes are ubiquitinated in vivo, suggesting that 
Rnf1/2 are functional in this complex and may contribute to silencing of Bcor target genes. Fbxl10 is a 
H3K36 de-methylase, a homolog of the Drosoplila KDM2, but it has not been addressed whether it also 
functions to stimulate ubiquitin ligase activity of the complex as it does in Drosophila. Nevertheless, it is 
an interesting possibility that the histone de-methylase activities within this complex (LSD1/Aof2 and 
Fbxl10/Jhdm1B) may provide additional regulatory function through these chromatin-modifying 
mechanisms. 
Therefore, it is of note that knockouts of PRC1 members may not only model Polycomb deficiency, but 
show a complex phenotype of deficiencies arising from loss of function of several complexes.  
 
2.6.4.9.  Reversing Polycomb-mediated marks 
 
In contrast to histone acetylation or phosphorylation, for a long time histone methylation was considered a 
permanent and irreversible mark, locking epigenetic states, especially histone tri-methylation, as the 
thermodynamic stability of the N-CH3 bond is very high. It was thought that the only way to remove histone 
methylation was by exchanging histones or by cleaving histone tails. The groundbreaking discovery of the 
first histone demethylase LSD1 changed this view (Shi et al., 2004). LSD1 was shown to demethylate 
histones through a flavin adenine dinucleotide (FAD)-dependent amine oxidase reaction, a reaction in 
theory only capable of demethylating mono- and di-methylated states. Indeed, LSD1 has been shown to 
demethylate H3K4me1/2 in a complex with the repressive CoREST (Shi et al., 2004) and to demethylate 
H3K9me1/2 in complex with the androgen receptor (Metzger et al., 2005). It was only until the identification 
of the Jumonji (JmjC) catalytic domain containing histone demethylase family when the possibility of 
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reversal of the tri-methyl mark became apparent (Cloos et al., 2006; Klose et al., 2006b; Tsukada et al., 
2006; Whetstine et al., 2006; Yamane et al., 2006). To date a number of JmjC domain protein family 
members have been assigned demethylase activities. Of our interest are the two enzymes that have been 
shown to demethylate H3K27me2/3: Utx and Jmjd3 (Agger et al., 2007; De Santa et al., 2007; Hong et al., 
2007; Lan et al., 2007; Xiang et al., 2007). In vitro, these enzymes catalyze transition of H3K27m2/3 to 
H3K27me1 on bulk histones, H3K27me3 being the preferred substrate. However, their enzymatic reaction 
on nucleosomal substrates is very weak, indicating the need for additional binding partners for activity in the 
context of chromatin (Lan et al., 2007). Indeed, ectopic expression of Utx alone seems to have little effect 
on K3K27 methylation levels in most cell types (Cloos et al., 2008).  
H3K27 demethylases have been shown to be required for normal development, as morpholino-mediated 
knockdown of the two zebrafish Utx homologs results in posterior abnormalities in the embryo (Lan et al., 
2007) and knockdown of a Jmjd3 homolog in C.elegans impaired normal gonad development (Agger et al., 
2007). Utx has also been shown to regulate Hox gene expression. Upon differentiation of NT2/D1 cells with 
retinoic acid, Utx is recruited to the promoters of the anterior genes of HoxA and HoxB loci. Utx recruitment 
correlates with the removal of H3K27me3, decreased occupancy of PRC2 members and gene activation. 
Furthermore, knockdown of Utx expression disables H3K27 demethylation and Hoxb1 activation upon 
differentiation (Agger et al., 2007).  
Another study demonstrates transient Jmjd3 binding to HoxA7 and HoxA11 promoters during bone marrow 
cell differentiation (De Santa et al., 2007). Jmjd3 is also rapidly induced in macrophages in response to an 
inflammatory stimulus. For example, at the promoter of the inflammatory response gene Bmp2, Jmjd3 
levels increase, while H3K27me3 decreases and transcription is initiated in response to inflammation (De 
Santa et al., 2007).   
Taken together, these results demonstrate that H3K27 de-methylases are functioning during differentiation 
at known Polycomb target genes like Hox clusters and Bmp2, to counteract Polycomb silencing at genes 
that need to be activated. 
In contrast to histone methylation, it has been clear for decades that monoubiquitination of histone H2A is a 
dynamic mark, as global levels vary over the cell cycle (Goldknopf et al., 1980; Matsui et al., 1979; Mueller 
et al., 1985; Wunsch and Lough, 1987). To date five H2A de-ubiquitinating (DUBs) enzymes have been 
identified: 2A-DUB belonging to the JAMM/MPN+ family and USP3, USP-16 (Ubp-M), USP-21 and USP-22 
from the Ubiquitin Specific Protease family (USP) (Joo et al., 2007; Nakagawa et al., 2008; Nicassio et al., 
2007; Zhang et al., 2008; Zhao et al., 2008b; Zhu et al., 2007). USP-3 and USP-22 are also capable of de-
ubiquitinating histone H2B. Although Rnf1/2 is known to be responsible for most H2AUb in the mammalian 
genome, it is likely that not all these DUBs would function to antagonize Rnf1/2.  
Only studies on the USP-16 enzyme suggest that a DUB functions in counteracting Polycomb repression. 
Depleting USP-16 in Xenopus embryos lead to de-regulation of HoxD10 expression and defects in posterior 
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development, (Sparmann and van Lohuizen, 2006) a phenotype consistent with Polycomb-antagonistic 
function. Furthermore, USP-16 knockdown in HeLa cells resulted in increased H2AK119Ub levels at the 
promoter and transcriptional repression of the HoxD10 gene, a known Polycomb target (Joo et al., 2007). 
However the function of USP-16 seems to be multi-layered, as it not only regulates gene expression, but 
also cell cycle progression (Joo et al., 2007). As previously mentioned it is known for a long time that de-
ubiquitination occurs at the G2/M transition and it is re-established in early anaphase (Goldknopf et al., 
1980; Matsui et al., 1979). It has been shown that USP-16 is the DUB responsible for this de-ubiquitination. 
Depletion of USP-16 in HeLa cells causes a G2/M delay, in part due to the H2AUb mark inhibiting Aurora B 
binding to chromatin, therefore inhibiting H3 serine 10 phosphorylation (H3S10P), a hallmark of condensing 
chromatin (Joo et al., 2007).  
USP-21, USP-22 and 2A-DUB have also been implicated in transcriptional control; however Polycomb-links 
have not been investigated (Nakagawa et al., 2008; Zhang et al., 2008; Zhao et al., 2008b; Zhu et al., 
2007).  
H2A ubiquitination/de-ubiquitination is emerging as an important regulator of gene activity, cell cycle control 
and even DNA damage response. Study of DUBs can provide new insights on H2AUb function. However, to 
what extent this is Polycomb-relevant, remains to be addressed.  
 
2.7. Development  - the epigenetic cycle 
 
At the onset of life, two gametes, sperm and oocyte come together to form a zygote. Both gametes are 
highly specialized types of cells, carrying a specialized set of epigenetic modifications. However, they are 
specialized for executing a program upon fusion that will produce a totipotent embryo. This program 
involves extensive chromatin remodeling, erasure of certain epigenetic modifications, followed by re-
establishment of others (Santos and Dean, 2004). This epigenetic re-programming event is thought to 
account for totipotency, correct initiation of embryonic gene expression, and early lineage development in 
the embryo. As the embryo develops and differentiates, epigenetic modifications direct and stabilize gene 
expression patterns that define a more and more restricted cell fate. However, certain epiblast cells of the 
post-implantation embryo that already contain epigenetic modifications characteristic of differentiating 
cells, undergo major re-programming again to reset the epigenetic slate and allow formation of primordial 
germ cells (PGCs), the precursors of the future gametes. PGCs undergoing the differentiation process of 
gametogenesis acquire sex-specific epigenetic modifications, and will ultimately specialize into the tiny 
one-cell transmission programs of life (Hajkova et al., 2002; Morgan et al., 2005; Surani, 2001). 
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    2.7.1.       The male germ line 
 
       2.7.1.1.  Spermatogenesis 
 
Spermatogenesis is a highly regulated sequence of differentiation and maturation events that result in the 
formation of spermatozoa from precursor cells (Clermont, 1972). In humans the entire process takes 
approximately 85 days, while in mice around 35 days (de Rooij and Grootegoed, 1998). There are three 
major phases that together make up spermatogenesis: mitotic proliferation of spermatogonial stem cells, 
reduction of chromosomal number by meiosis and the morphological transformation of the haploid germ cell 
into a spermatozoon termed spermiogenesis (de Kretser et al., 1998).  
 In the prenatal testis only gonocytes that have entered mitotic arrest are present (Huckins and Clermont, 
1968). Shortly after birth the gonocytes resume proliferation and become spermatogonia. These stem cells 
divide mitotically to constantly replenish the pool of cells that will eventually enter meiosis. Spermatogonia 
undergo differentiation to produce primary spermatocytes that enter meiosis.  
During meiosis reciprocal exchange of genetic information takes place between parental homologs, after 
which two subsequent divisions occur. The first division yields secondary spermatocytes that then further 
divide into haploid round spermatids (Clermont, 1972; de Kretser et al., 1998). Meiosis in the male mouse 
takes about 12 days, large part of which is spent in the prophase of the first division. Prophase 1 is further 
broken up into four stages: leptotene, zygotene, pachytene and diplotene. During leptotene, chromosomes 
start to condense and DNA double stranded breaks (DSBs) start to occur. DSBs are essential for 
recombination between homologs that takes place later in meiosis (Cobb et al., 1997; Roeder, 1997). 
During zygotene, sister chromatids start to pair and form synaptonemal complexes (SCs). The SC is a 
proteinaceous scaffold, consisting of two axial elements forming between sister chromatids and a central 
element that joins the axial elements as synapsis takes place (Yang and Wang, 2009). Meiotic DNA is 
arranged in loops that attach at their base to the axial elements. During pachytene synapsis is completed 
and homologous recombination takes place. In diplotene chromosomes start to separate and SCs 
disappear (Baarends and Grootegoed, 2003) at the end of prophase1.  
In the final post-meiotic part of spermatogenesis haploid round spermatids undergo extensive cytoplasmic 
metamorphosis and dramatic chromatin remodeling. This involves transcriptional silencing and condensing 
the chromatin into a volume of about 5% of that of a somatic cell nucleus, which is assisted by DSBs and 
histone-to-protamine exchange (Doenecke et al., 1997; Govin et al., 2004; Marushige and Marushige, 
1975).  
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2.7.1.2.  Epigenetics of the male germ line 
 
Epigenetic changes are known to accompany and to be critical for different steps of spermatogenesis. In 
this chapter I will discuss literature describing changes in DNA methylation and histone modifications during 
spermatogenesis. 
Before and during early steps of spermatogenesis transposable elements are silenced to prevent genomic 
instability. DNA methylation is essential for transposable element silencing and the involvement of Dnmt3l 
(Dnmt3-like) has been demonstrated in this process (Bourc'his and Bestor, 2004; Deininger et al., 2003; 
Hata et al., 2006; Webster et al., 2005). Dnmt3l is sequence-related to Dnmt3a and Dnmt3b but lacks 
enzymatic activity. It is expressed in germ cells specifically at the time when the de novo methylation occurs 
(Bourc'his and Bestor, 2004). In a complex with either Dnmt3a or Dnmt3b, it stimulates their activity 
(Suetake et al., 2004). 
Paternally imprinted genes are DNA methylated and silenced during germ cell development. To date three 
paternally imprinted regions have been identified: H19-Igf2, Rasgrf and Dlk1-Gtl2 (Davis et al., 1999; Li et 
al., 2004). All four Dnmts have been implicated in paternal imprinting (Li et al., 1993; Li et al., 1992; Sasaki 
et al., 2000).   
During meiosis several aspects of chromosome condensation, pairing and recombination are dependent 
on epigenetic modifications. Dnmt3l mutants fail to form appropriate heterochromatin and therefore 
chromosomes fail to pair at zygotene stage (Bourc'his and Bestor, 2004; Webster et al., 2005). The 
H3K9me3 HMTase Suv39h enzymes have also been shown to be essential for meiosis. In mice there are 
two paralogs Suv39h1 and Suv39h2, Suv39h2 being testis specific in the adult. Single knockout of either 
homolog does not affect viability and fertility; however, mice mutant for both enzymes displayed impaired 
spermatogenesis. Spermatocytes underwent apoptosis at the pachytene stage as a consequence of 
incomplete homolog pairing and synapsis (Peters et al., 2001). Mutant mice for the H3K9me1/2 HMTase 
G9a are also sterile due to spermatocytes unable to proceed beyond the pachytene stage due to deficient 
SC formation (Tachibana et al., 2007). Therefore H3K9 methylation seems to be crucial for male meiosis. 
Prdm9 (also known as Meisetz), a germ line specific H3K4 tri-methylase, is also crucial for synapsis and 
recombination of homologous chromosomes during meiotic prophase (Hayashi et al., 2005). In Prdm9-
deficient spermatocytes, a number of genes, including those that are specifically expressed in meiotic 
germ cells, were repressed. These results suggest that Prdm9 mediated H3K4 methylation is involved in 
the activation of genes important for synapsis and recombination (Hayashi et al., 2005).  
During meiosis, homologous recombination occurs preferentially at defined sites, known as hotspots. 
Crossovers generated during meiotic recombination are important for proper alignment of homologous 
chromosomes during metaphase of the first meiotic division and therefore for proper segregation of 
chromosomes. Moreover, crossovers are the central source for genetic variation among offspring. 
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Recently, a number of studies independently identified Prdm9 as a key factor responsible for specifying 
and initiating the activity of recombination hotspots in mammals (Baudat et al., 2010; Myers et al., 2010; 
Neale, 2010; Parvanov et al., 2010). 
 
 
2.7.1.3.  Meiotic Sex Chromosome Inactivation (MSCI) 
 
MSCI is the process of transcriptional silencing of the X and Y chromosomes during the pachytene stage of 
meiosis. Shortly after the zygotene-pachytene transition, when meiotic synapsis between autosomes is 
complete, the heterologous sex chromosomes that only homologously synapse at their pseudoautosomal 
regions, are rapidly silenced and compartmentalized into a peripherial nuclear subdomain termed the sex-
body (McKee and Handel, 1993; Solari, 1974; Turner, 2007). Phosphorylation of the histone variant H2AX 
at serine residue 139 (γH2AX) is essential for MSCI. In general γH2AX plays a crucial role in DNA DSB 
repair (Celeste et al., 2002; Rogakou et al., 1999). DSBs generated for homologous recombination on 
autosomes during leptotene and zygotene stages also acquire this modification (Mahadevaiah et al., 2001). 
However, at the time MSCI is initiated H2AX is rapidly and extensively phosphorylated at the sex 
chromosomes independent of DNA breaks (Turner et al., 2005). H2AX-null mice display complete meiotic 
arrest associated with MSCI failure (Fernandez-Capetillo et al., 2003). (H2AX phosphorylation is dependent 
on the DNA repair protein ATR (Ataxia telangiectasia and Rad3 related) and ATR recruitment is dependent 
on the tumor suppressor BRCA1 (Breast cancer 1) (Turner et al., 2004). MSCI is defective in BRCA1 
mutant mice, because H2AX phosphorylation does not take place on the XY chromosomes, but at ectopic 
sites throughout the nucleus, as a result of failure to properly localize ATR (Turner et al., 2004; Xu et al., 
2003). Thus the linear recruitment and function of BRCA1-ATR-γH2AX act to initiate MSCI. Other post-
translational modifications such as H2AUb (Baarends et al., 1999; Baarends et al., 2005), H3K9me2 as well 
as de-acetylation of histones H3 and H4 (Khalil et al., 2004) may serve in the maintenance of MSCI, as they 
are established shortly after MSCI initiation, but then remain associated with XY chromosomes throughout 
meiosis and into spermiogenesis, long after γH2AX is gone. Over the past years it has become apparent 
that MSCI is a consequence of synaptic failure and is therefore part of a more general meiotic silencing 
mechanism termed Meiotic Silencing of Unsynapsed Chromatin (MSUC). Inducing unsynapsis at autosomal 
regions using a mouse line with an X-16 reciprocal translocation showed that indeed, unsynapsed 
chromatin is inducing binding of BRCA1, ATR, γH2AX and silencing (Turner et al., 2005). Even female mice 
with only one X undergo MSCI at unsynapsed chromatin (Speed, 1986). Furthermore providing the normally 
unsynapsed chromatin with a synaptic partner, like in XYY male mice, lead to the YY chromosomes 
escaping MSCI (Turner et al., 2006).   
Despite previous debates, it is now clear that, at least in part, silencing of XY chromosomes persists 
throughout spermatogenesis, a process known as post-meiotic sex chromosome repression. Examining X 
43 
 
chromosome transcriptional activity using microarrays revealed that approximately 87% of X-linked genes 
are repressed in the post-meiotic period (Namekawa et al., 2006). This correlates with previous 
observations that modifications characteristic of heterochromatin stay associated with sex chromosomes 
after meiosis (Khalil et al., 2004). It has also been suggested that this repressed stated is carried over to the 
next generation, providing the basis for non-random paternal X chromosome inactivation in the early 
embryo (Huynh and Lee, 2003). This model however is highly debated, as other studies argue that paternal 
X inactivation only takes place in the early embryo in a Xist-dependent manner (Okamoto et al., 2005) or as 
recently proposed, in Xist-independent manner (Kalantry et al., 2009).  
Inactivation of the XY chromosomes during meiosis is intriguing and many questions remain regarding this 
phenomenon. It is clear that MSCI is essential for male fertility, but why sex chromosomes have to be 
silenced during meiosis is still poorly understood. 
 
2.7.1.4.  Histone-to-protamine exchange and the unique chromatin of the spermatozoon 
 
The high degree of condensation of spermatid chromatin during spermiogenesis is achieved by replacing 
histones by protamines (Marushige and Marushige, 1975). The histone-to-protamine exchange involves 
replacement of histones with transition proteins (TP1 and TP2) that are subsequently replaced by 
protamines. This exchange process is associated with hyperacetylation of of histone H4, which was 
proposed to promote a looser nucleosomal structure facilitating exchange (Hazzouri et al., 2000; Sonnack 
et al., 2002). 
Mice mutant for either TP1 or TP2 are fertile with only subtle abnormalities in chromatin packaging during 
spermiogenesis (Yu et al., 2000; Zhao et al., 2001). However, mice deficient for both TPs exhibited 
severe spermatogenesis defects. Defective chromatin condensation and DSBs were noted, which 
resulted in male sterility (Zhao et al., 2004).  
Protamines are small basic proteins rich in arginine and cysteine and are specific to spermatids (Wouters-
Tyrou et al., 1998). Mouse and human genomes encode for two different protamine (Prm) molecules, 
Prm1 and Prm2. Both are encoded by relatively short genes comprising two exons. Prm2 encodes a 
precursor protein that binds to DNA and undergoes proteolytic processing during the last stages of 
spermatid elongation. The mature forms of Prm1 and Prm2 bind to 10 and 15 base pairs of DNA, 
respectively. This binding neutralizes the negative charge of the DNA backbone and enables the DNA 
molecules to pack closely together. In a final step, which is happening after the spermatozoa leave the 
testis and proceed through epididymis, a network of bisulfate bonds is formed between the adjacent 
protamine molecules leading to a very compact arrangement (Balhorn, 2007). Disruption of one copy of 
either gene, i.e. haploinsufficiency for either protamine gene disrupts nuclear formation, processing of 
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Prm2 and sperm function (Cho et al., 2003). In humans even the ratio of Prm1:Prm2 is important, as 
perturbation of the normally 1:1 ratio is associated with male infertility (Balhorn et al., 1988; de Yebra et 
al., 1993). Furthermore, the JmjC-domain containing H3K9me1/2 de-methylase Jhdm2A was shown to at 
least in part regulate activation of TP1 and Prm1 genes (Okada et al., 2007). Jhdm2A binds directly to 
TP1 and Prm1 genes, and is responsible for the reduction of H3K9 methylation at their promoters. In the 
absence of Jhdm2A the promoters remain H3K9 methylated and silenced, causing defects in spermatid 
elongation, abnormal nuclear morphology and infertility (Okada et al., 2007). 
 Expression of both TPs and protamines is tightly regulated during spermatogenesis. Global transcription 
ceases along with the chromatin condensation. Therefore, transcription and translation of protamines are 
uncoupled. Protamine transcription starts in transcriptionally active round spermatids and the transcripts 
are stored in the cytoplasm as messenger ribonucleoprotein particles. They are activated for translation in 
elongated spermatids only one week later (Braun, 2000). 
The histone-to-protamine exchange process is not complete, 1% of nucleosomes in mouse and up to 
10% in humans are retained (Tanphaichitr et al., 1978; Wykes and Krawetz, 2003). The role of these 
retained nucleosomes is not understood, but it was speculated that they may be mere remnants of 
incomplete histone-to-protamine exchange or that they may have a biologically significant role in 
transgenerational epigenetic inheritance. Recent studies, including one from our lab, have demonstrated 
that retained histones in mouse and human sperm are not simply randomly distributed remains of 
inefficient protamine replacement, but are associated with specific promoters (Arpanahi et al., 2009; 
Brykczynska, in press.; Hammoud et al., 2009). Moreover these histones can carry PTMs such as the 
active H3K4me2 or the Polycomb mediated repressive H3K27me3 that occupy functionally defined 
groups of genes. H3K4me2-marked promoters control genes with functions in spermatogenesis and 
cellular homeostasis, suggesting that this mark reflects germline transcription. By contrast, multiple 
developmental regulators, which are Polycomb targets in pluripotent somatic cells, are marked by 
H3K27me3 in human sperm. Similarly to somatic cells, the presence of this mark correlates with gene 
repression during spermatogenesis and in the early embryo. These data suggest a model in which 
H3K27me3, transmitted by sperm, assures repression of developmental regulators at the totipotent stage 
of the pre-implantation development (Brykczynska, in press.). Functional testing of this model is a current 
project in our laboratory.  
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2.7.2. The female germ line 
 
2.7.2.1.  Oogenesis 
 
Oogenesis begins with the formation of primordial germ cells in the post-implantation embryo that migrate 
into the genital ridge. Once established in the prospective ovary, primordial germ cells lose their motility 
and go through several rounds of mitosis to create a large supply of oogonia. In the mouse, oogonia enter 
meiosis (hereafter referred to as oocytes) at approximately 13.5 dpc, pass through leptotene, zygotene 
and pachytene stages of meiotic prophase 1 before arresting at diplotene (referred to as dictyate arrest) 
(Pepling, 2006). This is in contrast to male germ cell development, where gonocytes halt in mitosis. 
Oocytes remain in this cell cycle stage until end of folliculogenesis. Coincident with the initiation of 
meiosis, oocytes become enclosed in a single layer of squamous pregranulosa cells resting on the 
basement membrane. This nest of cells together with the resting oocyte in the center is called the 
primordial follicle; the oocyte itself is classified as the primordial oocyte. Primordial oocytes remain resting 
until recruitment into the growing population starting a few days after birth. The dictyate arrest is 
characterized by 4C DNA content (four times the haploid amount), paired homologous chromosomes in a 
fully extended conformation and active transcription (Bukovsky et al., 2005). The mechanism by which 
primordial follicles are maintained or leave the resting pool and start the growing phase is not well 
understood. Follicle activation is initiated with granulosa cell proliferation and their change in shape to a 
cuboidal form (Braw-Tal, 2002; Hirshfield, 1991). In the mouse ovary, the first wave of oocyte growth is 
thought to be initiated synchronously shortly after birth. As oocytes progress through primary, secondary 
and different antral stages, granulose cells proliferate, eventually reaching 6-7 layers around the oocyte 
(Fortune, 2003). In growing follicles granulose cells become metabolically coupled with the oocytes 
through gap junctions that are of vital importance to oogenesis. Follicle activation also triggers the 
production and secretion of the oocyte specific Zona pellucida (ZP). The ZP is a glycoprotein membrane 
formed in the perivitelline space of the follicle that consists of three glycoproteins: ZP1, ZP2 and ZP3. The 
zona provides a protective coat around the oocyte and has a key role in fertilization (Litscher et al., 2009; 
Philpott et al., 1987; Ringuette et al., 1988). Numerous studies have been carried out to identify factors 
responsible for folliculogenesis, but the notion that the oocyte is the main driving force has been gaining 
acceptance (Eppig, 2001; Fair, 2003). During the growth phase the oocyte increases its volume more 
than 100-fold (Gougeon, 1996). This growth is not a simple process of increasing mass, but involves 
qualitative and quantitative changes in key molecules for metabolism, structure and information that are 
fundamental for acquiring meiotic competence (i.e. the ability to resume meiosis and progress to and 
arrest at metaphase-II) (Sorensen and Wassarman, 1976; Wickramasinghe and Albertini, 1992; 
Wickramasinghe et al., 1991) and developmental competence (i.e. the ability to be fertilized and develop 
to term) (Eppig and Schroeder, 1989). 
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The most striking change is the burst of transcription in the oocyte following follicle activation, which is 
sustained until the end of folliculogenesis. Increased transcription is also associated with increased protein 
synthesis, in part to meet the needs of the rapidly growing oocyte. However, a great portion of mRNAs 
made at this stage are stored and will only be recruited for translation during meiotic maturation or after 
fertilization (Bachvarova, 1985; Bachvarova et al., 1985). Transcription is rapidly shut down when the 
oocytes reach the fully grown Germinal vesicle (GV) stage (Bouniol-Baly et al., 1999; Liu and Aoki, 2002; 
Miyara et al., 2003).  
 
2.7.2.2.  Epigenetics and chromatin in the female germ line 
 
Chromatin in growing mouse oocytes is initially decondensed in a configuration termed Non-surrounded-
nucleolus (NSN). During the last stage of oocyte growth major chromatin remodeling takes place, 
condensing the chromatin around the nucleolus and resulting in oocytes with Surrounded-nucleouls 
configuration (SN) (Bouniol-Baly et al., 1999; De La Fuente and Eppig, 2001). Although transcription does 
correlate with chromatin configuration: NSN oocytes being transcriptionally highly active and SN oocytes 
virtually transcriptionally silent (Bouniol-Baly et al., 1999; Miyara et al., 2003), further studies have shown 
that chromatin remodeling is not required for transcriptional shut-down. For example, oocytes of mice 
mutant for the chromatin remodeler Nucleoplasmin 2 (Npm2) fail to condense into the SN configuration, but 
still achieve transcriptional silencing (De La Fuente et al., 2004a).  
In addition, the transition into SN configuration also correlates with timely progression of meiotic maturation 
(Debey et al., 1993; Wickramasinghe et al., 1991) and when fertilized and further cultured, SN oocytes 
readily developed to bastocyst stage, while embryonic development of NSN oocytes was comprised 
(Zuccotti et al., 1998). These results demonstrate that changes in large-scale chromatin structure are 
essential to confer growing oocytes with meiotic and developmental competence. 
Other chromatin-based processes, like epigenetic modifications have also been described to play  important 
roles in the regulation of oocyte chromatin structure. Histone acetylation (H3K9, H3K18; H4K5 and H4K12) 
was shown to actually increase during oocyte growth, fully grown oocytes having most modifications, 
despite that acetylation is associated with relaxation of chromatin (De La Fuente, 2006; Kageyama et al., 
2007; Kim et al., 2003a). Surprisingly, treatment of SN oocytes with an HDAC inhibitor, trichostatin A (TSA) 
resulted in decondensation of primarily euchromatic regions of chromatin (De La Fuente et al., 2004a). 
Furthermore, this decondensation did not restore transcriptional activity. In addition, overexpression of 
Hdac6 in GV oocytes induced premature and even over condensation of chromatin (Verdel et al., 2003). 
Two conclusions can be drawn from these studies: first, the appropriate balance of acetylation-
deacetylation has to be orchestred to achieve proper chromatin condensation and second, that acetylation 
and as previously pointed out, chromatin compaction is not associated with transcriptional activity. 
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HDACs also regulate critical aspects of chromatin remodeling during meiosis, as a wave of genome-wide 
deacetylation was shown to coincide with resumption of meiotic maturation (De La Fuente et al., 2004a; 
Kim et al., 2003a; Sarmento et al., 2004). Specifically, deacetylation of the H4K5 residue was essential to 
allow the chromatin remodeler ATRX to bind to centromeric heterochromatin in condensed chromosomes 
(De La Fuente et al., 2004b). Inhibition of HDACs by TSA resulted in hyperacetylated chromosomes with no 
ATRX binding, which in turn lead to abnormal chromosome alignments at metaphase-II (M-II) (De La 
Fuente et al., 2004b).  
 
2.7.2.3.  Transcription during oocyte growth  
 
As mentioned before, oocytes have the unique capacity to build up a program that will sustain further 
development such as meiotic maturation and early embryogenesis. Essential part of this program is 
production of maternal transcripts during oocyte growth (Figure 2). Over the past years considerable effort 
was made to characterize this maternal transcriptome. A number of studies performed expression profiling 
of oocytes and different stages of pre-implantation embryogenesis. By drawing out expression profiles for 
individual genes across different stages of development, sets of maternal transcripts with distinctive 
degradation patterns during pre-implantation development were identified.  
In one of the first reports published these maternal transcripts were associated with Gene Ontology (GO) 
terms such as “circadian rhythm”, “M-phase of mitotic cell cycle”, “DNA replication”, ”DNA repair”, “Golgi-
apparatus/intracellular protein transport”, “intracellular signaling cascade”, among others (Hamatani et al., 
2004). This shows that that the oocyte is already equipped with the transcripts that will produce the 
machinery to conduct essential processes in the embryo. Moreover, another simultaneously published 
study found maternal transcripts with predicted function in regulating polarity during pre-implantation 
embryogenesis (Wang et al., 2004c).  
Further insight on transcription during oocyte growth came from a report in which they performed global 
gene expression profiling of different stages of oocyte development, comparing transcriptomes of 
primordial, primary, secondary, small antral and large antral follicle oocytes (Pan et al., 2005). 
Hierarchical clustering analysis revealed that primordial oocytes have the most distinct transcription 
profile compared to any other oocyte stage. This major transition from primordial to primary oocyte is also 
reflected by the fact that ~50% of genes detected at these stages show an increase or decrease in 
transcription level (Pan et al., 2005). This transition likely reflects the dramatic reorganization in follicle 
structure and initiation of growth and development. Another apparent transition occurs between 
secondary and small antral follicle oocytes, which corresponds to the acquisition of meiotic competence 
(Sorensen and Wassarman, 1976; Wickramasinghe and Albertini, 1992; Wickramasinghe et al., 1991). 
Biological themes such as “protein synthesis”, “DNA repair” and “DNA damage response” are associated 
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with genes expressed throughout oocyte development. The primordial-to-primary oocyte transition 
includes changes in genes associated with “secreted proteins” involved in many key signaling pathways, 
“cell cycle” and “chromatin assembly or disassembly”, while the transition from secondary to small antral 
oocyte is specific for “microtubule-based processes”. These categories represent functions needed for the 
specialized development of oocytes as well as functions only needed in later development, again 
confirming the notion that the oocyte is a stock house for maternal transcripts essential for later 
development (Pan et al., 2005).  
 
 
2.7.2.4.  Meiotic maturation  
 
Follicular response to a surge of LH initiates ovulation, by stimulating granulose cells to shift from 
estrogen to progesterone production. Granulose cells also start to produce hyaluronic acid which leads to 
the mucification and expansion of the cumulus granulose cells and the disruption of gap junction contacts. 
The observation that oocytes removed from the ovary spontaneously resume meiosis lead to the 
conclusion that the follicle provides an inhibitory signal for cell cycle progression (Pincus and Enzmann, 
1935; Tsafriri, 1979). Indeed, 3‟,5‟-cyclic adenosine monophosphate (cAMP) provided to the oocytes from 
the surrounding cells via gap junctions was identified as the “meiotic arrestor”. Loss of intercellular 
contacts upon ovulation or isolation lowers cAMP levels in oocytes which initiates exit from the dictyate 
arrest (Dekel and Beers, 1978; Dekel and Beers, 1980). Resumption of meiosis commences with 
breakdown of the nuclear envelope, also known as Germinal vesicle breakdown (GVBD) and chromatin 
condensation. Oocytes progress through a prolonged (6-10 hours) metaphase-I (M-I), extrude the first 
polar body (PB) and without chromosome decondensation or replication proceed to M-II, where they 
become arrested again awaiting fertilization (Figure 2). The two M-phases of meiotic maturation are 
regulated differently to assure proper separation of maternal chromatin and appropriate maturity of the 
oocyte to support further development following fertilization. The cell cycle components involved in these 
processes are well described and excellently reviewed in Kubiak et al 2008 (Kubiak et al., 2008). 
 
 
2.7.2.5. Translational regulation in oocytes 
 
The stockpile of maternal messages that insures rapid development during later stages in the absence of 
transcription comes with a catch: the translation of these mRNAs must be prevented during their synthesis 
and storage during oogenesis, and then translation must be activated at specific time points of egg 
maturation or early embryonic development. The oocyte therefore needs a fine-tuned translation regulation 
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system. Mechanisms of translational regulation in oocytes have been extensively studied in Drosophila and 
Xenopus, but these basic mechanisms seem to be well conserved in mammals as well.   
The best described regulatory mechanism is regulation through the 3‟ poly(A) tail. The translational potential 
of maternal mRNAs is determined by the length of the poly(A) tail. Longer poly(A) tails (80-500 nucleotides) 
are associated with translational recruitment, while short tails (40-60 nucleotides) are linked to 
transcriptional repression (Piccioni et al., 2005).   
The 3‟ poly(A) tail is believed to mediate circularization of the mRNA mediated by interactions between 3‟ 
and 5‟ binding proteins. The poly(A)-binding protein (PABP) interacts with eIF4G, a member of the pre-
initiation complex on the 5‟ leading to the stabilization of the whole eIF4F pre-initiation complex. Poly(A) tail 
shortening thus leads to the destabilization of the pre-initiation complex (de Moor et al., 2005).   
Accurate regulation of translation through poly(A) tail length requires the coordinated action of the poly(A) 
polymerase and of the deadenylation complex. These proteins are recruited to the target mRNA by 
sequence specific factors that bind elements in the 3‟UTR, providing a mechanism by which poly-
adenylation can be regulated.  
Polyadenylation requires two elements: the hexanucleotide AAUAAA (Hex) (Sheets et al., 1994), which is 
bound by CPSF (cleavage and polyadenylation specificity factor) (Dickson et al., 1999) and the nearby 
Cytoplasmic polyadenylation element (CPE), which recruits CPEB (CPE-binding protein) (Hake and Richter, 
1994; McGrew et al., 1989). Activated (phosphorylated) CPEB binds CPSF, which in turn recruits the 
poly(A) polymerase GLD-2 (Germ line deficient 2) and decreases the affinity for the deadenylation complex 
(Kim and Richter, 2006; Mendez et al., 2000; Rouhana et al., 2005).  
Translation of mRNAs can be blocked by what‟s called “masking”. This involves binding of proteins to the 
3‟UTR of messages that inhibit translation by blocking lengthening of the poly(A) tail (Tadros and Lipshitz, 
2005). This inhibition requires unphosphorylated CPEB, which recruits an eIF4E-binding factor named 
Maskin, precluding the interaction of eIF4G with eIF4F and therefore the 40S ribosomal subunit recruitment 
(Stebbins-Boaz et al., 1999). Alternatively, CPEB can bind 4E-T, which in turn recruits the oocyte specific 
eIF4E isoform (eIF4loo in mouse), suggesting an oocyte specific version for CPEB-mediated mRNA 
repression (Evsikov et al., 2006; Minshall et al., 2007). 
Finally, another trans-acting factor required by some repressed mRNAs is Pumilio, which binds to PBEs 
(Pumilio binding element) in the 3‟UTR and interacts with CPEB to participate in translational repression. 
Recently, two interesting studies in Xenopus defined a combinatorial code based on the elements present 
in the 3‟UTRs of messages, the position of elements along the 3‟UTR and the distance between the binding 
sites to predict differential translational behavior of mRNAs during meiotic maturation. Furthermore, they 
identify positive and negative feedback loops that generate waves of polyadenylation and deadenylation, 
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creating a translational regulatory circuit that drives meiotic progression (Belloc and Mendez, 2008; Pique et 
al., 2008).  
As pointed out before, these mechanisms were primarily identified and studied in Xenopus and Drosophila. 
An example, to demonstrate that poly(A)-mediated mechanisms also exist in the mouse, comes from 
expression profiling of GV and M-II mouse oocytes. When expression profiles were compared, a large 
number of genes showed up-regulation between the two stages, despite the well known fact that there is no 
transcription during meiotic maturation (Bachvarova, 1985; Bachvarova et al., 1985). This “increase” in 
transcription was due to the technique used for RNA amplification, which involves annealing between the 
poly(A) tail and an oligo-(dT) primer. The elongation in the poly(A) tail of mRNAs was responsible for 
increased efficiency of annealing and therefore the detection of such transcripts (Wang et al., 2004c).  
Indeed, another study also comparing expression profiles of mouse GV and M-II oocytes but using 
amplifying primers that are unbiased towards the poly(A) tail length, basically found only message loss 
during maturation; 98.5% of transcripts changing between the two stages being down-regulated. GO 
analysis showed that transcripts involved in processes that are associated with meiotic arrest at the GV-
stage and the progression of oocyte maturation, such as oxidative phosphorylation, energy production and 
protein synthesis and metabolism were dramatically down-regulated. In contrast, transcripts encoding 
participants in signaling pathways essential for maintaining the unique arrested M-II stage, such as protein 
kinase pathways, were the most prominent among the stable transcripts (Su et al., 2007).  
Furthermore, the importance of poly(A) tail length-mediated regulation in mammals is also highlighted by 
polysome analysis performed in mouse oocytes and zygotes. This study provides direct analysis of 
transcripts that are utilized at these stages, demonstrating that a large portion of mRNAs are differentially 
associated with polysomes at each stage (Potireddy et al., 2006). 
A very recent study by the lab of Petr Svoboda, proposes means by which maternal transcripts are stored in 
the oocyte until recruitment (Flemr et al., 2010). They identify a novel type of RNA granule in oocytes, which 
is related to Processing bodies (P-bodies). P-bodies are cytoplasmic ribonucleoprotein particles that are the 
sites of translational repression and mRNA decay in somatic cells. P-bodies were also detected in the 
cytoplasm of growing, meiotically incompetent oocytes, however they disappear by the end of oocyte 
growth. Instead, sub-cortical accumulation of granules is observed that contain maternal messages and 
RNA binding proteins, some of which are shared with P-bodies, such as Ddx6, CPEB, Ybx2 Msy2 and the 
exon junction complex. These granules disperse during oocyte maturation, consistent with the recruitment 
of maternal mRNAs that occur at this time. In contrast to P-bodies, a component of the decapping complex 
Dcp1a is not associated with these sub-cortical oocyte granules. Dcp1a levels however increase during 
meiotic maturation, which correlates with the first wave of maternal message destabilization (Flemr et al., 
2010).  
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Another interesting type of transcript regulation in oocytes that involves small regulatory RNAs has 
emerged in the past few years. 
 
MicroRNAs (miRNAs) have been identified in oocytes by several groups (Murchison et al., 2007; Tang et 
al., 2007; Watanabe et al., 2006). MiRNAs are single-stranded RNA molecules of about 21-23 
nucleotides in length with 3' two-nucleotide overhangs and are complementary to sites in the 3'UTR of 
their target messages (Murchison and Hannon, 2004). MiRNAs are first transcribed as primary transcripts 
(pri-miRNA) and processed to 70 nucleotide stem-loop structures known as pre-miRNAs by the RNase III 
nuclease Drosha. These pre-miRNAs are further processed to mature miRNAs by the endonuclease 
Dicer which also initiates the formation of the Argonaut (ago)-containing RNA-induced silencing complex 
(RISC). The small RNA directs the RISC complex based on sequence homology to target mRNAs, which 
are subsequently translationally silenced or cleaved.  
Do miRNAs influence transcript regulation in oocytes? Conditional deletion of Dicer in growing oocytes 
results in loss of most maternal miRNAs. Moreover, maternal Dicer mutants are sterile. The mutant 
oocytes mature and undergo GVBD but are defective in meiotic spindle organization (Murchison et al., 
2007; Tang et al., 2007). Some Dicer mutant oocytes are capable to support fertilization but do not 
progress through the first cell cycle (Tang et al., 2007). Microarray analysis showed that in the absence of 
Dicer transcript levels of more than one-third of genes expressed in oocytes increased. Interestingly, the 
up-regulated set includes a number of genes involved in microtubule associated processes which might 
explain the observed chromosome segregation defect. However, the 3‟UTRs of transcripts up-regulated 
in Dicer-deficient oocytes were not enriched for predicted miRNA binding sites.  
This finding prompted other labs to further investigate the importance of miRNA-mediated regulation in 
oocytes. A recent study examined oocytes lacking Dgcr8 (Suh et al., 2010). Dgcr8 is an interacting 
partner of Drosha, the RNase that cleaves pri-miRNAs to release hairpin-shaped pre-miRNAs that are 
subsequently cut by the cytoplasmic RNase Dicer to generate mature miRNAs. The Drosha-Dgcr8 
complex, unlike Dicer, is only required for miRNA biogenesis, but not the RNAi pathway. Maternal Dgcr8-
deficiency was shown to result in a similar loss of miRNAs as in Dicer knockout oocytes, yet the 
transcriptome of Dgcr8-/- oocytes was more similar to wild-type. Moreover, Dgcr8 is not a maternal effect 
gene, as viable offspring can be produced from mutant oocytes (Suh et al., 2010). Another study tested 
the ability of endogenous miRNAs to mediate cleavage or translational repression of reporter mRNAs in 
oocytes (Ma et al., 2010). They found that miRNAs only poorly repress translation of reporter mRNAs and 
their mRNA degradation activity was even more inefficient. Together, these findings point towards the 
idea that not miRNAs, but rather siRNAs may control transcript regulation in mouse oocytes. 
Two very recent, simultaneous studies showed that uniquely, mammalian oocytes produce endogenous 
small interfering RNAs (siRNAs) and regulate transcripts through RNA interference (RNAi) (Tam et al., 
2008; Watanabe et al., 2008).  
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In contrast to the miRNA pathway, RNAi is induced by long dsRNA. The two pathways are closely related 
and some of the components, such as Dicer are shared. Before these studies, endogenous siRNA 
mediated gene regulation has only been observed in organisms possessing RNA-dependent RNA 
polymerase activity, a feature which is absent in mammals (Ambros, 2004; Pak and Fire, 2007; 
Vaucheret, 2006).  
In mouse oocytes, inverted repeat structures, bidirectional transcription and antisense transcripts from 
various loci are sources of dsRNA; such loci were shown to be either retrotransposons or pseudogenes.  
Antisense pseudogene (nonfunctional homolog) transripts were able to hybridize to mRNAs of 
homologous protein coding genes. Moreover, examining Dicer knockout oocytes revealed genes with 
abundant, pseudogene-derived siRNAs showed significant increase in expression. Thus the siRNA 
pathway is functional in mouse oocytes and is involved in retrotransposon and protein-coding transcript 
regulation (Tam et al., 2008; Watanabe et al., 2008).  
Taken together, it seems that the previously hypothesized miRNA pathway only has a weak impact on the 
maternal transcriptome, and the transcriptional misregulation in Dicer knockout oocytes can mainly be 
attributed to disruption of the siRNA pathway. 
 
2.7.3. Fertilization and early embryonic development 
 
Fully matured oocytes (M-II) are arrested in their cell cycle and show low metabolic activity (Acevedo and 
Smith, 2005). Triggered by external stimuli, oocyte activation initiates a number of events, which brings 
the oocyte out of its “dormant” state. In mammals, fertilization by a single sperm is responsible for 
activation. Sperm entry initiates Ca
2+
 spiking, a signal that is both necessary and sufficient to induce 
oocyte activation (Jones, 1998). Ca
2+
 oscillations lead to activation of a signaling cascade that triggers 
resumption of cell cycle progression (Jones, 2005). Meiosis II is completed by another asymmetric 
division that produces the secondary PB, rendering the maternal genome haploid. The paternal genome 
undergoes major remodeling events and eventually, like the maternal genome, forms a nucleosomal-
configured pronucleus (PN). Initially both PN are small in size and are far apart from each other. As 
zygotic development proceeds, the PN undergo decondensation (the paternal one always being bigger) 
and move towards each other to the center of the embryo. Based on morphology, zygotic substages have 
been defined (Adenot et al., 1997; Santos et al., 2002). PN0 refers to the zygote immediately after 
fertilization characterized by maternal chromosome segregation and paternal sperm decondensation, 
PN1 pronuclei are small and reside at the periphery of the embryo, PN2 pronuclei have an increased size 
and have started to migrate toward the center of the embryo, PN3 pronuclei have migrated toward the 
center, large PN4 pronuclei are close to each other and PN5 refers to large central pronuclei. A striking 
feature of this phenomenon is that maternal and paternal genomes will replicate in two physically distinct 
compartments. At the end of zygotic development, the pronuclear membranes break down and parental 
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genetic material fuses during the first mitotic division. However maternal and paternal genomes will only 
become fully intermingled by the 8-cell stage (Mayer et al., 2000b; Puschendorf et al., 2008) (Figure 2).  
 
 
 
 
 
 
Figure 2. Epigenetic events during mouse pre-implantation development. 
   (Adapted from (Albert et al. 2009.)) 
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2.7.3.1.  Epigenetics of early development 
 
At the time of fertilization, there is a marked difference in the way the genomes of the sperm and oocyte are 
organized, due to differential epigenetic programming during spermatogenesis and oogenesis (Sasaki and 
Matsui, 2008). The oocyte DNA comes in a nucleosomal configuration with a full arsenal of PTMs on 
histones, while the sperm DNA is tightly packed in protamines with only 1-10% of histones remaining. Upon 
fertilization, the sperm nucleus undergoes extensive remodeling in the oocyte cytoplasm (Figure 2). This 
chromatin reorganization can be divided into different phases, first dispersion, followed by rapid 
recondensation is observed as the nuclear envelope is removed and various cytoplasmic factors alter the 
highly compacted sperm nucleus. The final phase encompasses drastic expansion of the paternal genome 
(along with the maternal PN) (Adenot et al., 1991; Nonchev and Tsanev, 1990). The first two phases are 
concomitant with the replacement of protamines with histones of maternal origin.  
As this histone incorporation takes place in the absence of DNA replication, it is not surprising that the 
replication independent (RI) H3 variant H3.3 is specifically incorporated into paternal chromatin (Torres-
Padilla et al., 2006; van der Heijden et al., 2005) (Figure 2). A similar pattern of asymmetric localization is 
observed for the H3.3 specific chaperone HIRA. Canonical H3 histones will only be assembled onto 
paternal chromatin during the first S-phase (van der Heijden et al., 2005).   
It has also been documented that the early paternal PN is enriched for acetylated histones in contrast to the 
maternal PN, which shows gradual accumulation of acetylation only later (Adenot et al., 1997). The 
decondensing paternal genome already contains certain acetylated H4 histones (H4K8 and H4K12), 
indicating that some of these marks are inherited from sperm (van der Heijden et al., 2006). Moreover, it 
has also been shown that histones are deposited onto paternal DNA in a pre-acetylated form on different 
residues (H4K5, H4K12, H4K16, H3K9, H3K14 and H3K18) (Sobel et al., 1995; van der Heijden et al., 
2006). Histone acetylation is associated with a relaxed, transcriptionally active chromatin state (Eberharter 
and Becker, 2002), which may also account for the more expanded configuration of the paternal PN and the 
fact that the paternal PN supports a relatively higher transcriptional activity than the maternal PN (Aoki et 
al., 1997). Supporting this hypothesis, it has been shown that treatment of mouse zygotes with HDAC 
inhibitors up-regulated the activity of an ectopic promoter to the levels observed in the male PN (Wiekowski 
et al., 1993).   
Differential acetylation levels persist between parental genomes until resolution during the mid zygote 
stage. At subsequent embryonic stages, histone acetylation remains high during interphase but is absent 
from cleavage chromosomes (Kim et al., 2003a; Sarmento et al., 2004). 
Regarding other histone modifications, newly incorporated histones into the male genome are generally 
hypomethylated, whereas maternal chromatin displays abundant methylation, adding to the epigenetic 
asymmetry between the two genomes (Figure 2). Di- and tri-methylation of H3K4, H3K9, H3K27 and 
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H4K20 are initially only detected (by immunofluorescent staining) in the maternal PN. The earliest 
methylation mark that appears on paternal chromatin is H4K20me1 which is detected strikingly fast after 
gamete fusion, in the periphery of the expanding sperm nucleus (van der Heijden et al., 2005). Following 
mono-methylation of H3K4, H3K9 and H3K27 appear after paternal PN formation (PN1/2), resulting in equal 
levels at both parental genomes. Generally, the acquisition of histone methylation seems to follow a strict 
spatially and temporally coordinated program with mono-methylation marks appearing first, followed by di- 
and tri-methylation. 
Interestingly, the Polycomb proteins Ezh2 and Eed that confer the di- and tri-methylation of H3K27 are 
present very early in the paternal pronucleus (at PN1/2) but nonetheless H3K27me3 only appears around 
PN3/4 concurrent with DNA replication (Erhardt et al., 2003; Santos et al., 2005). The H3K27 mono-
methylase has not been identified in mammals; however, since H3K27me1 is already present at PN1 in 
paternal chromatin, lack of substrate for PRC2 cannot be the limiting factor. Absence of other essential 
PRC2 complex members or post-translational modifications on PRC2 itself may explain the catalytic 
inactivity (Cha et al., 2005). 
Whereas H3K4 and H3K27 tri-methylation states are acquired on the paternal genome until the end of the 
first cell cycle (Lepikhov and Walter, 2004; Santos et al., 2005; Sarmento et al., 2004), acquisition of 
H3K9me2 and H3K9me3 is further delayed until the 4- to 8-cell stage (Lepikhov and Walter, 2004; Liu et 
al., 2004; Merico et al., 2007; Santos et al., 2005; Yeo et al., 2005) (Figure 2). H3K9me2 on the maternal 
genome, which is inherited from the oocyte, declines from the 1- to the 2-cell stage, indicating that no 
active H3K9me2 HMTase is present in the zygotic cytoplasm to maintain H3K9me2 during DNA 
replication (Liu et al., 2004; Yeo et al., 2005).  In contrast, nuclear transfer of the unmethylated paternal 
PN into enucleated GV or M-II oocytes allows de novo H3K9 methylation to occur suggesting that the 
oocyte cytoplasm but not the embryonic cytoplasm contains H3K9 HMTase activity. Moreover, inhibition 
of protein synthesis with cyclohexamid in the zygote induces H3K9me2 at the paternal genome, 
suggesting that the H3K9me2 HMTase is active before fertilization but is deactivated by a newly 
synthesized protein in the early embryo (Liu et al., 2004). Alternatively, a histone demetylase may be 
involved in antagonizing H3K9 HMTase activity specifically in the embryo (Agger et al., 2008). Indeed, the 
KDM4 subgroup of demethylases known to demetylate H3K9 are expressed in the embryo (Katoh and 
Katoh, 2007). It remains to be resolved whether the stepwise appearance of the various histone lysine 
methylation marks simply reflects the consecutive mode of action of the mono-, di- and tri-HMTs or 
whether is it used as a means to distinguish the parental genomes.  
A striking parental asymmetry in epigenetic silencing pathways at pericentric heterochromatin (PCH) has 
previously been reported by our lab (Figure 2). Namely, paternal PCH in the zygote lacks the canonical 
Suv39h heterochromatin silencing pathway, while maternal PCH is enriched for H3K9me3 and Suv39h-
components, such as HP1 and H4K20me3. Instead, paternal PCH is targeted by the PRC1 complex, 
which is responsible for transcriptional repression of major satellite repeats specifically from the male 
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genome. Embryos maternally deficient for a Suv39h components accumulate PRC1 proteins at maternal 
PCH lacking H3K9me3, thereby revealing hierarchy between repressive pathways. The PRC1-mediated 
silencing pathway seems to function as a default back-up mechanism for PCH repression in the absence 
of the canonical Suv39h pathway. Moreover, parental epigenetic asymmetries are observed along 
cleavage chromosomes and are only resolved by the 8-cell stage, presumably marking the end of 
maternal to embryonic transition (Mayer et al., 2000b; Puschendorf et al., 2008). 
 The most studied epigenetic asymmetry, however, in the mouse embryo is the differential patterns of 
maternal and paternal DNA methylation (Figure 2). Within a few hours after fertilization the paternal 
genome is globally and rapidly demethylated by an active mechanism, since it occurs in the absence of 
DNA replication or transcription (Mayer et al., 2000a; Santos et al., 2002). The exact mechanisms 
involved in active demethylation are poorly understood. Recently the cytidine deaminase AID has been 
implicated in active DNA demethylation events during mammalian PGC development (Popp et al., 2010), 
and in the context of somatic cell nuclear re-programming to a pluripotent state (Bhutani et al., 2010). 
Other enzymes involved in DNA repair, such as PARP-1, have also been suspected to play a role in 
paternal genome de-methylation in the zygote (Mark Wossidlo, personal communication). Another group 
showed that the elongator complex is required for active paternal genome demethylation in the 1-cell 
embryo, but the exact role of the elongator complex or the molecular mechanism involved are not known 
(Okada et al., 2010).  
An important question is whether this paternal DNA demethylation is really global? A detailed study of a 
few genes that are highly methylated in sperm shows that they rapidly loose their methylation in zygotes 
(Oswald et al., 2000), except for paternally imprinted genes (Olek and Walter, 1997). But the overall 
hypomethylated state of promoters in sperm (Farthing et al., 2008) argue against the importance of global 
demethylation for gene regulation. So then where is the genome-wide DNA methylation lost from?  
Bisulfite sequencing identified certain retrotransposons, such as Long Interspersed Nucleotide Elements 
(Line1) as targets of demethylation (Lane et al., 2003), while others, like the intracisternal A particle (IAP) 
retrotransposon were excluded from active DNA demethylation (Lane et al., 2003). 
Like the imprinted loci of the paternal genome, the female PN is protected from demethylation. Although 
the maternal factor Stella (Pgc7) localizes to both PN, it has been shown to specifically protect maternal 
PN as well as paternal imprinted loci from demethylation. The protective mechanism remains to be 
uncovered, as well as the mechanism which attributes specificity to it (Nakamura et al., 2007).  
The maternal genome on the other hand gradually looses DNA methylation, with lowest levels of DNA 
methylation at the morula stage. This is a passive demethylation event, as unmethylated DNA 
accumulates step-by-step, increasing after each round of DNA replication (Rougier et al., 1998; Santos 
and Dean, 2004). This process seems to be primarily caused by the inability of the embryo to maintain 
current methylation patterns.  
Indeed, the oocyte specific form of Dnmt1 maintenance DNA methyl-transferase (Dnmt1o), for a long time 
the only identified Dnmt to be present in early embryos, was shown to be retained in the cytoplasm of 
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developing embryos by a so far unknown mechanism (Cardoso and Leonhardt, 1999). Dnmt1o transiently 
localizes to the nucleus at the 8-cell stage, where it is thought to ensure the methylation status of 
imprinted loci before being shuttled back into the cytoplasm (Howell et al., 2001). Offspring from females 
lacking Dnmt1o show around 50% reduction in the number of normally methylated alleles of imprinted 
genes (Howell et al., 2001). These data argue, that Dnmt1o maintains the methylation status of imprinted 
genes only during one round of embryonic DNA replication at the 8-cell stage. How are then imprint-
specific methylation patterns maintained during the rest of pre-implantation development? A more recent 
study by Hirasawa et al. reports the presence, albeit at low levels, of the somatic form of Dnmt1 in 
oocytes and early embryos. Conditional deletion of maternal and embryonic Dnmt1 results in complete 
demethylation of imprinted loci by the blastocyst stage, whereas Dnmt3a or Dnmt3b are dispensable for 
this methylation (Hirasawa et al., 2008). 
Taken together, DNA methylation dynamics in the zygote might facilitate paternal epigenetic remodeling 
by erasing previously acquired spermatogenesis specific DNA methylation marks. Alternatively, paternal 
DNA demethylation may be required to allow for the generalized de-repression of paternal alleles to 
accommodate the minor transcriptional burst at the zygote stage. Paternal specific DNA demethylation is 
in line with the general more active paternal chromatin state defined by histone hyperacetylation and lack 
of repressive histone methylation marks. 
 
2.7.3.2. Maternal to embryonic transition (MET) 
 
Fertilization brings together the haploid genomes of two highly differentiated cells, the sperm and oocyte. 
One of the first functions of the embryo is to re-program the specialized parental genomes into a totipotent 
state. Totipotency is a rare and transient property, characterized by the ability of a single embryonic cell to 
give rise to all differentiated cell types that build up the adult body of an organism. It is displayed only by 
very early embryos in mammals, spans over few cell cycles and is already lost at the blastocyst stage (or 
even earlier). This extensive re-programming in early embryos is also known as the maternal to embryonic 
transition (MET). MET comprises mainly of two acts: the destabilization of maternal transcripts and proteins 
and the activation of an embryo specific expression program on the initially silent parental genomes. 
Early development relies on maternal transcripts and proteins which are loaded into the egg during oocyte 
growth. Maternal RNAs have been implicated in oocyte specific processes and also in basic biosynthetic 
processes that fuel embryonic development. Embryo specific mRNAs are stored in an inactive, masked 
form and recruited for translation in a stage specific manner during embryogenesis (Stebbins-Boaz and 
Richter, 1997). Their recruitment for translation is thought to be mediated by similar mechanisms as 
described above for message regulation during meiotic maturation, although considerably fewer studies are 
available, especially for mammalian embryonic translational regulation. In general in mouse and Xenopus, 
regulating the length of the poly(A) tail is crucial, and it is also achieved through specific binding elements in 
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the 3‟UTR, such as CPEs (Paillard et al., 2000; Simon et al., 1992). The mechanisms by which proteins that 
bind to these elements and accomplish poladenylation are not known, but it is speculated that they 
resemble events that take place during oocyte maturation (Paillard et al., 2000; Wu et al., 1997). There is a 
connection between the Ca
2+
 increase and translation initiation of maternal mRNAs, but the molecular 
pathways involved are not understood. In mouse, inhibiting Ca
2+
 release after fertilization prevents many 
activation associated changes in protein synthesis (Xu et al., 1994). In contrast, translation can artificially be 
stimulated by Ca
2+
 increase in the unfertilized egg (Ducibella et al., 2002).   
Maternal message recruitment was demonstrated to be essential for zygotic genome activation (ZGA) 
and embryo development. Treating 1-cell mouse embryos with 3‟-deoxyadenosine, which functions as a 
chain terminator of poly(A) tail elongation of maternal mRNA, but not 3‟-deoxyguanosine, decreased 
transcriptional activity in 1-cell embryos (Aoki et al., 2003). Accordingly, inhibiting protein synthesis with 
cycloheximide also leads to inhibition of embryonic transcription (Wang et al., 2001; Wang and Latham, 
2000).   
Further studies provided examples as to which maternal messages are targets of recruitment: following 
fertilization, spindlin and cyclin A2 mRNAs undergo poly(A) tail elongation and translation (Fuchimoto et 
al., 2001; Oh et al., 2000). Moreover, cyclin A2 translation was shown to be essential for zygotic genome 
activation and development beyond the 2-cell stage (Foygel et al., 2008; Hara et al., 2005).  
Insights into what kind of messages are recruited for translation in the zygote on a global scale comes 
from the previously mentioned study, in which they performed polysome profiling of mouse zygotes. They 
identified actively translated mRNAs at this stage involved in metabolic processes, transcription, 
translation, cell cycle regulation (Potireddy et al., 2006).  
Concurrent with the translation of some maternal mRNAs is the degradation of others. While seemingly at 
cross-purposes, both processes are essential for maternal regulation of embryonic development. 
Degradation can be coupled to translation to remove mRNAs that have already been translated and whose 
products are no longer needed and/or degradation may also simply occur without translation, to remove 
oocyte specific messages that are not needed or may even inhibit embryonic development.  
There are at least two types of degradation activities in the early embryo. The first, “maternal”, degradation 
activity is exclusively maternally encoded and functions right after fertilization. The second, “zygotic” activity 
requires embryonic transcription. For example in Drosophila, due to the possibility to separate egg 
activation from fertilization, the two activities can easily be observed (Bashirullah et al., 1999; Tadros et al., 
2003). In mouse, a large portion of maternal mRNAs are degraded by the 2-cell stage (Piko and Clegg, 
1982). Large scale transcriptome analysis at different stages of mouse pre-implantation development have 
also identified different kinetics of maternal message degradation, one prominent wave just after fertilization 
and one coinciding with the timing of zygotic genome activation at the 2-cell stage. Of note, a third set of 
maternal transcripts show a relatively stable profile, indicating that some maternal information may still 
contribute to embryonic development after zygotic genome activation (Hamatani et al., 2004).  
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Just as polyadenylation is important for translation of messages, removal of the poly(A) tail is a key step in 
degradation. Specific sequences in the 3‟UTR have been shown to target messages for deadenylation. 
Again, not much is known in mammals, but in Xenopus two cis-elements have been identified that direct 
deadenylation after fertilization: an A/U rich element (ARE) with repeats of AUUUA and the Embryonic 
deadenlylation element (EDEN) (De Renzis et al., 2007; Paillard et al., 1998; Voeltz and Steitz, 1998). 
These sequences function as binding sites for RNA binding proteins that lead directly or indirectly to 
deadenylation of the transcript. 
A recent study performing large-scale computational analysis of 3‟UTRs of expressed genes from fully 
grown mouse oocytes and 2-cell embryos has uncovered valuable information regarding features 
associated with the stability of maternal transcripts during early mammalian development (Evsikov and 
Marin de Evsikova, 2009). Comparison of the transcriptomes of the two stages revealed two types of 
behaviour of maternal mRNAs: a stable and a transient group. Interestingly, the two sets of transcripts 
differed in the size of their 3‟UTRs, the stable transcripts possessing significantly longer 3‟UTRs than the 
transient ones. Furthermore, differential nucleotide content of 3‟UTRs was also observed between the two 
groups, caused primarily by a higher portion of cytosines in the UTRs of transient and uracils in the UTRs 
of stable transcripts. Finally, they also concluded that CPEs and PBEs are predominant in the UTRs of 
stable transcripts (Evsikov and Marin de Evsikova, 2009). This study may be the first step towards 
defining a code, presumably more complex than in Xenopus, based on 3‟UTR features that may define 
translational regulation of mammalian messages following fertilization. 
The second accomplishment of MET is the activation of a new gene expression program on the newly 
formed embryonic genome. ZGA in the mouse has been reported to occur in two waves, a minor one 
during zygotic development and a major on at the 2-cell stage (Bouniol et al., 1995; Flach et al., 1982; 
Schultz, 1993) (Figure 2).   
Various analyses based on, for example, reporter gene expression, BrUTP incorporation into nascent 
RNA and transgene expression in the paternal genome have demonstrated that the 1-cell embryo has 
transcriptional activity (Bouniol et al., 1995; Matsumoto et al., 1994; Ram and Schultz, 1993). Based on 
quantification of BrUTP incorporation, this wave of transcription reaches only approximately 40% of the 
transcription levels at the 2-cell stage and is primarily supported by the male PN (Aoki et al., 1997).  
Surprisingly, genome-wide expression profiling studies searching for products of de novo transcription in 
the zygote, meaning transcripts at the 1-cell stage that are sensitive to an RNAPII inhibitor α-amanitin, 
failed to detect any (Zeng and Schultz, 2005). It therefore remains elusive what BrUTP incorporation 
represents at this stage. 
The chromatin structure in somatic cells is inherently repressive, as a consequence of DNA packaging 
into chromatin, which obstruct the access of transcription factors to DNA. Therefore, enhancers of cis-
acting elements are required to relieve the transcriptionally repressive state of chromatin structure. In 2-
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cell embryos, enhancers are necessary to achieve maximal transcription of reporter genes. However, in 
the 1-cell embryo reporter genes are actively transcribed even in the absence of enhancers (Wiekowski et 
al., 1991). These results suggest that on top of ZGA, a transcriptionally repressed chromatin state is 
established by the 2-cell stage, perhaps to confer specificity to genome activation.  
The chromatin-based nature of this repressive state is also supported by the observation that induction of 
a more active chromatin state by hyperacetylation at the 2-cell stage relieved the repression of enhancer-
less reporter genes and increased global BrUTP incorporation (Aoki et al., 1997; Wiekowski et al., 1993).   
Around 20% of genes detected at the 2-cell stage have been shown to be α-amanitin sensitive, also 
supporting the notion that ZGA is not as global as previously anticipated, but rather specific (Zeng and 
Schultz, 2005). Among the genes transcribed during major ZGA are genes involved in basic cellular 
function, ion transport, ribonucleotid metabolism, ribosome biogenesis, protein synthesis and transcription 
(Hamatani et al., 2004; Zeng et al., 2004; Zeng and Schultz, 2005).  
A dramatic change in promoter utilization also takes place during early embryogenesis, such that TATA-
less promoters are more efficiently utilized in early embryos compared to oocytes. Such change in 
promoter utilization could specifically enhance expression of genes needed in the embryo. For example, 
housekeeping genes are actually under-represented in the fully grown oocyte transcriptome (Evsikov et 
al., 2006), but their high expression is needed to support the increased energy and metabolic demands of 
the rapidly developing pre-implantation embryo. Many housekeeping genes are regulated by TATA-less 
promoters (Nothias et al., 1995), supporting the idea that promoter utilization change could contribute 
significantly to the re-programming of gene expression that occurs during the maternal-to-zygotic 
transition (Davis and Schultz, 2000).  
Although in general the molecular mechanisms regulating ZGA are poorly understood, it is established that 
in general translation of maternal messages is a prerequisite, as discussed before. Only a few specific 
maternal transcripts that are known to be involved in ZGA have been identified. Some of these will be 
discussed in the next chapter. 
 
2.7.3.3.  Maternal effect genes 
 
Maternal transcripts serve important roles during oocyte maturation and early embryonic development 
including embryonic genome activation. A handful of "maternal effect” genes have been identified over 
the past years which refers to the dependence of early embryonic development on maternal products and 
their deletion results in female sterility (Acevedo and Smith, 2005; Bettegowda et al., 2008). Such genes 
are: Mater (maternal antigen that embryos require) (Tong et al., 2000), Hsf1 (heat shock factor 1) 
(Christians et al., 2000), Dnmt1o (Howell et al., 2001), Npm2 (nucleoplasmin 2) (Burns et al., 2003; De La 
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Fuente et al., 2004a), Stella (Payer et al., 2003), Zar1 (zygotic arrest 1) (Wu et al., 2003), Pms2 (Gurtu et 
al., 2002), Dnmt3a (Kaneda et al., 2004), mHR6A (RAD6-related) (Roest et al., 2004), Basonuclin (Ma et 
al., 2006), Tif1α (Torres-Padilla and Zernicka-Goetz, 2006), Brg1 (Bultman et al., 2006), Dicer (Tang et 
al., 2007), and CTCF (Wan et al., 2008). In a strict sense, loss of maternal effectors only effects 
embryonic development, but not oogenesis, although for most identified genes the full extent of their 
effects on oocyte development are simply unknown. Majority of maternal effect genes have been 
identified using traditional knockout technology, however, this approach can only uncover maternal effect 
genes with relativly minor functions in other essential processes, as maternal effect genes that have 
important general functions preclude the analysis of homozygous null females. More recent studies have 
started to use oocyte specific promoter driven cre-recombinases to delete floxed alleles of target genes 
only in oocytes without affecting maternal viability or transgenic RNAi approaches. Loss of maternal effect 
genes in oocytes can lead to 1-cell arrest (like Npm2, Zar1, Hsf1 and Dicer), 2-cell arrest (Zar1, Mater, 
mHR6A and Brg1) or comprised pre-implantation development (Stella, Pms2 and CTCF). In most cases 
the exact phenotypes and the underlying molecular mechanisms are poorly described or not known at all. 
Zar1 was identified as a gene exclusively expressed in the growing oocyte and accordingly, Zar1-/- mice 
are viable and grossly normal but Zar1-/- females are sterile. Oocytes from Zar1-/- mice progress 
normally through meiotic maturation, but early embryonic development arrests at the 1- or 2-cell stage 
though the exact mechanisms remain elusive (Wu et al., 2003).  
Similarly, oogenesis is unaffected in females mutant for Mater, a factor that has been identified as an 
oocyte antigen in a mouse model of autoimmune premature ovarian failure. Mater mutant 2-cell embryos 
were able to synthesize the transcription-related complex (TRC) a marker of ZGA in mice (Conover et al., 
1991), although only at 40% reduced levels (Tong et al., 2000).  
Another maternal effect gene, whose molecular role in still unclear in the mouse, is the nucleoplasmin 
Npm2. Npm2-/- oocytes, as previously described are a model for global chromosome condensation 
defects at the end of oocyte growth, which however does not impair meiotic progression. In Xenopus, 
Npm2 removes sperm protamines, facilitates nuclear assembly and replication of the paternal genome. In 
contrast, sperm decondensation occurs normally in Npm2 maternal mutant mouse embryos; however, no 
nucleoli are visible in zygotes, first mitosis is delayed followed by fragmentation and death of most 
embryos (Burns et al., 2003; De La Fuente et al., 2004a). Interestingly, a recent study shows that 
maternal nucleoli are essential for embryonic development (Ogushi et al., 2008).  
 Basonuclin was knocked down in growing oocytes using a transgenic RNAi approach. This is not strictly 
a maternal effect gene as oogenesis is also affected. Basonuclin is a zinc-finger protein involved in the 
transcription of rRNA. In oocytes, Basonuclin co-localizes with RNAPI activity in the nucleus, however, 
Basonuclin is also abundant in the nucleoplasm and interacts with RNAPII promoters. In Basonuclin 
depleted oocytes, RNA polymerase I and II mediated transcription and normal oocyte morphology were 
affected. However, some oocytes do mature and are capable to support fertilization. In the resulting 
embryos chromatin decondensation of the paternal PN is decreased, chromatin is frequently observed to 
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fragment and DNA is unequally distributed between daughter cells resulting in embryonic arrest at the 2-
cell stage (Ma et al., 2006).  
Brg1 encodes a catalytic subunit of the SWI/SNF-related complexes. Conditional deletion of Brg1 in 
oocytes or depletion in early embryos resulted in incomplete ZGA (~1/3 of embryonically expressed 
genes were down regulated at the 2-cell stage) that was linked to decrease in H3K4me3 levels and a 2-
cell arrest phenotype (Bultman et al., 2006).  
At the onset of first genome activation Transcription intermediary factor 1 α (Tif1α) translocates from the 
cytoplasm into the pronuclei to sites of active transcription, that are also enriched in chromatin 
remodelers, such as Brg1 and Snf2h (Torres-Padilla and Zernicka-Goetz, 2006). Ablation of Tif1α by 
microinjection of dsRNAs or anti-Tif1α antibodies induces mislocalization of active RNAPII and the 
chromatin remodelers. Using a ChIP cloning approach authors identify 18 Tif1α targets in the zygote. In 
Tif1α-depleted embryos some of these target genes were found misregulated at the 4-cell stage. 
Therefore, Tif1α has no general effect on transcription but only affects certain genes. Moreover, it is 
unclear whether transcriptional misregulation of these targets occurs at the 1-cell or rather at the 2-cell 
stage during major ZGA. Nevertheless, ablation of Tif1α results in embryonic arrest at the 2/4-cell stage, 
therefore qualifies as a maternal effect gene (Torres-Padilla and Zernicka-Goetz, 2006). 
Stella (PGC7) is a gene specifically expressed in PGCs, oocytes, pre-implantation embryos and 
pluripotent cells. It encodes a protein with a Sap-like domain and a splicing factor motif-like structure, 
suggesting possible roles in chromosomal organization or RNA processing (Aravind and Koonin, 2000; 
Sato et al., 2002). As previously discussed, Stella protects the female PN and imprinted loci from active 
DNA de-methylation in the zygote (Nakamura et al., 2007). Stella-/- females are infertile, due to pre-
implantation embryonic lethality (Payer et al., 2003). 
Recently the pluripotency factor Oct4 has been shown to behave as a maternal effect gene. The first 
indication came from a study that tried to dissect the molecular basis of the differential developmental 
competence of embryos that are produced from NSN GV oocytes or SN GV oocytes (Zuccotti et al., 
2008). While SN GV oocyte derived embryos developed normally, NSN GV-embryos did not progress 
beyond the 2-cell stage. Oct4 expression was revealed as a major difference between the two GV 
groups. Interestingly, the absence of Oct4 in NSN oocytes was also proposed to cause down-regulation 
of Stella in NSN oocytes, as it does in ES cells (Levasseur et al., 2008; Loh et al., 2006). Another study 
reports morpholino-mediated Oct4 knockdown in zygotes, resulting in embryonic arrest around the 8-cell 
stage. Expression profiling of 2-cell Oct4 depleted embryos revealed that Oct4 at this stage is 
predominantly an activator of key genes mainly involved in transcription and translation (Foygel et al., 
2008).   
CTCF is the only known protein required for insulator activity in vertebrates. It can bind both DNA and 
itself, providing means by which CTCF molecules bound at remote sites in the genome can be brought 
together physically. According to the model for insulator activity, this would prevent enhancer-promoter 
interactions between elements on different chromatin loops, while facilitate interactions of those within the 
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same loop (Engel and Bartolomei, 2003; Wallace and Felsenfeld, 2007). CTCF binding sites were shown 
on the X chromosome, at imprinted loci and even at boundaries of active and inactive chromatin (Barski 
et al., 2007; Chao et al., 2002; Fitzpatrick et al., 2007; Yoon et al., 2005). Depleting maternal CTCF in 
growing oocytes results in misregulation of hundreds of genes in oocytes (overrepresented categories 
related to embryogenesis), problems in oocyte meiotic maturation and mitotic defects in the embryo that 
are accompanied by defects in ZGA (Wan et al., 2008).  
The maternal effect of Dicer was described in chapter 2.7.2.5. 
 
2.7.4. First differentiation events in the mouse embryo 
 
In the mouse the first three cleavage divisions give rise to eight morphologically indistinguishable embryonic 
blastomeres. During the 8-cell stage the embryo undergoes a process called compaction, which converts 
the embryo with eight clearly visible blastomeres into a tightly packed cell aggregate (Figure 2). 
Compaction is signaled by a marked increase in cell-to-cell contact between blastomeres, driven by 
formation of adherens junctions, consisting of E-cadherin and catenin complexes, and tight junctions 
(Eckert and Fleming, 2008; Johnson and McConnell, 2004). Upon compaction, an apical-basal polarity 
emerges in all blastomeres that are manifested in polarized distributions of various membrane and 
cytoplasmic factors along the axis from the surface (apical) to the center (basal) of the embryo (Johnson 
and McConnell, 2004). The 4
th
 cleavages generate a 16-cell embryo, where for the first time some cells in 
the center loose contact with the surface of the embryo. By the 32-cell stage these inner cells loose polarity, 
while the outer ones maintain it. After the 5
th
 cleavage, small cavities start to form between the blastomeres, 
which continually expand and fuse with each other to eventually form a single blastocoelic cavity. At this 
point the embryo is comprised of around 100 cells (divisions of blastomeres are asynchronous, leading to 
non-2
n
 blastomere numbers in the mouse embryo) and is known as the blastocyst (Cockburn and Rossant, 
2010).   
The first differentiation event in mammalian development is the establishment of two distinct cell lineages: 
the trophectoderm (TE) and the inner cell mass (ICM) that are clearly defined by the blastocyst stage. The 
outer TE, which will give rise to extraembryonic tissues of the developing conceptus, possesses the 
characteristics of an epithelium. The epithelium starts to form at the late 8-cell stage, is completed by the 32 
cell-stage and is marked by the previously mentioned AJ and TJ formation, which are necessary to seal off 
the blastocyst cavity. On the other hand, the aggregate formed by the internal cells of the blactocyst form 
the ICM, which will give rise to all cell types of the embryo proper (Cockburn and Rossant, 2010; Johnson 
and McConnell, 2004).  
The 32-cell stage is the first known time point when internal and external blastomeres of the embryo are 
morphologically distinguishable, inner cells being un-polarized in contrast to polarized outer cells. However, 
64 
 
in terms of developmental fate, when do inner and outer cells become committed to ICM and TE fates, 
respectively? Many studies have addressed this question by various micromanipulation techniques, leading 
to the general conclusion that blastomere fate in not determined until the 5
th
 cleavage. 
For example, external blastomeres of a 16-cell embryo can give rise to ICM when transplanted internally 
and internal blastomeres transplanted externally develop into TE (Johnson and Ziomek, 1983; Rossant and 
Vijh, 1980; Ziomek and Johnson, 1982). Moreover, an interesting study made use of a technique where 
surface cells of intact embryos were labeled with a dye and therefore could be identified and traced after 
dissociation and aggregation of a new embryo. When isolated internal or external cells of 16-cell embryos 
were aggregated, embryos developed readily to blastocyst stage, expressed appropriate markers and even 
produced viable mice after being transplanted into surrogate mothers. On the other hand, the same 
experiment performed on 32-cell embryos yielded strikingly different results. Aggregated external cells 
formed only TE, while internal cells did eventually form a blastocyst-like embryo but then failed to implant 
(Suwinska et al., 2008). These results clearly demonstrate that a significant change occurs in the 
developmental potential of blastomeres around the 5th cleavage so that cell fates become fixed by the 32-
cell stage. 
Interestingly, genome wide gene expression analyses of different pre-implantation stages of embryogenesis 
revealed the second most drastic gene expression transition (after the major ZGA at the 2-cell stage) 
between morula (around 32-cell stage) and blastocyst stage, demonstrating that cell fate commitment is 
accompanied by major gene expression changes. It would be very interesting to look in more detail into 
these gene expression profiles and try to pinpoint important factors involved in cell fate determination 
(Hamatani et al., 2004).  
Irreversible fate determination only at the 32-cell stage does not however exclude the possibility of certain 
earlier blastomeres having a developmental preference towards a certain lineage. It has been proposed that 
already at the 2-cell stage the two blastomeres show preference towards contributing to one or the other 
half of the blastocyst (Gardner, 2001; Piotrowska et al., 2001). However, further independent studies have 
clearly proven that this is not the case (Alarcon and Marikawa, 2003; Chroscicka et al., 2004; Kurotaki et al., 
2007; Motosugi et al., 2005). Another model proposes that a certain blastomere in the 4-cell embryo 
preferentially gives rise to TE on the half of the blastocyst that is on the opposite side of the ICM. This 
hypothesis has been supported by a number of observations. Apart from lineage tracing experiments, it has 
been noted that when these particular blastomeres are isolated and aggregated into an embryo, such 
embryos do not develop as efficiently as embryos aggregated from other blastomeres (Piotrowska-Nitsche 
et al., 2005; Piotrowska-Nitsche and Zernicka-Goetz, 2005). In addition, another study shows that this 
particular blastomere has reduced levels of H3R26me compared to the other blastomeres, and that this 
may interfere with ICM gene activation (Torres-Padilla et al., 2007). Nevertheless, this model is also under 
heavy debate. Just to mention one example, this certain blastomere only exists in about half of embryos (a 
subgroup that arises from specific asynchronous divisions of the 2
nd
 cleavage, termed ME-patterned 
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embryos); therefore this developmental bias is not universal and raises the question about its general 
importance in embryo patterning. An interesting way to approach this would be to determine expression 
profiles of individual early blastomeres and searching for molecular signatures of biased development. 
A few transcription factors have been identified to be essential for the formation of the first two lineages. 
Oct4, well known from ES cell work, is strongly expressed in the ICM (Okamoto et al., 1990; Rosner et al., 
1990; Scholer et al., 1990). Oct4 mutant embryos can develop to a blastocyst-like stage, however, on a 
closer look, the inner cells of such an embryo express TE markers (Nichols et al., 1998). Also, inactivation 
of Oct4 in ES cells results in differentiation into cells with TE characteristics (Niwa et al., 2000). Thus, Oct4 
is essential in repressing TE differentiation of ICM cells.  
Another key transcription factor essential for maintaining pluripotency of the ICM and ES cells is the 
homeodomain containing Nanog. Nanog has been shown to repress primitive endoderm (the third cell 
lineage arising in the mouse blastocyst) differentiation of the ICM (Chambers et al., 2003; Mitsui et al., 
2003; Rodda et al., 2005).  
Caudal-related homeobox2 (Cdx2) is a TE specific transcription factor. Cdx2 expression commences at the 
8-cell stage and at this point is co-expressed with Oct4 in all blastomeres. By the 16 to 32-cell stages, Cdx2 
expression increases in outer cells and decreases in inner cells, and by the blastocyst stage is exclusively 
TE specific (Dietrich and Hiiragi, 2007; Ralston and Rossant, 2008). This change in Cdx2 expression is the 
first known molecular distinction to occur in the mouse embryo. However, Cdx2 null embryos are capable of 
forming a blastocyst with TE-like cells, so loss of Cdx2 does not prevent TE formation (Beck et al., 1995; 
Ralston and Rossant, 2008; Strumpf et al., 2005). This indicates that mechanisms up-stream of Cdx2 must 
exist that will define TE commitment. Cdx2 however is essential to maintain TE fate, as Cdx2 null late 
blastocysts loose epithelial integrity and fail to maintain the blastocyst cavity and TE derivatives cannot be 
derived from Cdx2 null embryos (Strumpf et al., 2005).  
The TEA domain containing transcription factor Tead4 has been shown to act upstream of Cdx2. 
Interestingly, while expressed in both ICM and TE, Tead4 deficiency only affects TE formation, 
accompanied by the absence of Cdx2 and the presence of Oct4 and Nanog in all cells of the embryo 
(Nishioka et al., 2008; Yagi et al., 2007).  
A candidate down-stream target of Cdx2 is the T-box transcription factor Eomes, also specific for TE. Cdx2 
mutant embryos express lower levels of Eomes, while Eomes mutant embryos express normal levels of 
Cdx2. Eomes was shown to be required for late stage trophoblast differentiation in embryos (Ciruna and 
Rossant, 1999; Russ et al., 2000; Strumpf et al., 2005). 
Taken together, molecular mechanisms, including transcription factors or epigenetic mechanisms 
responsible for first cell fate determination are currently unknown and will be topics of exciting new 
discoveries. 
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2.8. Cell cycle and checkpoints in the embryo 
 
       2.8.1.   The first two cell cycles of the embryo 
 
Parameters of cell cycles of the pre-implantation mouse embryo are known to differ in many ways from the 
well conserved pattern of somatic cell cycles. Especially the first two mitotic cell cycles that each last for 
about 20 hours. Cell cycle progression of the early embryo takes place in the absence of transcription and 
is therefore reliant on maternal mRNAs and proteins provided by the oocyte. The overwhelming maternal 
contribution of cell cycle regulators has made it difficult to study cell cycle regulation of the first cleavage 
divisions. 
Although the timing of cell cycle phases can differ greatly between mouse strains (Molls et al., 1983), the 
first S-phase is shown to start 4-10 hpf, lasting for 4-8 hours. Replication is always initiated first in the male 
PN (Abramczuk and Sawicki, 1975). G2 is estimated to last for 3-5 hours and is followed by the first M-
phase. Interestingly, the duration of the first M-phase (120 min) is almost twice as long as the second 
mitosis (70 min). This increase seems to be due to a transient metaphase arrest independent of the spindle 
assembly checkpoint (SAC) (Sikora-Polaczek et al., 2006). The second G1-phase is very short (1-2 hours), 
followed by a 6 hour S-phase and then a very long G2-phase (12 hours) (Gamow and Prescott, 1970; 
Luthardt and Donahue, 1975; Molls et al., 1983). Interestingly, it is during this prolonged G2-phase that 
major ZGA takes place (Flach et al., 1982). The following divisions of the pre-implantation embryo are much 
faster, on average lasting for 10 hours each (Barlow et al., 1972; MacQueen and Johnson, 1983).  
 
2.8.2. Checkpoints 
 
At key transitions during cell cycle progression, signaling pathways monitor the successful completion of 
upstream events prior to proceeding to the next phase. These regulatory pathways are referred to as cell 
cycle checkpoints (Hartwell and Weinert, 1989). Cells can arrest at checkpoints due to external stimuli 
(stress signals, lack of growth factors or nutrients) or internal signals stemming from for example DNA 
damage or replication fork stalling. In the later cases, checkpoints induce a delay in cell cycle and therefore 
allow time for cells to repair DNA or finish replication, or - if the damage cannot be repaired or S-phase is 
not complete - checkpoints can trigger apoptosis to eliminate genetically instable cells. Defects in 
checkpoints can lead to chromosome segregation problems and aneuploidy, resulting in cell death later on. 
The G1/S checkpoint is where eukaryotes typically arrest the cell cycle if environmental conditions make 
cell division impossible or if the cell passes into G0 for an extended period.  
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Cell cycle progression is coupled with the sequential activation of of cyclin dependent kinases (Cdks) by 
their regulatory components, the cyclins. During normal G1-phase progression Cdk4,6/Cyclin D 
complexes form, they phosphorylate the tumour suppressor retinoblastoma (Rb), this in turn relieves the 
inhibition of the transcription factor E2F. E2F is then able to stimulate expression of Cyclin E which then 
interacts with Cdk2 and promotes G1/S-phase transition.  
The G1/S checkpoint is mainly exerted by action of the Cdk inhibitor p16 (Ink4a). p16 can bind to Cdk4,6 
and inhibit its interaction with Cyclin D. Another Cdk inhibitor causing G1/S arrest is p21 (Waf1/Cip1).  
After exposure of cells to genotoxic agents p21 is induced by p53-dependent transactivation. The 
elevated p21 binds and inactivates Cdk4,6/Cyclin D and Cdk2/Cyclin E complexes. The action of both 
inhibitors results in hypophosphorylation of RB and cell cycle arrest (Stewart and Pietenpol, 2001). 
 The G2 cell cycle checkpoint is an important control measure that allows suspension of the cell cycle 
prior to chromosome segregation. Entry into mitosis is controlled by the activity of the cyclin dependent 
kinase Cdc2 (Cdk1) (Nurse, 1990). Maintenance of the inhibitory phosphorylations on Cdc2 (on T14 
andY15) is essential for G2 checkpoint activation. ATM and ATR indirectly modulate the phosphorylation 
status of these sites in response to DNA damage. The response to DNA damage inducing irradiation is 
mediated primarily by ATR (Graves et al., 2000) with ATM playing a back-up role; the response to 
replication blocks is primarily controlled by ATR. 
 It should be noted that the stage of the cell cycle when the DNA damage occurs may influence whether 
the response is mediated through ATR or ATM (Abraham, 2001). In any case, upon DNA damage, ATM 
or ATR kinases are responsible for early steps of damage sensing and inducing a signaling cascade 
leading to checkpoint activation, DNA repair or apoptosis (Zhou and Elledge, 2000). Downstream kinases 
Chk1 and Chk2 are activated by ATR- and ATM-dependent phosphorylation, respectively, which then 
phosphorylate the dual specificity phosphatase Cdc25C on position Ser216 (Furnari et al., 1997; 
Matsuoka et al., 1998; Peng et al., 1997; Sanchez et al., 1997). Phosphorylation of this residue creates a 
binding site for the 14-3-3 proteins. The 14-3-3/Cdc25C protein complexes are sequestered in the 
cytoplasm, thereby preventing Cdc25C from activating Cdc2 through removal of the T14 and Y15 
inhibitory phosphorylations (Lopez-Girona et al., 1999). This results in the maintenance of the 
Cdc2/Cyclin B complex in its inactive state and blockage of entry into mitosis.  
ATM and ATR kinases phosphorylate a variety of targets including p53 and serine 139 on H2AX (γH2AX). 
γH2AX is a well known marker of DNA damage that forms nuclear foci at sites of damage (Rogakou et al., 
1999; Rogakou et al., 1998). The exact function of γH2AX is not known, but it has been suggested to 
function as a platform to recruit checkpoint and DNA repair proteins (Downey and Durocher, 2006). 
Depending on the nature of the lesion, co-localization of γH2AX can occur with DNA repair proteins such 
as 53BP1, Mre11, Rad50 and Nbs1 (Bekker-Jensen et al., 2006; Downey and Durocher, 2006). Although 
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originally thought to be a molecular sensor for DSBs, the involvement of γH2AX in recognizing other 
types of DNA damage  and even replication fork stalling is becoming evident (Ewald et al., 2007; 
Fernandez-Capetillo et al., 2004; Marti et al., 2006; Ward and Chen, 2001). 
During DNA replication, DNA damaging agents or stalled replication forks - which can potentially collapse 
and cause under-replication of chromosome regions, therefore constitute potential sources for genomic 
instability - can induce the intra-S-phase checkpoint which will reduce or arrest DNA synthesis (Bartek 
et al., 2004; Lambert et al., 2005). This might be achieved by inhibiting further initiation events and/or by 
slowing progression of existing replication forks. The current knowledge of the intra-S-phase checkpoint 
mainly comes from experimentally inducing the checkpoint response in cells by means of DNA damaging 
agents or replication inhibitors such as hydroxyurea (HU) that reduces the production of 
deoxyribonucleotides. However there is indication that checkpoint proteins might have roles even in 
normal S-phase regulation, although the level of the checkpoint activation might not be easily detected 
(Brown and Baltimore, 2000; Liu et al., 2000). As mentioned before ATR is the main kinase to function 
following DNA replication-dependent damage. ATR phosphorylates Chk1 on Ser317 and Ser345 residues 
(Chen and Sanchez, 2004), which then inhibits the Cdc25A phosphatase from dephosphorylating the 
Tyr15 residue of the S-phase cyclin-dependent kinase Cdk2 (Busino et al., 2004). Thus, in response to 
replication stress, the inactive Cdk2 is unable to promote S-phase progression.  
 
2.8.2.1.  Checkpoints in the early embryo 
 
Mouse pre-implantation embryos in general are hypersensitive to ionizing radiation. This is attributed to a 
deficiency in the function of checkpoints or DNA repair mechanisms. If DNA repair is not functioning 
properly in the embryo when they are irradiated, the cell cycle stops, but the DNA damage will not be 
repaired. Consequently, the cell cycle remains arrested and the embryos eventually die. If checkpoint 
mechanisms do not function properly, the cell cycle will not stop, not allowing sufficient time for DNA repair. 
Consequently, the cells will divide heterogeneously and die later. 
A difficulty in studying damage response in conventional cellular systems is that the effect of DNA damage 
itself and the effect of cellular responses are hard to distinguish in irradiated cells. The separate entities of 
the parental PN in the mouse zygote give a unique opportunity to analyze these effects separately. DNA 
damage can be delivered through irradiated sperm, while the response can be analyzed in the damage-free 
female PN (Shimura et al., 2002a). 
It was shown by analyzing cell cycle progression of zygotes produced with this method that the onset of 
DNA replication is not delayed compared to wild-type. The rate of DNA synthesis however, is suppressed 
throughout S-phase. By prolonging S-phase, about half of the sperm-irradiated zygotes managed to 
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synthesize a full DNA content, while the other half failed to do so. Regardless of the DNA content, all 
zygotes cleaved to become 2-cell embryos (Shimura et al., 2002a; Shimura et al., 2002b). 
These results indicated two things, first, that mouse zygotes do not possess a G1/S checkpoint, and 
second, that they do have an intra-S-phase checkpoint, however, this checkpoint is not too strong and it 
does not induce apoptosis, as it allows embryos to proceed with inappropriate DNA content.  
Two explanations have been found for the lack of Rb-dependent G1/S checkpoint. In one study, Rb mRNA 
and protein were barely detectable before the blastocyst stage, which could account for the lack of the 
checkpoint. In line with this, induction of Rb expression in zygotes by injecting an Rb-containing plasmid 
induced arrest before the morula stage (Iwamori et al., 2002). Another study found phosphorylated forms of 
RB throughout pre-implantation development, suggesting that rather PTMs regulate Rb activity than 
expression (Xie et al., 2005). Interestingly, ES cells also lack somatic-type Rb-dependent G1/S checkpoint 
(Savatier et al., 1994). A further study shows that actually the G1/S Cdk inhibitor p21 is not functioning at 
these early stages (Adiga et al., 2007b). Sperm-irradiated mouse embryos – apart from S-phase delay – 
progress relatively normally up to E2.5, however by E3.5 they start to show a cleavage delay. This start of 
cleavage delay coincides with the activation of p21 expression. Moreover, cleavage delay is not apparent in 
p21-deficient embryos, but chromosome instability and apoptosis were more pronounced as in wild type 
control embryos (Adiga et al., 2007b).  
The intra-S-phase checkpoint was shown to be dependent on p53, as p53-deficient zygotes did not 
suppress DNA replication (Shimura et al., 2002a). Although p53 is expressed at very high levels in early 
embryos, its apoptotic activity is non-functional until post-implantation stages (Jurisicova et al., 1998). 
Interestingly, ES cells also lack p53-dependent G1/S checkpoint control despite the presence of p53 in 
these cells too (Aladjem et al., 1998). In addition, based on immunofluorescent stainings, activated ATM 
also seems to be involved in this checkpoint. However, its function is not to phosphorylate p53, but possibly 
other yet unknown components of the pathway. In somatic cells, ATM involvement has been show at S-
phase checkpoint (Gottifredi and Prives, 2005) and p53 has also been shown to accumulate after HU 
induced replication fork stalling (Gottifredi et al., 2001; Nayak and Das, 2002).  
The G2/M checkpoint in embryos is a bit more controversial. The previously described sperm-irradiated 
embryo studies did not detect any G2/M delay. Another study reports that about half of X-irradiated zygotes 
arrested at G2-phase and never developed into 2-cell embryos. However, some of them had undergone 
late mitosis without cytokinesis and engaged in a new S-phase (Jacquet et al., 2002). A further report 
demonstrates mechanisms induced in 1- and 2-cell embryos in response to DSB inducing γ-irradiation 
(Yukawa et al., 2007). Zygotes and 2-cell embryos were irradiated at the G2-phase of their cell cycle and 
subsequently checkpoint proteins and DNA repair were analyzed. In summary, they observe a delay with 
both 1- and 2-cell stage embryos cleaving to the next stage. They conclude that a G2/M checkpoint is 
operating at these stages; however, it may not function strongly, as almost all embryos continue to develop 
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but run into problems around the blastocyst stage. The G2/M checkpoint can induce a delay in cleavage, 
but this delay is not long enough to allow complete repair of DSBs. They observe activation of ATM and 
DNA protein kinase (DNA-PK) in response to irradiation, but they do not detect γH2AX at the 1- and 2-cell 
stages (Yukawa et al., 2007).  
The absence of γH2AX in DNA damage induced and non-induced 1- and 2-cell mouse embryos has been 
simultaneously shown by another group. Early embryos showed γH2AX only after the 2-cell stage in 
response to γ-irradiation during the first two cell cycles (Adiga et al., 2007a). A different γH2AX-pattern in 
non-induced early embryos was demonstrated recently (Ziegler-Birling et al., 2009). γH2AX is very high in 
zygotes right after fertilization, is reduced to only a few foci at the 2-cell stage and is abundant again at the 
4-cell stage. They also report γH2AX on mitotic chromatin at all cleavage divisions. Importantly, these 
γH2AX patterns are independent of any DNA damage process, as they do not co-localize with 53BP1. 
These contradicting γH2AX results can be due to different antibodies and/or different staining protocols 
used. 
To summarize, although our understanding of checkpoints and DNA repair mechanisms in the early embryo 
is very limited, it seems that there are two checkpoints operating: one in S-phase and another at G2/M. 
However these checkpoints are weak and do not provide sufficient protection for the embryo when DNA 
damage is induced.  
 
2.8.3. Control of DNA re-replication in mouse pre-implantation embryos 
 
In late mitosis and early interphase, many proteins are required to prepare the next round of DNA 
replication in the cell cycle. These include members of the pre-replication complex (pre-RC), like the origin 
recognition complex (ORC), Cdc6 and Cdt1 which associate with replication origins on chromatin before the 
minichromosome maintenance (MCM) complex can be added, so that the origin is licensed for replication 
(Bell and Stillman, 1992; Coleman et al., 1996; Maiorano et al., 2000). It is essential that DNA replication 
occurs only once every cell cycle, therefore important mechanisms have evolved to prevent re-replication. 
One key mechanism includes inhibition of licensing by the pre-RC by inhibition through Geminin. Geminin 
starts to be expressed at S-phase, after licensing took place in G1. It binds to Cdt1, inhibiting its association 
with replication origins and therefore blocking re-replication (Wohlschlegel et al., 2000). Geminin is present 
throughout G2- and M-phases and is targeted for proteolytic degradation by the anaphase promoting 
complex (APC) (McGarry and Kirschner, 1998). Its inactivation frees Cdt1, which can then license the next 
round of DNA replication. 
Developmentally programmed endoreduplication in mammals is only known to happen twice: when 
trophoblast stem (TS) cells differentiate into trophoblast giant (TG) cells (Cross, 2005) and when bone 
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marrow megakaryoblasts differentiate into megakaryocytes (Ravid et al., 2002). This requires orchestered 
inhibition of mitosis and simultaneous licensing of pre-RCs. The mitotic Cdk1 was shown to be inhibited by 
the Cdk inhibitor p57 (Kip2) during TS to TG transition, while p21 served to prevent apoptosis of these cells 
(Ullah et al., 2008). The involvement of Geminin in this process was not examined. 
Geminin depletion in human cancer cells or Drosophila cells in culture induces random re-replication of 
DNA with formation of giant cells accompanied by ATR, Chk1 DNA damage signaling pathway (Melixetian 
et al., 2004; Mihaylov et al., 2002; Tachibana et al., 2005; Zhu and Dutta, 2006b). These cells arrest at G2-
phase and die soon after. Involvement of Geminin in endocycles comes from an observation in Drosophila, 
where oscillating levels of Geminin was shown to accompany endocycles (Zielke et al., 2008). Thus, the 
primary role of Geminin appears to be suppression of re-replication at inappropriate cell cycle stages.  
In mouse, zygotic deficiency for Geminin also results in DNA re-replication from the 8 cell stage onwards, 
presumably from the time the maternal stock of Geminin is depleted (Gonzalez et al., 2006; Hara et al., 
2006). Embryos develop large nuclei containing more that 2n DNA and express at least some genes 
characteristic of TE. However, these Geminin-deficient embryos also contain damaged DNA and undergo 
apoptosis, suggesting that they have undergone DNA re-replication rather then endoreduplication. These 
results nevertheless indicate that Geminin-mediated cell cycle safeguarding is functional at pre-implantation 
stages.  
 
 
2.9. Scope of the thesis 
 
Our laboratory is interested in understanding how chromatin-based epigenetic mechanisms regulate gene 
expression programs during gametogenesis and early embryonic development in the mouse, with a 
special focus on the possible transgenerational role of inherited epigenetic information. A certain 
chromatin state is inherited from the oocyte and the sperm to the early embryo. Although early embryonic 
development is associated with extensive chromatin remodeling and re-programming of certain 
epigenetic marks to produce a totipotent embryo, some epigenetic modifications are fatefully retained 
during early embryogenesis (Reik et al., 2001; Surani, 2001). Dynamic chromatin changes during pre-
implantation development indicate that mechanisms are present in the early embryo to retune certain 
epigenetic settings. However, inefficiency of reproductive cloning by nuclear transfer highlights that the 
correct “parental priming” of chromatin is a prerequisite for normal embryonic development to occur (Dean 
et al., 2003). We focus on the importance of this inherited epigenetic information, its role in establishing 
proper embryonic events, such as chromatin remodeling and zygotic genome activation.  
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At the time when I started my PhD studies Polycomb proteins had just started to receive increasing 
attention. PcG proteins were known for a long time to maintain the silenced state of Hox genes 
throughout development, but apart from a handful of other targets (Gil et al., 2004; Jacobs et al., 1999a; 
Molofsky et al., 2005), genome-wide mapping of Polycomb targets was not yet published. It was known 
that core subunits of PRC2 and Rnf2 of PRC1 were essential for embryonic development, as mutants 
lacking embryonic Ezh2, Eed, Suz12 or Rnf2 arrested development at post-implantation stages (Faust et 
al., 1995; O'Carroll et al., 2001; Pasini et al., 2004; Voncken et al., 2003). Initial studies of adult stem cells 
revealed that multipotent stem cell fate is at least in part governed by PcG proteins (Bruggeman et al., 
2005; Jacobs et al., 1999a; Molofsky et al., 2005; Sharpless and DePinho, 1999; Valk-Lingbeek et al., 
2004). These findings already outlined an exciting function of Polycomb proteins in developmental 
processes. It was however, only shortly after that the central role of Polycomb proteins in proper lineage 
specification became clear: genome-wide ChIP-Chip studies of Polycomb binding and characterization of 
Polycomb mutant ES cells revealed that Polycomb-mediated silencing targets important lineage specific 
factors in ES cells and that this repression is essential for directing proper differentiation (Boyer et al., 
2006; Bracken et al., 2006; Chamberlain et al., 2008; Lee et al., 2006; Leeb and Wutz, 2007; Pasini et al., 
2007; Shen et al., 2008; van der Stoop et al., 2008). These findings prompted us to investigate the role of 
Polycomb proteins during the crucial phase of developmental, when two highly specialized gametes fuse 
and form a totipotent embryo.  
Previous data from our laboratory demonstrated that Polycomb proteins are present in the mouse oocyte 
and are inherited by the embryo. My project therefore was designed to address the transgenerational role 
of PcG proteins, in particular the role of PRC1. We knew from previous studies that embryos maternally 
and zygotically deficient for Rnf2 develop similarly as Rnf2 zygotically deficient embryos, suggesting no 
major role for PRC1 in early embryonic development. This was very surprising in the light of the important 
role for PRC1 in ESCs (Endoh et al., 2008; van der Stoop et al., 2008) and during differentiation 
(Voncken et al., 2003) and raised the suspicion of possible functional redundancy between Rnf2 and its 
paralog Rnf1. To address this issue, we produced embryos maternally and zygotically double deficient for 
Rnf1 and Rnf2.  
Taken together, the players involved in defining chromatin states and thereby regulating gene expression 
programs in the germline and during early embryonic development are not well known. Given its 
important role in directing development, the Polycomb silencing pathway was an attractive candidate to 
examine in this process.  
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3. Results (published manuscript or manuscript in preparation) 
 
3.1.    Chromosome-wide nucleosome replacement and H3.3 incorporation during mammalian 
meiotic sex chromosome inactivation 
  
Chromosome-wide nucleosome replacement and
H3.3 incorporation during mammalian meiotic sex
chromosome inactivation
Godfried W van der Heijden1,6, Alwin A H A Derijck1,6, Eszter Po´sfai2, Maud Giele1,5, Pawel Pelczar2,5,
Liliana Ramos1, Derick G Wansink3, Johan van der Vlag4, Antoine H F M Peters2 & Peter de Boer1
In mammalian males, the first meiotic prophase is
characterized by formation of a separate chromatin domain
called the sex body1. In this domain, the X and Y chromosomes
are partially synapsed and transcriptionally silenced, a process
termed meiotic sex-chromosome inactivation (MSCI)2,3.
Likewise, unsynapsed autosomal chromatin present during
pachytene is also silenced (meiotic silencing of unsynapsed
chromatin, MSUC)2,4,5. Although it is known that MSCI and
MSUC are both dependent on histone H2A.X phosphorylation
mediated by the kinase ATR, and cause repressive H3
Lys9 dimethylation4, the mechanisms underlying silencing
are largely unidentified. Here, we demonstrate an extensive
replacement of nucleosomes within unsynapsed chromatin,
depending on and initiated shortly after induction of MSCI
and MSUC. Nucleosomal eviction results in the exclusive
incorporation of the H3.3 variant, which to date has primarily
been associated with transcriptional activity. Nucleosomal
exchange causes loss and subsequent selective reacquisition of
specific histone modifications. This process therefore provides
a means for epigenetic reprogramming of sex chromatin
presumably required for gene silencing in the male mammalian
germ line.
The nucleosome core particle comprises an octamer of four histone
proteins (H2A, H2B, H3 and H4) each present twice, around which
146 base pairs of DNA are folded. Functioning as a carrier of post-
translational modifications (PTMs), which regulate gene transcription
and chromatin architecture, the nucleosome is at the center of
chromatin dynamics and epigenetic memory6. A further diversifica-
tion of chromatin is enabled by the use of histone variants7. The
canonical H3.1 and H3.2 proteins are expressed during S phase and
deposited during replication by a DNA replication–dependent
nucleosome assembly pathway8. Beside H3.1 and H3.2, two H3
variants exist. CENP-A, a highly specialized variant, is only present
at the centromere. Mammalian H3.3 differs from H3.1 and H3.2 at
only five and four amino acid positions, respectively, and is expressed
throughout the cell cycle. It is deposited by a DNA replication–
independent nucleosome assembly pathway8–10.
Pachytene spermatocytes, characterized by fully synapsed homo-
logous autosomal chromosomes, have been reported to undergo
extensive changes in chromatin configuration1,5,11–13. Chromosome-
wide, replication-dependent nucleosome assembly is completed after
premeiotic S phase. Loss of H3.1 and H3.2 therefore becomes a
marker for nucleosome eviction. To study nucleosomal dynamics
during mouse meiosis, we performed immunofluorescence analysis
using an antibody that, on the basis of one amino acid difference in
the amino tail, specifically detects H3.1 and H3.2 but not H3.3 (ref. 9).
In early pachytene spermatocytes, abundances of H3.1/H3.2 are equal
in autosomal and sex body chromatin. At later stages, however,
we observed a progressive disappearance of H3.1 and H3.2 in the
XY body, eventually resulting in complete loss of H3.1 and H3.2
from the sex chromosomes for the remainder of spermatogenesis
(Fig. 1a). To establish whether this loss was also reflected in the
overall levels of histones and in nucleosome structure, we used
antibodies directed against the C terminus of H3 (detecting H3.1,
H3.2 and H3.3) and an antibody that specifically recognizes
nucleosomes14. Signal intensities of both antibodies underwent a
transient reduction at sex chromatin of pachytene up to early
diplotene (Fig. 1b and Supplementary Fig. 1 online) and returned
to autosomal levels when the XY axial elements developed their bulged
appearance, a typical feature of mid-late diplotene spermatocytes15.
These data suggest that de novo replication-independent nucleo-
some assembly of nucleosomes and H3.3 incorporation takes place
during MSCI.
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To investigate whether H3.1 and H3.2 removal and de novo
nucleosome deposition occur simultaneously, we localized the
H3.3H4-specific chaperone HirA16. Concomitant with the removal
of H3.1 and H3.2, we observed a relative increase of signal in the XY
body (Fig. 1c), suggesting that H3.1 and H3.2 removal coincides with
de novo H3.3H4 deposition. HirA levels in the XY body were equal to
or lower than autosomal levels in mid-late diplotene spermatocytes
(Fig. 1c and Supplementary Table 1 online).
Replication-independent nucleosome assembly by HirA is predicted
to yield H3.3-containing nucleosomes16. As no specific antibody
against unmodified H3.3 is available, we examined the H3.3-specific
phosphoepitope H3.3S31ph. This modification is prominently present
during mitosis in human cells17 and meiosis of the urochordate
Oikopleura dioica (A. Schulmeister, M.
Schmid and E.M. Thompson, unpublished
data). At diakinesis (Fig. 1d) and meiosis II,
the antibody to H3.3S31ph bound to all
chromosomes, but to a much greater degree
in sex chromosomes, confirming the enrich-
ment of H3.3-containing nucleosomes in XY
chromatin. In contrast, phosphorylation of
Ser28, which also occurs during mitosis and
meiosis in H3.1, H3.2 and H3.3, showed a
similar labeling index for autosomal and XY
chromatin (Fig. 1d).
To establish whether the depletion of H3.1 and H3.2 is conserved in
humans, we performed a double staining, combining antibodies to
H3.1/H3.2 and the synaptonemal complex protein 3 (SYCP3) on hu-
man spermatocytes. As in mice, we observed loss of H3.1 and H3.2
from sex chromosomes at pachytene in human spermatocytes (Fig. 1e).
To estimate the onset and duration of H3.1 and H3.2 removal,
we carried out double stainings with an antibody to gH2A.X, which
stains the sex chromosomes from the zygotene-pachytene transition
onward18. This event preceded loss of H3.1 and H3.2 (Fig. 2a).
The histone H1 testis variant (H1t) is present from mid-pachytene
onward19. A strong H1t signal always correlated with lack of H3.1
or H3.2 staining (Fig. 2b). To more precisely determine the timing
of remodeling (Fig. 2c), we selected pachytene spermatocytes, as
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Figure 1 Gradual removal of H3.1 and H3.2 in
the XY body in spermatocytes during meiotic
prophase I. Arrows indicate sex chromosomes.
(a) Spermatocytes in progressing stages of pro-
phase I, metaphase I and a round spermatid
stained by antibody to H3.1/H3.2 (green) and
DAPI (blue). We observed a gradual loss of H3.1/
H3.2 from the XY body, resulting in sex chromatin
lacking H3.1 and H3.2. (b) Spermatocytes in
progressing stages of prophase I and metaphase I
stained by antibody to H3.1/H3.2 (upper panels),
antibody to H3 (middle panels) and DAPI (lower
panels). Whereas loss of H3.1 and H3.2 is per-
sistent, staining with antibody to H3 only shows
a temporary decrease in signal. (c) Localization
of the replication-independent nucleosome
assembly histone chaperone HirA in pachytene
and diplotene spermatocytes (upper panels)
combined with H3.1/H3.2 (middle panels) and
DAPI (lower panels) staining. HirA is enriched in
the XY body in pachytene and early diplotene
spermatocytes and diminishes to autosomal levels
or lower in mid-late diplotene spermatocytes.
(d) Presence of H3.3 was confirmed by
localization of the H3.3-specific modification
phosphorylated Ser31. Metaphase I spermatocytes
stained for H3.3Ser31ph and H3Ser28ph are
shown on the left and right, respectively. Histone
H3.3–specific phosphorylation of Ser31 is
enriched in XY chromatin, whereas phosphory-
lation of H3.1 and H3.2 or H3.3 on Ser28 is
equally present in XY and autosomal chromatin.
(e) Localization of H3.1 and H3.2 (green) in a
human pachytene spermatocyte. SYCP3 (red)
labels lateral elements of the synaptonemal
complex and axial elements of the sex chromo-
somes; DAPI labels DNA. Loss of H3.1 and H3.2
from the XY chromatin, as identified by typical
SYCP3 configuration, is observed during prophase
I. Scale bar, 10 mm.
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defined by complete synaptonemal complexes, and scored them for
the H3.1/H3.2 status of the sex body (Fig. 2d). Ten percent of
246 spermatocytes showed no difference in signal intensity between
the XY body and autosomal bivalents, 42% showed a decreased signal
and 48% showed a complete loss of H3.1 and H3.2 from the sex
chromatin. Given that in mice the pachytene stage lasts for 6.6 d
(159 h), these quantifications show that the decrease in H3.1 and
H3.2 labeling is first detectable approximately 16 h after the zygo-
tene-pachytene transition. It is expected, however, that the actual
replacement process starts somewhat earlier. Histone H3.1 and H3.2
removal was completed at 3.5 d, coinciding with upregula-
tion of autosomal transcription3 (Supplementary Table 2 online).
In terms of the Oakberg scheme of stages of the seminiferous
epithelium, we conclude that removal of H3.1 and H3.2 occurs during
stages I–V (Fig. 2c)20.
To address the kinetics of de novo H3.3 incorporation into XY
chromatin during MSCI, we generated two transgenic mouse models,
one with a gene encoding V5-tagged H3.3
and the other with a gene encoding hemag-
glutinin (HA)-tagged H3.1 (Supplementary
Fig. 2 online) and studied the spatial and
temporal appearance of the tagged histones.
In both a high- and a low-expressing
transgenic line (Supplementary Fig. 2), the
meiotic H3.3-V5 signal became visible in
chromatin of the X chromosome at mid-
pachytene, after desynapsis of the axial ele-
ments of the XY chromosomes had begun
(Fig. 3a–e; Supplementary Table 3 online).
This was later than detection of HirA in
the XY body (Fig. 1c and Supplementary
Table 1), probably as a result of a lower
sensitivity of the H3.3-V5 staining. The inten-
sity of the signal progressively increased, and
the staining extended to chromatin of the Y
chromosome during late pachytene. For auto-
somal chromatin, we observed a concomitant
rise that may relate to the increasing auto-
somal transcription observed at this stage3.
The H3.3-V5 signal reached its maximal intensity at the diplotene
stage in both autosomal and sex chromatin (Fig. 3f–j). In round
spermatids, both sex chromosomes could be easily recognized by their
accumulation of H3.3 (Fig. 3j). The behavior of HA-tagged H3.1
supports the findings with the monoclonal antibody to H3.1 and
H3.2, though with a reduced sensitivity for stages before late pachy-
tene as a result of a low expression of the transgene (Fig. 3k).
Structural differences between H3.1-, H3.2- and H3.3-containing
nucleosomes are expected to be small8, suggesting that the replace-
ment of H3.1 and H3.2 by H3.3 as such is not the prime aim of the
observed nucleosomal exchange. Eviction of H3.1 and H3.2 may
follow from the need to remove certain histone PTMs carried by
the H3H4 dimers. To test this hypothesis, we studied the temporal
dynamics of methylated forms of H3 and H4 in the XY body from
early pachytene spermatocytes up to round spermatids.
We detected all 13 modifications (mono-, di- and trimethy-
lated H3K4; mono-, di- and trimethylated H3K9; mono-, di- and
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c
d
Pachytene
γH2AX
H3.1/H3.2
H3.1/H3.2 H3.1/H3.2 H1t H1t
γH2AX
H3.1/H3.2 H3.1/H3.2 H3.1/H3.2
Pachytene
Premeiotic
differentiation
Leptotene
Pachytene (XII) Pachytene (I–V) Pachytene (I–V) Pachytene (I–V) Pachytene (VI–VIII)
IX
Duration (h)
H3.1
Sycp3
DAPI
23.6 15.5 15.5 21.3 12.0 8.6 16.8 16.8 24.6 24.3 23.6 15.5 15.520.47.620.4
X XI XII I II III IV V VI VII VIII IX X XI XII
Zygotene Pachytene Diplotene MI/MII
Meiosis
(282 h)
Spermiogenesis
(336 h)
Pachytene Pachytene
Figure 2 Timing of onset and duration of
H3.1 and H3.2 removal. Arrows indicate sex
chromosomes. (a) Localization of gH2A.X (red)
and H3.1 and H3.2 (green) in pachytene
spermatocytes. Phosphorylation of H2A.X at
Ser139 in the XY body precedes loss of H3.1
and H3.2. (b) Localization of H1t and of H3.1
and H3.2 in pachytene spermatocytes. Loss of
H3.1 and H3.2 precedes full expression of H1t.
(c) Schematic representation of spermatogenesis,
showing the sequence of epithelial stages
(roman numerals) and their duration (hours)20.
We adapted the pachytene-to-diplotene
transition from a previously published study15.
(d) Determination of the start and completion
of H3.1 and H3.2 removal. We stained
spermatocytes with antibody to H3.1/H3.2
(green), antibody to Sycp3 (red) and DAPI.
Pachytene spermatocytes were identified on
the basis of synaptonemal complex morphology
(n ¼ 246). Roman numerals in brackets
denote the corresponding stages of the
seminiferous epithelium.
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trimethylated H3K27; dimethylated H3K79; and mono-, di- and
trimethylated H4K20) in varying degrees of intensity in early pachy-
tene XY chromatin (Table 1, Fig. 4 and Supplementary Fig. 3 online).
Loss of H3.1 and H3.2 coincided with loss of all histone PTMs, with
the exception of the monomethylated forms of H3K9 and H4K20.
We distinguished four patterns of histone lysine methylation
dynamics from early pachytene to haplophase (Table 1): (i) the
mark was lost and reappeared gradually during stages VI–XII (six
cases; for example, trimethylated H3K9 in Fig. 4a); (ii) the mark was
lost and reappeared at haplophase (two cases; for example, dimethy-
lated H3K79 in Fig. 4b); (iii) the mark accumulated during nucleo-
some replacement, was absent in mid-late diplotene (stages X–XI) and
reappeared during the meiotic divisions or haplophase (two cases; for
example, monomethylated H4K20 in Fig. 4c); (iv) the mark was lost
from the sex chromosomes (three cases; for example, trimethylated
H4K20 in Fig. 4d). The temporary absence of certain histone
modifications as a consequence of nucleosome replacement clarifies
variations between reported staining patterns of these methylated
lysine residues during pachytene5,11–13. Moreover, it is conceivable
that it largely precludes H2A.Z from being incorporated into sex
chromatin during pachytene and diplotene whereas autosomal
chromatin is amenable to this process13. In conclusion, nucleosomal
replacement during pachytene causes loss of almost all studied
H3- and H4-associated methyl marks and leads to a selective
reappearance of specific histone modifications in later meiotic and
postmeiotic stages.
To assess whether nucleosome replacement is a sex chromosome–
specific trait, or whether asynapsed autosomal segments also undergo
this process, we analyzed primary spermatocytes from mice that are
double heterozygous for two semi-identical reciprocal transloca-
tions21. In such T(1;13)70H/T(1;13)1Wa spermatocytes, translocation
bivalents (Fig. 5a–c) often contain asynapsed autosomal chromosome
segments that are subjected to MSUC5 and positioned adjacent to the
XY bivalent. Localization of Sycp3 and H3.1/H3.2 showed eviction of
H3.1 and H3.2 in such asynapsed autosomal regions (Fig. 5d–f). Loss
of H3.1 and H3.2 also occurred when asynapsed autosomal and sex
chromatin were localized in separate domains, indicating that nucleo-
somal replacement is a general feature of MSUC and independent of
sex body formation (Fig. 5g). Notably, inB40% of late pachytene and
early diplotene spermatocytes, we observed a residual H3.1/H3.2
signal in asynapsed autosomal segments or adjacent sex chromosomes,
or both (Fig. 5e and Supplementary Table 4 online). Thus, the
capacity for nucleosomal replacement seems to be limited in sperma-
tocytes. As sex bodies containing asynapsed autosomal chromatin
show increased levels of transcription22, nucleosomal replacement is
probably a prerequisite for proper gene silencing in the context of
MSCI and MSUC.
According to recent reports, MSUC and MSCI are initiated in
late zygotene cells by targeting of the PI3-kinase ATR via BRCA1
to asynapsed chromatin23,24 that later phosphorylates H2A.X
(gH2A.X)18 and ultimately leads to sex body formation in early
pachytene spermatocytes. Timely induction of MSCI and MSUC by
ATR targeting to asynapsed chromatin depends on the capacity of
cells to monitor the state of synapsis at the zygotene-pachytene
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f
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h
k
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b cLeptotene
Mid-pachytene
Mid-pachytene
Late-pachytene
Late-pachytene
Diplotene
Diplotene
Diakinesis Round spermatids
Sycp3H3.3-V5
Sycp3 Sycp3H3.3-V5
Sycp3H3.3-V5
Sycp3H3.3-V5
DAPI
Sycp3DAPI
Sycp3DAPI
Sycp3H3.3-V5
Sycp3H3.3-V5
Sycp3H3.1-HA
Sycp3H3.3-V5 DAPIH3.3-V5
Sycp3DAPI
Sycp3DAPI
Sycp3H3.3-V5 Sycp3H3.3-V5
Zygotene Early pachytene Figure 3 Progressive incorporation of H3.3 at sex chromosomes and
autosomes during mouse meiotic prophase. All H3.3-V5 images are from
the high-expressing transgenic line TgN(H3.3-V5)1Apet. Spermatocytes
were staged on the basis of morphological criteria of chromosome axial
and lateral elements (Supplementary Table 3 online), visualized by staining
with antibody to Sycp3 (red). DNA was stained by DAPI (white).
(a–d) From leptotene onward, H3.3-V5 (green) became visible throughout
chromatin only in midpachytene spermatocytes. (d–g) In the sex
chromosomes, H3.3-V5 incorporation was first detected at X-linked
chromatin, and later during late pachytene also at Y-linked chromatin.
(h,i) H3.3-V5 labeling increased up to the diplotene stage and remained
detectable during both meiotic divisions. (j) H3.3-V5 labeled X and Y
territories4,12,13 in haploid round spermatids. (k) H3.1-HA staining (green)
at XY chromosomes was lost in diplotene spermatocytes of transgenic line
TgN(H3.1-HA)1Apet.
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transition2,25. For example, in Sycp1–/– spermatocytes that do not
finalize synaptonemal complex formation, staining patterns of ATR
and gH2A.X do not differ between sex chromosomes and autosomes
or between the zygotene, pachytene and diplotene stages25. Accord-
ingly, such mutants do not form sex bodies. To determine whether
nucleosome replacement depends on induction of MSUC and MSCI,
we probed Sycp1–/– zygotene, pachytene and diplotene-like spermato-
cytes25 with antibodies specific for H3.1/H3.2 and Sycp3. We did not
obtain any evidence for nucleosome exchange at XY or autosomal
chromatin (Fig. 5h and Supplementary Table 4).
Together, our data on eviction of H3.1 and H3.2 in wild-type,
T(1;13)70H/T(1;13)1Wa and Sycp1–/– spermatocytes and on incor-
poration of H3.3 in transgenic H3.3-V5 spermatocytes show that
nucleosome replacement is a general feature of MSUC, initiated
shortly after induction of MSUC in early pachytene cells (Supple-
mentary Fig. 4).
A function of gH2A.X in DNA double-strand break repair is to
attract chromatin remodelers26, and an analogous role for gH2AX in
MSUC is therefore probable (as elimination of H2A.X results in failure
to induce MSCI27). The accumulation in the XY body1 of DNA repair
proteins, such as Mre11 and Rad50, could therefore be connected to
MSUC-induced nucleosome replacement. Hence, we propose that
during MSUC these repair proteins facilitate chromatin remodeling
rather than being instrumental in DNA repair.
In summary, we describe massive chromatin remodeling of the sex
chromosomes to be a feature of human and mouse male meiotic
prophase I. The unique chromatin composition obtained in this
process potentially serves a role in MSCI and postmeiotic functioning
of the sex chromosomes when a selective gene reactivation of MSCI-
subjected genes occurs12.
METHODS
Mice. We made initial observations in male F1(CBA/B6) mice. We used
homozygous T(1;13)70H male mice on a Swiss random-bred background for
collecting all data presented here. We used male T(1;13)70H/T(1;13)1Wa double
heterozygous mice, also on a Swiss random-bred background, to study translo-
cation chromosome–involved autosomal asynapsis21. Procedures involving mice
were approved by the animal ethics committee of the Radboud University
Nijmegen Medical Centre and conformed to Dutch Council for Animal Care
and US National Institutes of Health guidelines. Generation, handling and
housing of transgenic H3.3-V5 and H3.1-HA mice conformed to the Swiss
Animal Protection Ordinance, chapter 1. We obtained human testicular tissue as
remnant material from a diagnostic testicular biopsy with informed consent.
Surface-spread preparations. We obtained nuclear spreads as previously
described28, with some modifications24. Briefly, we obtained a suspension of
spermatogenic cells which we treated with a hypotonic buffer (17 mM sodium
citrate, 50 mM sucrose, 30 mM Tris HCl, pH 8.2). After centrifugation, we
carefully resuspended the pellet in a 100 mM sucrose solution and applied it
over a PFA-coated glass slide (1% PFA, 0.15% Triton-X-100, pH 9.2–9.5). We
kept the slides for 2 h in a humidified atmosphere. After 1.5 h, we opened the
box and washed slides with 0.08% photoflow (Kodak).
Fluorescent immunostaining. We stained surface-spread slides as previously
described24. Briefly, we blocked slides for 1 h at 37 1C. After blocking, we applied
primary antibodies diluted in blocking solution. We followed priming for 40 min
at 37 1C by overnight incubation at 4 1C. The next day, we washed slides, after
which we blocked nuclei for 1 h at 37 1C. We diluted secondary antibodies in
blocking solution and incubated them for 2 h at 37 1C. After washing in PBS, we
incubated slides with DAPI and mounted them with Vectashield.
Antibodies. We used the monoclonal antibody #34 to localize H3.1/H3.2 at a
dilution of 1:1,500 (ref. 9). The monoclonal antibody #32 recognizes
nucleosomes and we used it at a dilution of 1:2,000 (ref. 14). We purchased
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Table 1 Temporal dynamics of histones and histone PTMs in sex chromatin during pachytene, diplotene, the meiotic divisions and in round
spermatids
Staining
pattern Antibody
Early pachytene
(stage XII)
Mid pachytene to mid
diplotene (stages VI–X)
Mid to late diplotene
(stages X–XI)
Meiotic divisions
(stage XII)
Round
spermatidsc
Image in
figure
H3.1/H3.2 + – – – – Fig. 1
H3 + +/– + + + Fig. 1
i H3K4me1 +/– +/–a +/– + +/– Supplementary Fig. 3
H3K4me2 +/– – – + +/– Supplementary Fig. 3
H3K4me3 +/– – – +/– + Supplementary Fig. 3
H3K9me2 + +a + + + Supplementary Fig. 3
H3K9me3 + +a + + + Fig. 4a and Supplementary Fig. 3
H4K20me2 +/– – +/–a +/– – Supplementary Fig. 3
ii H3K27me1 + – – – + Supplementary Fig. 3
H3K79me2 + – – – + Fig. 4b
iii H3K9me1 +/– +/–b – – +/– Supplementary Fig. 3
H4K20me1 +/– +b – +/– + Fig. 4c and Supplementary Fig. 3
iv H3K27me2 + – – – – Supplementary Fig. 3
H3K27me3 +/– – – – – Supplementary Fig. 3
H4K20me3 + – – – – Fig. 4d
Corresponding stages of the seminiferous epithelium are denoted between brackets. See Methods and Supplementary Figures and Tables for substaging of spermatocytes. Stage I–V
spermatocytes in the process of H3.1 and H3.2 removal showed reduced levels of all histone PTMs except for monomethylated H3K9 and monomethylated H4K20 and are not
referred to in this table. Variation between spermatocytes within a stage was limited with the exception of monomethylated H3K4, H3K9, H4K20 and di- and trimethylated H3K4 in
stage XII pachytene spermatocytes. At this stage, levels of these modifications were heterogeneous and varied from faint to absent. me1, monomethylated; me2, dimethylated; me3,
trimethylated.
aDe novo appearance of histone PTM after temporary previous absence. bDe novo appearance during stages I–V. cPeriod of appearance of histone modifications in sex chromatin of round spermatids
differed between marks. +, abundant; +/–, faintly present; –, not present.
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polyclonal rabbit antibodies to Pan-H3 (ab1793; 1:500) and H3.3S31ph
(ab2889, 1:20) from Abcam. We used polyclonal rabbit antibody D34, which
recognizes HirA, at a dilution of 1:100 (P. Adams, Fox Chase Cancer Center). We
used polyclonal rabbit antibody to Sycp3 in a 1:400 dilution (C. Heyting,
Wageningen University and Research Centre). We purchased the mouse mono-
clonal antibody against gH2A.X from Upstate Biotechnology (clone JBW301;
1:10,000). We used polyclonal rabbit antibody against histone H1t in a 1:100
dilution (P. Moens, York University). We used polyclonal rabbit antibodies to
mono-, di- and trimethylated H3K9 at a dilution of 1:250; antibodies
to mono-, di- and trimethylated H3K27 at a dilution of 1:250; antibody to
monomethylated H4K20 at 1:1,000; antibody to dimethylated H4K20 at 1:50;
and antibody to trimethylated H4K20 at 1:250 (T. Jenuwein, Research Institute
of Molecular Pathology and the Vienna Biocenter). We purchased rabbit
polyclonal antibodies for mono-, di- and trimethylated H3K4 from Abcam
(respectively: ab8895, 1:100; ab7766, 1:100; ab8580, 1:1,500). We used polyclonal
rabbit antibody to detect dimethylated H3K79 in a 1:500 dilution (F. van
Leeuwen, Netherlands Cancer Institute). We used antibody to V5 (Invitrogen) at
a dilution of 1:500, and antibody to HA (Roche) in a 1:100 dilution. To identify
the epitopes for the pan-H3, dimethylated H3K79, H3.3S31ph, V5-specific and
HA-specific antibodies, we first incubated slides in 4 M HCl for 6 min before
blocking, after which we extensively washed slides in PBS. We detected primary
antibodies by labeling with Molecular Probes A11001 Fluor 488–conjugated
goat antibody to mouse IgG (H+L) and A11012 Fluor 594–conjugated goat
antibody to rabbit IgG (H+L). We used both at a 1:500 dilution.
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Pachytene (XII)
DAPI
H3.1/H3.2
DAPI
H3.1/H3.2
H4K20me1
DAPI
H3.1/H3.2
H4K20me3
H3K9me3
DAPI
H3.1/H3.2
H3K79me2
Pachytene (VI–VIII) Pachytene (XII) Pachytene (VI–VIII)Diplotene (X–XI)
Pachytene (XII) Pachytene (XII)Pachytene (I–V) Diplotene (IX–X) Diplotene (IX–X)Diplotene (X–XI)
Metaphase I (XII) Metaphase I (XII) Round spermatid
Metaphase I (XII) Round spermatid
Figure 4 Dynamics in histone lysine-methylation patterns in relation to nucleosomal exchange at the XY body (a–d). Progressing stages of spermatogenesis
are shown from left to right. Nuclei were stained with DAPI (upper panels) and with antibodies against H3.1/H3.2 (middle panels) and the indicated post-
translational histone modification (lower panels). Arrows and dotted white lines indicate the position and shape of sex chromosomes. (a) Trimethylated H3K9:
before removal of H3.1 and H3.2 removal, trimethylated H3K9 was enriched in the sex body. Loss of H3.1 and H3.2 depleted most of this marker, though
some signal remained present in the heterochromatic region of the X chromosome. By stages X and XI, a prominent signal had accumulated in the XY
chromatin, which persisted throughout the meiotic divisions and haplophase (Supplementary Fig. 3). (b) Dimethylated H3K79: in stage XII pachytene
spermatocytes, dimethylated H3K79 was present in XY chromatin, although less prominently than in the autosomes. A complete loss of signal was observed
with removal of H3.1 and H3.2. A signal accentuating the sex chromatin reappeared in round spermatids. (c) Monomethylated H4K20: in stage XII
pachytene spermatocytes, monomethylated H4K20 was reduced in sex chromatin as compared to autosomes. During nucleosome replacement, levels of this
marker increased vastly, were then absent in stage X–XI diplotene and reappeared in round spermatids (Supplementary Fig. 3). (d) Trimethylated H4K20 was
present prominently in X heterochromatin and the pseudoautosomal region and faintly throughout the euchromatin of the sex chromosomes in stage XII
pachytene spermatocytes30. A complete loss of signal was observed in concert with removal of H3.1 and H3.2. No return of this marker was observed up to
the round spermatid stage.
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Analysis and image capture. We analyzed a minimum of 100 pachytene or
diplotene nuclei, or round spermatid nuclei, per staining. We performed all
stainings except those with the nucleosome antibody in combination with the
antibody to H3.1 and H3.2. As immunofluorescence stainings were done in
combination with DAPI staining, the identification of first meiotic prophase
stages relied on DAPI staining pattern, in particular the morphology of the sex
body. We made the assumption that pachytene had commenced when a sex
body could be identified with DAPI. More precise staging was based on
antistaining of the axial elements of the XY chromosomes by DAPI15,29. The
DAPI staining characteristics of centric heterochromatin that change over
prophase I constituted the other criterion29 (Fig. 1 and Supplementary
Fig. 1). The pachytene-diplotene transition could not be precisely determined
with this approach. We grouped diakinesis and metaphase I (stage XII) as
metaphase I. Images were collected on a Zeiss Axioplan fluorescence micro-
scope. Pictures were captured by a Zeiss AxioCam MR camera on Axiovision
3.1 software (Carl Zeiss). Adobe Photoshop 7.0 was used to reduce background
when necessary.
Spermatocytes from H3.3-V5 and H3.1-HA transgenic mice were co-stained
with antibody to Sycp3 and either antibody to V5 or antibody to HA.
Staging criteria for substages of pachytene are described in Supplementary
Table 3 online.
Note: Supplementary information is available on the Nature Genetics website.
ACKNOWLEDGMENTS
We thank T. Jenuwein, A. Schulmeister, F. van Leeuwen, C. Heyting, P.B. Moens,
P.D. Adams and H.G. Stunnenberg for providing antibody reagents; J.-F. Spetz,
A. Kelly and M. Puschendorf for their help in the generation and initial
characterization of H3.1-HA and H3.3-V5 transgenic mice; C. Heyting,
A. Pastink and E. de Boer for male meiotic preparations of Sycp1–/– knockout
mice; and W.M. Baarends, C. Logie and P.J. Wang for critical reading of
the manuscript. Research in the laboratory of A.H.F.M.P. is supported by the
Novartis Research Foundation and the NoE network ‘‘The Epigenome’’ (LSHG-
CT-2004-503433).
AUTHOR CONTRIBUTIONS
G.W.v.d.H., A.A.H.A.D., E.P., A.H.F.M.P. and P.d.B. conceived and designed the
experiments. G.W.v.d.H., A.A.H.A.D., E.P. and M.G. performed the experiments.
G.W.v.d.H., A.A.H.A.D., E.P., A.H.F.M.P. and P.d.B. analyzed the data. P.P.
generated histone-tagged transgenic mice. L.R. was responsible for human
material. J.v.d.V. contributed H3.1- and H3.2-specific antibodies. G.W.v.d.H.,
A.A.H.A.D., D.G.W., J.v.d.V., A.H.F.M.P. and P.d.B. contributed to the writing of
the manuscript. J.V.d.V. and A.H.F.M.P. contributed equally to this work.
COMPETING INTERESTS STATEMENT
The authors declare that they have no competing financial interests.
Published online at http://www.nature.com/naturegenetics
Reprints and permissions information is available online at http://npg.nature.com/
reprintsandpermissions
1. Handel, M.A. The XY body: a specialized meiotic chromatin domain. Exp. Cell Res.
296, 57–63 (2004).
2. Turner, J.M. et al. Silencing of unsynapsed meiotic chromosomes in the mouse. Nat.
Genet. 37, 41–47 (2005).
3. Kierszenbaum, A.L. & Tres, L.L. Nucleolar and perichromosomal RNA synthesis during
meiotic prophase in the mouse testis. J. Cell Biol. 60, 39–53 (1974).
4. Turner, J.M., Mahadevaiah, S.K., Ellis, P.J., Mitchell, M.J. & Burgoyne, P.S.
Pachytene asynapsis drives meiotic sex chromosome inactivation and leads to
substantial postmeiotic repression in spermatids. Dev. Cell 10, 521–529
(2006).
5. Baarends, W.M. et al. Silencing of unpaired chromatin and histone H2A ubiquitination
in mammalian meiosis. Mol. Cell. Biol. 25, 1041–1053 (2005).
6. Nightingale, K.P., O’neill, L.P. & Turner, B.M. Histone modifications: signalling
receptors and potential elements of a heritable epigenetic code. Curr. Opin. Genet.
Dev. 16, 125–136 (2006).
©
20
07
 N
at
ur
e 
Pu
bl
is
hi
ng
 G
ro
u
p 
 h
ttp
://
w
w
w.
n
at
ur
e.
co
m
/n
at
ur
eg
en
et
ic
s
a
d
e
f
g h
b
1
T70H
T1Wa
T70H T70H
T1Wa
T1Wa
T70H T1Wa
Bivalent
Bivalent
13
T70H/T1Wa
*
*
T70H/T1Wa
T70H/T1Wa
T70H/T1Wa Sycp1–/–
H3.1/H3.2 Sycp3
H3.1/H3.2 Sycp3
Sycp3DAPI
Sycp3DAPI
H3.1
/H3.2 Sycp3 Sycp3DAPI
H3.1
/H3.2
H3.1
/H3.2Sycp3 Sycp3
113
131
113
131
c Figure 5 Localization of H3.1 and H3.2 in asynapsed autosomal chromatin
of the T(1;13)70H and T(1;13)Wa translocation–containing spermatocytes
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semi-identical ‘homologous’ chromosomes: 113 and 131. (c) During early
meiotic prophase I, the nonhomologous segments (green) are initially
asynapsed. In the 131 bivalent, this segments readjusts during late
zygotene and early pachytene, whereas in the 113 bivalent, it frequently
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(d) When full heterologous synapsis was accomplished, a horseshoe-like
synaptonemal complex was produced (indicated by asterisk). No loss of
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3.2.1. Abstract 
 
In many sexual reproducing organisms, early embryonic development is driven by factors provided by the 
oocyte to exert the maternal-to-embryonic transition. The nature of the maternal contribution and the 
mechanisms specifying it are largely unknown. Polycomb proteins are evolutionarily conserved chromatin 
modifying proteins that are thought to maintain cellular identity and developmental potential by 
transcriptionally repressing genes that promote differentiation during development.  Here we report the 
role of Rnf1 (Ring1a) and Rnf2 (Ring1b), two core components of the Polycomb Repressive Complex 1 
(PRC1), in defining the maternal contribution. Embryos deficient for maternal Rnf1 and Rnf2 expression 
failed to develop beyond the two-cell stage. Numerous developmental regulator genes that are 
established Polycomb targets in other cellular systems are derepressed in Rnf1/Rnf2 double mutant (dm) 
fully grown oocytes. Translation of aberrant maternal transcripts is, however, delayed until after 
fertilization, resulting in the inappropriate presence of differentiation factors during the otherwise totipotent 
stage of early embryogenesis. Transfer of maternal pro-nuclei between control and Rnf1/Rnf2 maternally 
deficient early zygotes revealed, however, that the developmental arrest is not only due to maternal 
transmission of inappropriate cytoplasmic factors, but also to an altered chromatin state inherited from the 
Rnf1/Rnf2 dm oocyte. Together, these data reveal an essential role for Polycomb during oogenesis in 
defining cytoplasmic and nuclear maternal contributions that are required for proper initiation of 
embryonic development. The data suggest that Polycomb acts in the germline and early embryogenesis 
to sustain developmental potency across generations. 
 
 
3.2.2. Materials and Methods 
 
Mice  
The generation of conditionally deficient Rnf2 mice was performed as previously described (Puschendorf 
et al., 2008; van der Stoop et al., 2008) and also illustrated in Supplementary Figure 1.  
Maternally deficient Rnf2 zygotes were generated by crossing Rnf2
F/F
; Zp3-cre/+ females with Rnf2
F/F 
males. Maternally and zygotically deficient Rnf2 embryos were generated by crossing Rnf2
F/F
; Zp3-cre/+ 
females with Rnf2
F/F
; Prm1-cre/+ males. Wild-type control embryos were generated by Rnf2
F/F
 females 
and Rnf2
F/F 
males.  
Generation of maternally or maternally and zygotically double deficient embryos for Rnf1 and Rnf2 was 
performed as described above but on a Rnf1
-/-
 background (del Mar Lorente et al., 2000). Control 
embryos used in experiments are generated form littermate females lacking Zp3-cre and therefore are 
Rnf1
-/-
 (unless specifically stated wildy-type). Mice were maintained on a mixed background of 129/Sv 
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and C57BL/6J. All experiments were performed in accordance with the Swiss animal protection laws and 
institutional guidelines. 
 
Collection, in vitro fertilization and culture of mouse oocytes and embryos 
Mouse oocytes and embryos were derived from superovulated 5-10 week old females according to 
standard procedures (Hogan et al., 1994). Fully-grown germinal vesicle (GV)-intact oocytes were 
collected 46 h after PMSG injection (5 U, Intervet) in M2 medium (Sigma) containing 2.5 μM milrinone 
(Sigma). For Germinal Vesicle Break Down (GVBD) and meiotic maturation experiments GV oocytes 
were transferred into M16 medium (Sigma) without milrinone. Oocytes were harvested at indicted time 
points. 
Metaphase II-arrested eggs were collected from PMSG- and hCG-primed (5 U each, Intervet) mice 14 h 
after hCG injection. Late M-II oocytes were collected 18 h after hCG injection. Embryos were harvested 
from superovulated females mated to appropriate males in FHM medium (Chemicon) at indicated time 
points after hCG injection: late zygotes (26 h), early 2-cell (36 h), mid 2-cell (42 h), late 2-cell (48 h), and 
blastocyst stage embryos (94 h). Where precise timing of progression of embryonic stages was required, 
oocytes were fertilized in vitro. Sperm was obtained from 10-16 week old control males, and M-II oocytes 
used for IVF were collected from appropriate females 14 h after hCG injection. Sperm capacitation was 
carried out in HTF containing 9 mg/ml BSA for 2h. IVF was performed in capacitation medium for 2 h and 
thereafter the embryos were cultured in FHM or KSOM medium plus amino acids (Chemicon) in a 
humidified atmosphere of 5% CO2 in air until required. Zygotes were substaged according to morphology 
of pronuclei using criteria as defined previously (Adenot et al., 1997; Santos et al., 2002). In brief, PN0 
refers to oocytes immediately after fertilization, PN1 pronuclei are small and reside at the periphery of the 
embryo, PN2 pronuclei have an increased size and have started to migrate towards the center of the 
embryo, PN3 pronuclei have migrated towards the center, large PN4 pronuclei were close to each other 
in the center of the embryo and PN5 refers to large central pronuclei. 
Meiotically incompetent growing oocytes were collected from 12-14 day old mice. For expression analysis 
by qRT-PCR ovaries were dissected and washed in Ca
2+
- and Mg
2+
-free CZBT medium (CMF-CZBT) 
(85.35 mM NaCl, 4.83 mM KCl, 1.18 mM KH2PO4, 25.12 mM sodium bicarbonate
 
(NaHCO3), 10 µg/mL 
gentamicin, 10 µg/mL phenol red, 0.27 mM sodium pyruvate, 7 mM taurine, 0.11 mM EDTA
 
, 31.3 mM 
sodium lactate, 0.1% polyvinylalcohol (PVA)
 
), transferred to CMF-CZBT containing 1mg/ml collagenase 
(Worthington Biochemical Corp) and 0.2mg/ml DNaseI (Sigma) and dissociated by repeated pipeting. 
Oocytes free of follicle cells were washed in CMF-CZBT and staged primary (diameter 50-60 µm) or 
secondary (diameter >60 µm) growing oocyte based on size before harvesting (Pan et al., 2005).  
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Antibodies  
For immunofluorescence analyses of Polycomb group proteins, the following antibodies were used : 
monoclonal anti-Rnf2 (Atsuta et al., 2001), 1:400), monoclonal anti-Rnf1 (Vidal;, 1:100), polyclonal anti-
Bmi1 (van Lohuizen, 1:400), monoclonal anti-Bmi1 (van Lohuizen, 1:100), polyclonal anti-Pc1 (Otte, 
1:500).  
Other antibodies used: monoclonal anti-RNAPII (8WG16, 1:5), polyclonal anti-Gata4 (SC-9053, 1:100), 
monoclonal anti-Pax6 (Hybridoma Bank, 1:1000), polyclonal anti-Eomes (Abcam 23345, 1:100) and 
monoclonal anti-Myc (Ascites 9E10, 1:200).  
 
Immunofluorescence  
Before fixation of oocytes and embryos, the zona pellucida was removed by incubation in acidic tyrode for 
30 seconds. Embryos were washed twice in FHM, fixed for 15 min in 4% paraformaldehyde in PBS (pH 
7.4) and permeabilized with 0.2% Triton-X 100 in PBS for 15 min at room temperature (RT). Fixed 
embryos were blocked at least 4 hours at RT in 0.1% Tween-20 in PBS containing 2% BSA and 5% 
normal goat serum, and were then incubated with primary antibodies in blocking solution overnight at 4ºC. 
Double antibody stainings were accomplished by mixing appropriate different primary and different 
secondary antibodies for simultaneous incubation. Embryos were washed three times for 30 min in 0.1% 
Tween-20 in PBS containing 2% BSA before application of secondary antibodies. For detection, anti-
rabbit IgG-Alexa 488, anti-mouse IgG-Alexa 488 and anti-mouse IgG-Alexa 555 (Molecular Probes) 
secondary antibodies were diluted 1:500 in blocking solution and embryos were incubated for 1 h at RT 
followed by three washing steps for 30 min in 0.1% Tween-20 in PBS containing 2% BSA in the dark. 
Embryos were mounted in Vectashield containing DAPI (Vector) (Santos et al., 2005).  
Ovaries form 12-14 day old mice were dissected, washed in CMF-CZBT and frozen in Tissue-Tek 
O.C.T.
TM 
compound (Sakura Finetek) on dry ice. 10µm thick cryo-sections were cut from frozen blocks 
with Microm HM355S. Cryo-sections were fixed on slides with 2% paraformaldehyde in PBS (pH 7.4) for 
10 min on ice, permeabilized in 0.1% Triton-X100 in 0.1% sodium citrate for 15 min and blocked for 30 
min in 0.1% Tween-20 in PBS containing 2% BSA and 5% normal goat serum at RT. Incubation with 
primary and secondary antibodies as well as mounting was performed as described above. 
If not stated otherwise in figures, at least 10 oocytes or 5 embryos were analysed for each IF staining. 
 
Microscopy and image analysis 
Immunofluorescence stainings of embryos were analyzed using a laser scanning confocal microscope 
LSM510 META (Zeiss) and LSM510 software. For embryos, either a z-series 1.3 µm slices was recorded 
or one confocal slice through the maximal radius of each (pro)nucleus was scanned. Images were 
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analysed using Imaris (Bitplane) software and exported as TIFF files. DIC images were recorded with a 
2.45 Zeiss Z1 microscope by transferring embryos into a drop of immersion oil and placing the 40x 
objective directly in the drop. 
 
Quantitative real-time RT-PCR 
For RNA isolation, oocytes and embryos were pooled from several mice and RNA was isolated from 
batches of 20-50 oocytes or embryos. Total RNA was extracted using the PicoPure
TM
 RNA Isolation Kit 
(KIT0202) according to the manufacturer‟s instructions (Stratagene) with the addition of adding 100 ng 
E.Coli rRNA as carrier and a bacterial probe set as spike (GeneChip®Eukaryotic Poly-A RNA Control Kit). 
The bacterial spike stock (as provided by the manufacturer) was diluted 1:2000 and 1 µl was added per 1 
oocyte or embryo. Reverse transcription was performed from total RNA corresponding to 20-25 oocytes 
or embryos using random primers (200 ng) and SuperScript III Reverse Transcriptase (Invitrogen) 
according to the manufacturer‟s protocol. For quantitative real time PCR reactions, cDNA corresponding 
to 0.4 oocytes or embryos was used as a template. Real time PCR was performed using SYBR Green 
PCR Master Mix (Applied Biosystem) and ABI Prism 7000 Real time PCR machine. All real time PCR 
measurements were normalized against endogenous LnmB1 and to exogenous bacterial spike gene Thr. 
All real time PCR experiments were performed on at least 2 biological replicates form independent 
isolations. 
Primers used: 
Rnf1 (F: 5‟-GCCATCATGGATGGTACAGAG, R: 5‟-TATTCCTCCCGGCTAGGGTAG),  
Rnf2 (F: 5‟-AGGCAATAACAGATGGCTTGG, R: 5‟-GAGAGCCTGCTGATTGTTGTG),  
Cbx2 (F: 5‟-GTAGTCCCAAAGCCCAGTCAG, R: 5‟-CAAGTGCCTACATCAGCTTGC),  
Bmi1 (F: 5‟-AAGACCGAGGAGAAGTTGCAG, R: 5‟-CCCAGAGTCACTTTCCAGCTC),  
Phc1 (F: 5‟-GCCTTCTTCAGGATTGACTGG, R: 5‟-GATCACCACTTGCTTCTGCTG),  
Phc2 (F: 5‟-CAGTGCTCTACCACGCATGTC, R: 5‟-GCTGGATGTTGGGACTCTTG),  
Phc3 (F: 5‟-GTACCTGCAGCAGATGTACGC, R: 5‟-CTGCAGACTGACAGGAAGGTG),  
Ezh2 (F: 5‟-AGCCTTGTGACAGTTCGTGC, R: 5‟-TTTAGAGCCCCGCTGAATG),  
Eed (F: 5‟-ACCAGCCATTGTTTGGAGTTC, R: 5‟-ACCTCCGAATATTGCCACAAG),  
Gata4 (F: 5‟-TCTCTGCATGTCCCATACCA, R: 5‟- AGAAAGTCCCAGAGCCAGGT), 
Pax6 (F: 5´-GCACATGCAAACACACATGA, R: 5´-ACTTGGACGGGAACTGACAC), 
Eomes  (F: 5‟-AAGCCCGATATTATAACGGTGAGA, R: 5‟-GCTTGTTGGTCACAGGTTGCT), 
Klf4 (F: 5‟-CCAGACCAGATGCAGTCACAAG, R: 5‟-ACGACCTTCTTCCCCTCTTTG), 
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Gata6 (F: 5‟-GGGCCTTGTCTGCTAAGGAAG, R: 5‟-CCACGAACGCTTGTGAAATG), 
Nestin (F: 5‟-CAGCAACTGGCACACCTCAA, R: 5‟-CCCAAGGAAATGCAGCTTCA), 
Sox2 (F: 5‟-CGAGATAAACATGGCAATCAAATG, R: 5‟-AACGTTTGCCTTAAACAAGACCAC) 
Bmp4 (F: 5‟-TCGAGGCGACACTTCTACAG, R: 5‟- CCTGGGATGTTCTCCAGATG),  
Hoxa1 (F: 5‟-CACGTAGCCGTACTCTCCAAC, R: 5‟-CACCAAGAAGCCTGTCGTTC), 
Thr (F: 5‟-ATTGCCGACTGATGAAGACAG, R: 5‟-ACAAATCTGCGGTCCGTTTAG), 
LnmB1 (F: 5‟-GCCCTGGACATGGAGATCAGC, R: 5‟-CGACTGGAGGACGCTCTGGA). 
 
Expression profiling of GV oocytes and data analysis 
GV oocytes were pooled from several mice and RNA was isolated from batches of 50 oocytes, 3 
biological replicates per genotype. RNA was isolated using the PicoPure
TM
 RNA Isolation Kit (KIT0202) 
according to the manufacturer‟s instructions (Stratagene). The quality of the RNA was assessed using the 
Agilent 2100 bioanalyzer and RNA 6000 Pico Chip. The extracted RNA was converted into OmniPlex 
WTA cDNA libraries and amplified by WTA PCR using reagents supplied with the TransPlex Whole 
Transcriptome Amplification kit (WTA1, Sigma, USA) following the manufacturer‟s instructions with minor 
modifications. The obtained cDNA was purified using the GeneChip cDNA Sample Cleanup Module 
(Affymetrix). The labeling, fragmentation and hybridization of cDNA was performed according to 
Affymetrix instructions (GeneChip Whole Transcription Sense Target Labeling technical manual, Rev. 2) 
with minor modifications. Samples were hybridized to Mouse Gene 1.0 arrays from Affymetrix. 
Quality control and background normalization was performed using Refiner 4.5 from Genedata AG 
(Basel, Switzerland). Expression value estimates were obtained using the GC-RMA implementation in 
Refiner 4.5. Quantile normalization and median scaling of the genes called present (detection P-value 
<0.05) was performed in Expressionist pro 5.0 (Genedata AG). Statistically significant changes were 
identified using N-way ANOVA (P>0.05). To identify transcripts that are differentially
 
expressed between 
control and mutant mice, we defined
 
a criterion of a 1.5-fold and greater difference plus a p-value
 
of 
<0.05. The P-values reported for enriched GO terms were obtained using GO Stat 
(http://gostat.wehi.edu.au). 
 
Microinjection of Rnf2 mRNA 
N-terminally myc-tagged Rnf2 open reading frame (accession number NM_011277) was cloned into a 
pcDNA3.1-polyA vector. The plasmid was linearized and in vitro transcribed using the mMessage 
mMachine T7 kit (Ambion, AM1344). The synthesized mRNA was diluted to the optimal concentration 
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using nuclease-free water (not DEPC-treated; Ambion, AM9937). 2-4 pl mRNA (50ng/ul) was 
microinjected into the cytolplasm of in vitro fertilized zygotes using the Eppendorf FemtoJet injector 
system. Zygotes were then cultured in M16 (Sigma, M7292) under a 5% CO2 atmosphere at 37ºC, and 
fixed at various stages as indicated in the figure legends.  
 
Pronucear transfer experiments 
Fertilized eggs were collected at 22-24 h post hCG injection in M2 medium (Sigma) after a brief treatment 
with 1 mg/ml of hyaluronidase in phosphate-buffered sodium (PBS, pH 7.5) to separate them from the 
surrounding follicular cells. After collection embryos were transferred to FHM medium (Millipore) and kept 
at 37°C under 5%CO2 until subsequent manipulations.  
Pro-nucleus exchanges were performed between 24 and 28 h post hCG. For the micromanipulation, 
embryos were transferred in M2 medium containing 5µg/ml Cytochalasin B and placed in a chamber on 
the stage of an inverted microscope (Nikon) equipped with micromanipulators (Nikon-Narishige MO-188). 
The maternal pronuclei from donor embryos (visualized under differential interference contrast) were 
identified using both size and position in respect to the polar body. The polar bodies were removed using 
an enucleation/injection pipette containing low viscosity silicone oil. The maternal pronuclei were 
aspirated into the pipette and subsequently re-injected into the perivitelline space of receiver embryos, 
from which the maternal pronuclei had been previously removed. The receiver embryos were transferred 
into an electroporation chamber containing a solution of Mannitol (Sigma) 0.3M/0.3%BSA (Sigma) 
sterilized by filtration on 0.22 µm filters. The electroporation was performed using a BTX electro cell 
manipulator 200 (BTX).  To operate the fusion between the exogenous maternal pronuclei and the 
receiver embryos, the embryos were positioned so that the pronucleus-embryo axis was perpendicular to 
that of the electrodes. The space between the electrodes was 250 µm, and 2 pulses of 40µsec each at 
30V were performed. After the fusion procedure, embryos were transferred in 50µl drops of FHM medium 
under mineral oil and kept in culture at 37°C under 5% CO2. 
 
Comparison to expression patterns during oocyte development and early embryogenesis 
Defining expression states  
To relate data to expression status genes in different stages of oogenesis and embryogenesis, we 
processed data from publicly available Affymetrix CEL files (Pan et al., 2005; Zeng et al., 2004; Zeng and 
Schultz, 2005) using Expressionist pro 5.0 (Genedata AG). Expression values were estimated using the 
RMA-Bioconductor function
 
and their distributions were standardized by quantile normalization and scaled 
by transforming the median expression value to 20.  
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Probe sets with a detection P-value < 0.04 (Affymetrix default) in at least three out of four replicates (Pan 
et al., 2005; Zeng et al., 2004; Zeng and Schultz, 2005) were considered to be expressed and annotated 
with Gene symbols. Lists of genes expressed at a given stage were compared to current data set using 
the Gene symbol for mapping. For analysis of absolute expression levels the mean of replicates was 
calculated for each probe set and the highest value was taken in case of multiple probe sets per gene.  
Defining expression profiles  
To identify classes of genes with similar expression profiles during oogenesis and embryogenesis, we 
first selected probesets with an expression value >10 (oogenesis) or >20 (embryogenesis) in at least one 
developmental stage. Probes with significantly changing expression levels between developmental states 
(P-value < 0.05 in N-way ANOVA analysis) were assigned to different expression profiles using the self 
organizing map (SOM) clustering algorithm. We combined profiles with similar changes in expression 
states during development. In brief, for oogenesis, expression levels in primordial, primary, secondary, 
small antral and large antral oocytes were analyzed (Pan et al., 2005). Probe sets expressed throughout 
the five stages were termed “stable”, genes not detected at either stage were termed “not detected”, 
probe sets expressed in primordial oocytes only and probe sets showing decreasing expression during to 
course of oogenesis were termed “early expressed” and finally, probe sets expressed at all stages except 
in primordial oocytes and probe sets showing increasing expression during oogenesis were termed “late 
expressed”. For embryogenesis, expression levels in GV oocytes, 1-cell, 2-cell, 8-cell embryos and 
blastocysts were analyzed (Zeng et al., 2004). To distinguish between maternally provided transcripts and 
de novo transcription in 2-cell stage embryos, we compared expression levels in embryos treated and 
untreated with the transcription inhibitor α-amanitin (Zeng and Schultz, 2005). Probe sets not detected at 
any stage were termed “not detected”, probe sets expressed in GV oocytes were termed “maternal”, 
probe sets showing α-amanitin sensitive expression at the 2-cell stage were termed “early expressed” 
and probe sets showing α-amanitin sensitive expression at the 8-cell or blastocyst stage were termed 
“late expressed”. Probe sets in groups of combined profiles were annotated with gene symbols. Groups 
were compared to current data set based on mouse gene symbols. 
Matching to published data sets 
For each comparison a data set of genes common in both array platforms (current data on Mouse Gene 
1.0 array and each published array platform) was determined and only these genes were used in 
subsequent analyses. 
 
Comparison to maps of Polycomb proteins and H3K27me3 in mouse ES cells and expression in 
PRC1/PRC2 deficient mouse ES cells 
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To compare our expression data to published studies, we processed data from publicly available 
Affymetrix CEL files using Expressionist pro 5.0 (Genedata AG) or from provided supplementary excel 
files. (Ku et al., 2008; Leeb et al., 2010) Probe sets were matched between platforms based on gene IDs 
or gene symbols. For each comparison only probe sets common to both platforms were taken into 
account. 
 
3.2.3. Results and discussion 
 
In mammals, fusion of two highly differentiated germ cells leads to the formation of a totipotent pre-
implantation embryo. Acquisition of totipotency concurs with extensive remodeling of chromatin states of 
parental genomes (commonly referred to as “epigenetic reprogramming”), changes in maternally provided 
transcriptomes and proteomes, and zygotic genome activation (Evsikov and Marin de Evsikova, 2009; 
Santos and Dean, 2004; Tadros and Lipshitz, 2009). Genomes in mature germ cells are marked by 
various active and repressive histone modifications, including tri-methylation of histone H3 at lysine 27 
(H3K27me3) mediated by the Polycomb Repressive Complex 2 (PRC2), suggesting a transcriptional 
regulatory function for PcG proteins during gametogenesis and possibly across generations (Arpanahi et 
al., 2009; Brykczynska, in press.; Hammoud et al., 2009; Puschendorf et al., 2008; Santos et al., 2005). 
Components of PRC2, like Ezh2, Eed and Suz12, as well as of PRC1, such as Rnf2 (Ring1b), Bmi1, 
Phc2 and Cbx2, are maternally provided. Both complexes are required for genome-wide establishment 
and propagation of repressive chromatin on paternal and maternal genomes, respectively, in early 
embryos. Nonetheless, pre-implantation embryos maternally and zygotically deficient for Rnf2 or Ezh2, 
which lack detectable levels of PRC1 or of PRC2 proteins and H3K27me3 respectively, develop similarly 
as Rnf2 or Ezh2 zygotically deficient embryos, suggesting no major role for maternally provided PRC1 or 
PRC2 for early embryonic development (Supplementary Fig. 1) (Puschendorf et al., 2008; Terranova et 
al., 2008). However, loss of Rnf2 or Ezh2 function may be compensated by low expression of the Rnf1 
(Ring1a) or Ezh1 paralogs, as observed in embryonic stem cells (Endoh et al., 2008; Shen et al., 2008; 
van der Stoop et al., 2008).  
To address the definite function of maternal PRC1 for oogenesis and early embryogenesis, we performed 
loss-of-function analysis of Rnf1 and Rnf2 during oogenesis by conditionally deleting Rnf2 in growing 
oocytes that are constitutively deficient for Rnf1 (Rnf1
-/-
; Rnf2
F/F
; Zp3-cre), hereafter referred to as 
Rnf1/Rnf2 dm oocytes (Supplementary Fig. 1). When fertilizing such oocytes with sperm deficient for Rnf1 
and Rnf2 (from Rnf1
-/-
; Rnf2
F/F
; Prm1-cre males), we observed that the development of embryos (deficient 
for maternal and zygotic Rnf1 and Rnf2 expression) beyond the two-cell stage  was abrogated. Similarly, 
even when fertilized by wild type sperm, maternal Rnf1/Rnf2
  
dm
 
(matRnf1/Rnf2 dm) embryos got arrested 
at the two-cell stage, demonstrating the maternal-effect nature of the phenotype (Fig. 1a).  
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Figure 1 │ Loss of maternal Rnf1 and Rnf2 delays early embryonic development and impairs 
progression beyond the two-cell stage.   
a, Differential interference contrast image of matRnf1 mutant (further used as control) and matRnf1/Rnf2 
dm embryo at embryonic day 3.5. b, Immunofluorescent (IF) staining for Rnf1 and Rnf2 of wild-type, Rnf2 
mutant, Rnf1 mutant and Rnf1/Rnf2 dm growing oocytes (secondary oocytes) surrounded by follicle cells  
in sections of ovaries from 12-14 day old mice. Due to constitutive deletion, granulosa cells lack Rnf1 in 
Rnf1 mutant ovaries. c, Detailed developmental progression analysis of control (C) and matRnf1/Rnf2 dm 
(DM) oocytes and embryos at indicated developmental stages. All embryos carry wild-type paternal 
alleles for Rnf1 and Rnf2. d, DAPI staining of control and matRnf1/Rnf2 dm zygotes 5 hours post in vitro 
fertilization showing pronuclear stages. 100% refers to number of fertilized embryos analyzed. e, Timing 
of first cleavage division of control and matRnf1/Rnf2 dm embryos. X-axis represents hours post in vitro 
fertilization. 100% refers to number of embryos that progress to two-cell stage. Total numbers of 
oocytes/embryos analyzed at each stage are shown in brackets. 
 
To investigate at which developmental stage Rnf1 and Rnf2 are required for supporting embryonic 
development, we analyzed mRNA and protein levels of PRC1 members in mutant and control oocytes 
and early embryos. While Rnf2 and most other PRC1 members (Cbx2, Bmi1, Phc1) were continuously 
expressed during oogenesis and maternally provided to one- and two-cell embryos, Rnf1 was only 
moderately expressed in primary and secondary oocytes, and barely detectable in fully grown oocytes 
(Supplementary Fig. 1). Furthermore, apart from Rnf1 and Rnf2, we measured no major change in 
transcript levels of other PRC1 components in single or double deficient oocytes and embryos. In wild-
type early embryos, we observed nuclear localization of PRC1 components Rnf2, Bmi1 and Cbx2 (and 
not of Rnf1) by immunofluorescence whereas we failed to detect these proteins in matRnf1/Rnf2 dm as 
well as in matRnf2 single mutant embryos, despite abundance of the Bmi1 and Cbx2 mRNAs 
(Supplementary Fig 2). During oogenesis, we detected several PRC1 members, including Rnf1 and 
Rybp, in nuclei of wild-type growing oocytes. Notably, Rnf1 protein levels were up-regulated in Rnf2 
single mutant growing oocytes, reminiscent to Rnf2 deficient ES cells (Fig. 1b). Moreover, Rnf1 
expression during oocyte growth is able to compensate for Rnf2 in stabilizing the PRC1 complex as we 
detected Cbx2, Bmi1 and Rybp in nuclei of Rnf2 single mutant oocytes (Supplementary Fig. 2). These 
data therefore suggest that the two-cell arrest displayed by matRnf1/Rnf2 dm embryos is primarily caused 
by loss-of-function of both Ring finger proteins during oogenesis.  
To characterize the nature of the two-cell arrest phenotype, we assessed the development of Rnf1/Rnf2 
dm oocytes and matRnf1/Rnf2  dm embryos in more detail. Upon hormonal stimulation, Rnf1
-/-
; Rnf2
F/F
; 
Zp3-cre and control littermates produced a similar number of phenotypically normal germinal vesicle (GV) 
oocytes (Fig 1c). When released into meiotic maturation, Rnf1/Rnf2 dm GV oocytes showed a delay in 
germinal vesicle break down, and in condensation and alignment of chromosomes on the metaphase-I 
plate, possibly due to impaired spindle formation (Supplementary Fig. 3). Likewise, although the majority 
of Rnf1/Rnf2 dm oocytes completed the first meiotic division (Fig. 1c), spindle formation and chromosome 
congression were impaired at the metaphase-II stage as well. Prolonged in vitro culture promoted spindle 
formation and chromosome alignment (Supplementary Fig. 3). Nevertheless, despite the delay,  
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Figure 2 │ Massive transcriptional misregulation in Rnf1/Rnf2 dm oocytes.   
a, IF staining for RNA polymerase II (RNAPII) in control and Rnf1/Rnf2 dm growing oocytes and fully 
grown germinal vesicle (GV) stage oocytes (with a non-surrounded nucleolus (NSN) or surrounded 
nucleolus (SN)). b, Venn diagram showing overlap among genes up- or down-regulated (>1.5-fold; P < 
0.05) in Rnf2 mutant (blue), Rnf1 mutant (pink) and Rnf1/Rnf2 dm (red) GV oocytes compared to wild-
type. c, Gene Ontology (GO) analysis of genes up- (red) or down-regulated (green) in Rnf1/Rnf2 dm GV 
oocytes. Fold over-representation indicates the observed percentage of up-regulated genes in a particular 
GO category over the percentage expected on the basis of all GO-annotated genes on the array. P-
values indicate significance of enrichment. d, Classification of genes up- and down-regulated in 
Rnf1/Rnf2 dm GV versus wild-type oocytes according to their expression patterns over subsequent 
stages of oogenesis (upper panels) and pre-implantation development (lower panels) in wild-type 
condition as measured by expression profiling (outlined in Supplementary Fig. 1) (Pan et al., 2005; Zeng 
et al., 2004; Zeng and Schultz, 2005). 
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Rnf1/Rnf2 dm oocytes completed meiosis as we isolated equivalent numbers of one-cell embryos from 
Rnf1
-/-
; Rnf2
F/F
; Zp3-cre and control littermates (Fig. 1c). Under in vitro fertilization conditions, Rnf1/Rnf2 
dm oocytes displayed a moderate increase in fertilization frequency (controls: 63% (n=101); dm: 87% 
(n=73)) and a 3-fold increase in polyspermia occurrence (controls: 11% (n=101); dm: 32% (n=73)) 
(Supplementary Fig. 2), suggesting impaired function of the zona pellucida (Gardner and Evans, 2006). 
Furthermore, compared to control embryos, the formation and subsequent maturation of maternal and 
paternal pronuclei was delayed in matRnf1/Rnf2 dm zygotes (Fig. 1d; Supplementary Fig. 3). 
Correspondingly, the first cleavage division occurred with a 2.5 hour delay in vitro (Fig. 1e) and reduced 
number of mutant embryos entered the two-cell stage in vitro and in vivo (Fig. 1c). Finally, development of 
matRnf1/Rnf2 dm embryos ceased before entrance into the second cleavage division, as we failed to 
detect signs of chromatin condensation, spindle formation, and genome-wide acquisition of 
phosphorylation at histone H3 serine 10, a marker of late G2/M phase chromatin (Supplementary Fig. 3). 
To dissect the mechanism underlying the maternal effect caused by Rnf1/Rnf2 deficiency during 
oogenesis, we first determined by IF staining for RNA polymerase II (RNAPII) that genome-wide 
transcriptional shut down, normally occurring in fully grown GV oocytes, was correctly achieved in double 
deficient oocytes (Fig 2a). Second, to examine gene-specific expression defects during oocyte growth we 
performed mRNA profiling of GV oocytes that naturally store the majority of transcripts produced during 
the growing phase for subsequent meiotic maturation and early embryogenesis. Compared to wild-type 
oocytes, we observed that 2662 genes were misexpressed over 1.5 fold in Rnf1/Rnf2 dm oocytes with 
over 60% being up-regulated. In contrast, only 181 and 92 genes were misregulated in Rnf1 and Rnf2 
single mutants, respectively (P < 0.05) (Fig. 2b, Supplementary Fig. 4, Supplementary Table 1). For nine 
genes tested, we validated by quantitative PCR (qPCR) analyses that up-regulated gene expression was 
restricted to oocytes double deficient for Rnf1 and Rnf2 (Fig. 3a, 3c; Supplementary Figs. 4, 5). For genes 
up-regulated in Rnf1/Rnf2 dm oocytes, gene ontology (GO) analyses revealed among others a significant 
over-representation of developmental gene functions, consistent with a role of PRC1 in repressing 
developmental master regulators in ES cells and during development (Fig. 2c; Supplementary Table 2) 
(Azuara et al., 2006; Bernstein et al., 2006; Boyer et al., 2006; Lee et al., 2006). In addition to several Hox 
genes, known as classical Polycomb targets, we found that many genes marking lineage specification 
during pre-implantation development, like Sox2, Fn1, Gata4, Klf4, Ahcy, Gata6, Msx2, Eomes, Fgf2r, Krt8 
and Tcfap2a were up-regulated (Guo et al.). Among loci down-regulated in Rnf1/Rnf2 dm GV oocytes we 
found the majority of genes encoding the four core histones involved in nucleosomal assembly (Fig. 2c), 
providing a possible explanation for the delay in pronuclear formation. Consistent with reduced Atrx 
transcript levels, we observed reduced Atrx protein levels in Rnf1/Rnf2 dm GV and meiotically maturing 
oocytes (data not shown). The meiotic maturation defects observed in Rnf1/Rnf2 dm oocytes are 
reminiscent of those reported for Atrx deficiency (De La Fuente et al., 2004b).  
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Figure 3 │ Transcripts of developmental regulators de-repressed in Rnf1/Rnf2 dm oocytes are 
only translated after fertilization.   
a, c, Real-time PCR analysis of Eomes (a) and Pax6 (c) transcripts in wild-type (light blue), (mat)Rnf2 
mutant (dark blue), (mat)Rnf1 mutant (pink) and (mat)Rnf1/Rnf2 dm (red) growing oocytes (primary and 
secondary), GV oocytes, zygotes and early 2-cell embryos. Transcript levels were normalized to LnmB1 
control. Error bars indicate standard deviation based on 2-3 biological replicates. b, d, IF staining for 
Eomes (b) and Pax6 (d) in control and (mat)Rnf1/Rnf2 dm GV oocytes, zygotes and early 2-cell embryos.  
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To identify when Rnf1 and Rnf2 serve transcriptionally regulatory functions during oogenesis, we 
compared the expression status of genes misregulated in Rnf1/Rnf2 dm GV oocytes to the temporal 
expression pattern of genes during subsequent stages of normal oogenesis and embryogenesis, as 
measured by genome-wide transcriptome analyses (Fig. 2d) (Pan et al., 2005; Zeng et al., 2004; Zeng 
and Schultz, 2005). In contrast to genes down-regulated, the majority of genes up-regulated in Rnf1/Rnf2 
dm GV oocytes are either never or only early expressed during normal oogenesis (Fig. 2d). Consistently, 
qPCR analyses confirmed that Eomes, Pax6 and Gata4 were already up-regulated in Rnf1/Rnf2 dm 
primary oocytes, concurrent with Zp3-cre-mediated deletion of Rnf2 (Fig. 3a, 3c; Supplementary Figs. 1, 
5). Furthermore, substantially more genes up- than down-regulated in Rnf1/Rnf2 dm GV oocytes are 
never expressed or become up-regulated during normal pre-implantation development. Interestingly, 78% 
of up-regulated genes that are never expressed during normal oogenesis (n = 510), are also never 
expressed during pre-implantation development. Comparison to transcriptomes of ES cells deficient for 
Eed and/or Rnf2 revealed that up to 24% and 7% of genes up- or down-regulated in Rnf1/Rnf2 dm GV 
oocytes are similarly misexpressed in deficient ES cells (data not shown) (Leeb et al., 2010). Finally, we 
related the gene expression status in Rnf1/Rnf2 dm oocytes to the occupancy of various Polycomb 
proteins and H3K27me3 at promoters in mouse ES cells (Ku et al., 2008). We observed for genes up- 
versus down-regulated that 15% versus 5% were Rnf2 targets while 38% versus 14% were bound by at 
least one Polycomb protein (Rnf2, Ezh2, Suz12) or H3K27me3 in ES cells (data not shown). Together, 
these data suggest that a substantial fraction of genes up-regulated in Rnf1/Rnf2 dm GV oocytes are 
direct targets of PRC1 throughout oogenesis as well as during early embryogenesis and in ES cells.  
To investigate the fate of developmental gene transcripts up-regulated in Rnf1/Rnf2 dm GV oocytes, we 
analysed mRNA and protein expression of Eomes, Pax6 and Gata4 in zygotes and two-cell embryos (Fig 
3; Supplementary Fig. 5). We failed to detect protein of all three genes in control oocytes and embryos, 
as well as in Rnf1/Rnf2 dm oocytes, despite elevated transcript levels in the latter sample. In 
matRnf1/Rnf2 dm zygotes and two-cell embryos, however, we detected nuclear localization of Eomes, 
Pax6 and Gata4 protein concurrent with a progressive decrease in transcript levels, indicating translation 
of these aberrant maternal messages only upon fertilization (Fig 3; Supplementary Figs. 4, 5). These data 
suggest that the impairment of Rnf1/Rnf2-mediated transcriptional repression during oogenesis is, at 
least in part, functionally suppressed in GV oocytes via translational repression of aberrant maternal 
transcripts, a widely-conserved gene regulatory mechanism functioning during gametogenesis and the 
maternal-to-embryonic transition in a variety of species (Bettegowda and Smith, 2007; Rajyaguru and 
Parker, 2009; Vardy and Orr-Weaver, 2007).  
It is unclear to what extent the developmental arrest observed for matRnf1/Rnf2 dm two-cell embryos is 
due to inheritance of an aberrant set of maternally provided transcripts (representing gain- and loss-of-
functions), to inheritance of aberrantly programmed chromatin states on the maternal genome and/or to 
impaired genome activation potentially resulting from PRC1 deficiency during the two-cell stage. To 
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Figure 4 │ Rnf1/Rnf2 expression during oogenesis defines maternal cytoplasmic and nuclear 
contributions required for embryonic development.   
a, Diagram showing developmental potential scored at embryonic day 3.5 of control and matRnf1/Rnf2 
dm early zygotes microinjected with buffer only or Rnf2 mRNA. b, Diagram showing developmental 
potential scored at embryonic day 4.5 of reconstructed zygotes with exchanged maternal PN (matPN). 
Control groups include control (matRnf1 mutant) matPN transferred into control (matPN enucleated) 
zygote (cyto-C/matPN-C) and matRnf1/Rnf2 dm matPN transferred into matRnf1/Rnf2 dm zygote (cyto-
DM/matPN-DM). Experimental groups include control (matRnf1 mutant) matPN transferred into 
matRnf1/Rnf2 dm zygote (cyto-DM/matPN-C) and matRnf1/Rnf2 dm matPN transferred into control 
zygote (cyto-C/matPN-DM). Total number of injected or matPN transferred embryos shown in brackets. 
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address whether exogenous Rnf2 expression could alleviate the two-cell arrest of matRnf1/Rnf2 dm 
embryos we microinjected Rnf2 mRNA into such early zygotes. We noticed nuclear localization of myc-
tagged Rnf2 in control and matRnf1/Rnf2 dm zygotes and two-cell embryos as well as a re-appearance of 
Cbx2 in the (pro)-nuclei of matRnf1/Rnf2 dm embryos, arguing for reconstitution of a chromatin-bound 
PRC1 complex (Supplementary Fig. 6). Nonetheless, development of matRnf1/Rnf2 dm embryos beyond 
the two-cell stage was not restored, indicating that Rnf1/Rnf2 function during oocyte growth is required to 
ensure proper programming of the oocyte for early embryonic development (Fig. 4a). 
To assay the relative contribution of transmission of aberrant maternal transcripts and proteins versus a 
potential abnormally-programmed chromatin state of the maternal genome to the two-cell arrest, we 
exchanged maternal pro-nuclei (matPN) between control and matRnf1/Rnf2 dm early zygotes, thereby 
generating diploid hybrid embryos. To first evaluate the efficacy of the experimental procedure, we 
assayed the developmental potential of reconstructed embryos in which matPNs had been exchanged 
between control zygotes or between matRnf1/Rnf2 dm zygotes. Embryos reconstructed with cytoplasm 
and a matPN from different control zygotes (cyto-C/matPN-C) developed into morulae and blastocysts 
with 80% efficiency, as observed for naturally produced embryos. All embryos reconstructed with 
cytoplasm and a matPN from different matRnf1/Rnf2 dm zygotes (cyto-DM/matPN-DM) showed the 
expected one- to two-cell arrest (Fig. 4b; Supplementary Fig. 6). As these reconstructed embryos 
recapitulated the developmental phenotypes observed in naturally generated embryos, we subsequently 
exchanged matPNs between control and matRnf1/Rnf2 dm genotypes. Notably, 87% of reconstructed 
hybrid cyto-DM/matPN-C embryos composed of double mutant cytoplasm and a control matPN failed to 
develop into morulae or blastocysts. In contrast, development of 69% of hybrid cyto-C/matPN-DM 
embryos reconstructed with control cytoplasm and a double mutant matPN was impaired (Fig. 4b). In both 
conditions, we ruled out that the observed changes in developmental potential were due to cytoplasm that 
was transferred along with a control or mutant matPN (Supplementary Fig. 6). The severely reduced 
developmental potential of cyto-DM/matPN-C hybrid embryos indicates that Rnf1/Rnf2-mediated gene 
regulation during oogenesis is essential to provide the oocyte the proper maternal cytoplasmic factors to 
support pre-implantation development. On the other hand, as illustrated by the cyto-C/matPN-DM hybrid 
embryos, Rnf1 and Rnf2 expression during oogenesis is required to program the chromatin state of the 
maternal genome to sustain pre-implantation development. Nonetheless, while transmission of the proper 
maternal cytoplasmic factors is essential for development, wild-type maternal factors can, to some extent, 
reprogram a refractory chromatin state inherited from Rnf1/Rnf2 dm oocytes. 
In summary, here we reveal an essential function for Rnf1 and Rnf2, two PRC1 core components, during 
oogenesis to support early embryogenesis. Notably, our results challenge the classical paradigm of 
Polycomb functioning in the maintenance of the transcriptionally repressed state of genes, initially 
established by gene specific transcriptional repressors during early development. In contrast to the loss-
of-zygotic-function studies in flies and mice, underlying the paradigm, our work of maternal deficiency 
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demonstrates that many Polycomb targets, including homeotic genes, are stably repressed by Polycomb 
in the female mouse germline. Our work extends comparable observations in germlines of plants and 
Caenorhabditis elegans (Capowski et al., 1991; Leroy et al., 2007; Luo et al., 2009; Rodrigues et al., 
2008). Together with marking of similar target genes by PRC2-mediated H3K27me3 in mature human 
and mouse spermatozoa (Brykczynska, in press.; Hammoud et al., 2009), we propose that in mammals 
Polycomb functions in both germ lines and in early embryos to repress expression of differentiation 
promoting factors, thereby maintaining cell identity and preserving developmental potency across 
generations.  
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3.2.4. Supplementary information 
 
 
 
 
 
 
 
 
Supplementary Fig. 1. │Conditional gene disruption during gametogenesis. 
a. Schematic diagram illustrating different stages of gametogenesis and early embryonic development.  
b. Conditional genetic strategy to generate embryos maternally and zygotically deficient for Rnf2 function. 
Zp3-cre drives Cre recombinase expression during oogenesis from the primary oocyte stage onwards, 
resulting in loss of Rnf2 expression during the transcriptionally active growth phase of oogenesis. Prm1-
cre drives Cre recombinase expression during the elongation phase of spermiogenesis during which 
transcription is largely shut-down in a genome-wide manner.  
Comparative expression analyses described in Fig. 2d was based on genome-wide transcriptomic 
analyses in wild-type oocytes at five subsequent stages of development (from primordial oocyte to large 
antral follicle stage) and in wild-type GV oocytes and early embryos (late zygotes, 2-cell, 8-cell and 
blastocyst embryos). 
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Supplementary Fig. 2. │Transcript and protein levels of PRC1 components in wild-type, matRnf1, 
matRnf2 and matRnf1/Rnf2 dm mutant growing oocytes and early embryos. 
a. Real-time PCR analysis of Rnf1, Rnf2 and other PRC1 members Cbx2, Bmi1, Phc1, Phc2 and Phc3 
gene transcripts in wild-type (light blue), (mat)Rnf2 mutant (dark blue), (mat)Rnf1 mutant (pink) and 
(mat)Rnf1/Rnf2 dm (red) growing oocytes (primary and secondary), GV oocytes, zygotes and early 2-cell 
embryos. Transcript levels were normalized to LnmB1 control. Error bars indicate standard deviation 
based on 2-3 biological replicates. 
b. Immunofluorescent (IF) staining for Cbx2, Bmi1 and Rybp of wild-type, Rnf2 mutant, Rnf1 mutant and 
Rnf1/Rnf2 dm growing oocytes (secondary oocytes) surrounded by follicle cells  in sections of ovaries 
from 12-14 day old mice. Due to constitutive deletion, granulosa cells lack Rnf1 in Rnf1 mutant ovaries. 
c. IF staining for Rnf1, Rnf2, Cbx2 and Bmi1 in wild type, matRnf2 mutant, matRnf1 mutant and 
matRnf1/Rnf2 dm 2-cell embryos. 
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Supplementary Fig. 3. │Delay in meiotic maturation and early embryonic development of 
matRnf1/Rnf2 dm oocytes and embryos. 
a. Chart showing percent of control and Rnf1/Rnf2 dm GV oocytes that have undergone germinal vesicle 
break down (GVBD) at subsequent time points of in vitro culture after release from milrinone-inhibition.  
b. c. Representative images of control and Rnf1/Rnf2 dm oocytes (b) undergoing meiotic maturation at 
indicated time points after GVBD (in vitro culture) and of M-II oocytes (c) isolated at 14 hours post hCG 
injection and after subsequent 4 hours of in vitro culture (late M-II oocytes). Microtubules were visualized 
by IF staining with anti-α-tubulin antibody (green) and DNA was counterstained with DAPI (red).  
d. Diagram showing detailed developmental progression analysis (pronuclear stage analysis) of control 
(matRnf1 mutant) and matRnf1/Rnf2 dm embryos scored at 2 hours (left panel) and 5 hours (right panel) 
post in vitro fertilization. 100% refers to number of embryos analyzed. Total number of embryos analyzed 
at each stage are indicated in brackets. 
e. IF staining of control and matRnf1/Rnf2 dm late 2-cell embryos (37-43 hours post in vitro fertilization) 
for phosphorylated H3S10, a late G2-/M-phase marker. 
The total number of GV oocytes or embryos analyzed at each stage is indicated in brackets. 
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Supplementary Fig. 4. │ Majority of genes misregulated in Rnf1/Rnf2 dm GV oocytes are normally 
expressed in Rnf1- or Rnf2 single mutant oocytes. 
a. Heat map of relative expression levels of probe sets showing >1.5-fold misregulation in any mutant 
genotype compared to wild-type. For each genotype (wild-type, Rnf2 mutant, Rnf1 mutant and Rnf1/Rnf2 
dm) expression analysis was performed in triplicate on 50 GV oocytes per sample. Each column 
corresponds to a single expression microarray. For each probe set, expression is shown relative to the 
average expression level of that probe set across all samples. Green and red represent lower-than-
average and higher-than-average signal levels, respectively. 
b. Real-time PCR analysis of Sox2, Klf4, Bmp4, Gata6, Nestin and Hoxa1 gene transcripts in wild-type 
(light blue), (mat)Rnf2 (dark blue), (mat)Rnf1 (pink) and (mat)Rnf1/Rnf2 dm (red) growing oocytes 
(primary and secondary), GV oocytes, zygotes and early 2-cell embryos. Transcript levels were 
normalized to LnmB1 control. Error bars indicate standard deviation based on 2-3 biological replicates. 
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Supplementary Fig. 5. │ Transcripts of Gata4, de-repressed in Rnf1/Rnf2 dm oocytes, are only 
translated after fertilization.  
a. Real-time PCR analysis of Gata4 transcripts in wild-type (light blue), (mat)Rnf2 mutant (dark blue), 
(mat)Rnf1 mutant (pink) and (mat)Rnf1/Rnf2 dm (red) growing oocytes (primary and secondary), GV 
oocytes, zygotes and early 2-cell embryos. Transcript levels were normalized to LnmB1 control. Error 
bars indicate standard deviation based on 2-3 biological replicates. b. IF staining for Gata4 in control and 
matRnf1/Rnf2 dm GV oocytes, zygotes and early 2-cell embryos.  
109 
 
 
 
 
 
110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Fig. 6. │ 
a. Microinjection of Rnf2 mRNA into matRnf1/Rnf2 dm zygotes leads to de-novo PRC1 complex 
formation. IF analyses of control (left panels) and matRnf1/Rnf2 dm (right panels) zygotes microinjected 
with water only (upper panels) or with Rnf2 mRNA (lower panels). Embryos are stained with anti-Myc 
antibody to detect injected Myc-tagged Rnf2 and with anti-Cbx2 antibody. 
b. Developmental potential of non-reconstructed control (C) and matRnf1/Rnf2 dm (DM) embryos 
assessed at E4.5, under culture conditions of matPN transfer experiment. Number of embryos analyzed 
is indicated in brackets.  
c. Microinjection of cytoplasm obtained from control or matRnf1/Rnf2 dm zygotes into control or 
matRnf1/Rnf2 dm zygotes does not influence developmental potential. Diagram shows developmental 
potential assessed at E3.5 of control (C) and matRnf1/Rnf2 dm (DM) embryos (not matPN transferred) 
microinjected with 5% cytoplasm obtained from control (C) or matRnf1/Rnf2 dm (DM) embryos shortly 
after fertilization.  
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Supplementary Table 2. │ Gene Ontology (GO) categories of genes up- or down-regulated in 
Rnf1/Rnf2 dm GV oocytes.  
Over- (green) and under-represented (red) GO categories of misregulated probe sets in Rnf1/Rnf2 dm 
GV oocytes. GO categories that do not differ by 2 or more genes are shown together in one box. All GO 
terms shown with a P-value <0.05. 
 
  
Supplementary Table 1. │ Normalized expression profiling data of wild-type, Rnf1 mutant, Rnf2 
mutant and Rnf1/Rnf2 dm GV oocytes. 
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4. Unpublished results and ongoing work 
 
 
4.1. Cell cycle defects in maternal Rnf1/Rnf2 double mutant embryos 
 
4.1.1.  Introduction 
 
Polycomb group proteins (PcG) were originally discovered as factors responsible for maintaining the 
silenced state of Hox genes (Deschamps et al., 1999). Over the past years PcG proteins have been 
found to target many other key developmental regulators and repress cell-type-inappropriate expression 
of these genes (Bernstein et al., 2006; Boyer et al., 2006; Lee et al., 2006). Although PcG proteins are 
usually regarded as stable repressors, they are also involved in the regulation of cell proliferation, and 
their mutation has been linked to cycle defects in cells or embryos (Valk-Lingbeek et al., 2004). Some 
studies describe Polycomb mutations effecting mitosis (O'Dor et al., 2006; Phillips and Shearn, 1990), 
while in others the exact phase of the cell cycle arrest is not even determined (Endoh et al., 2008; Wang 
et al., 2004a). The mechanisms by which Polycomb proteins may regulate the cell cycle remain largely 
elusive.  
An exception to this is the well studied Polycomb target, the Ink4a/Arf locus (Bracken et al., 2007; Kotake 
et al., 2007). The Ink4a/Arf locus encodes two cell cycle repressors, Cdkn2a (p16) and Ink4d (p19) that 
are important players in the retinoblastoma (Rb) and p53-mediated pathways, respectively. Several PcG 
proteins were shown to target this locus (Bracken et al., 2007; Dietrich et al., 2007; Gil et al., 2004; 
Jacobs et al., 1999a; Voncken et al., 2003) and some, such as Bmi1, Cbx7 and Cbx8 have also been 
functionally linked to the repression of these cell cycle inhibitors (Dietrich et al., 2007; Gil et al., 2004; 
Molofsky et al., 2005). Another cyclin-dependent kinase inhibitor Cdkn1c (p57, Kip2) has also been 
shown to be a direct target of PRC2 (Yang et al., 2009) and the paternally imprinted allele to be 
expressed upon the loss of Eed (Mager et al., 2003), Ezh2 or Rnf2 (Terranova et al., 2008). Inactivation 
of these Cdk inhibitors has been implicated in cancer (Jacobs et al., 1999a; Jacobs et al., 1999b; Yang et 
al., 2009). Finally, Cyclin A has been described to be directly bound by Polycomb in Drosophila (Martinez 
et al., 2006). Apart from direct regulation of cell cycle gene, accumulating evidence suggests that PcG 
proteins may exert their regulatory effect indirectly. For a more detailed review on Polycomb-cell cycle 
connection, see 2.6.4.6. 
The early pre-implantation embryo has several unique cell cycle properties. Initially, cell cycle progression 
is controlled by maternal factors in the early embryo, also underlined by the observation that cell cycle 
regulators are over-represented among maternal messages (Hamatani et al., 2004; Potireddy et al., 
2006). The first two cell cycles of the embryo are exceptionally long, each comprising around 20 hours. 
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The second cell cycle is characterized by a very short G1-phase and a prolonged G2-phase, presumably 
due to zygotic genome activation taking place during this period (Flach et al., 1982). Finally, some studies 
demonstrate a non-somatic-like cell cycle regulation in the early embryo. For example, somatic cell-like 
patterns of proliferation controlling factors Rb, Dp-1 and max are acquired only during the third cell cycle 
(Xie et al., 2005). Cell cycle checkpoints are also altered in early embryos: while the G1/S checkpoint 
seems to be non-functional altogether, an intra-S and a G2/M checkpoint can be activated in response to 
DNA damage. However, although these checkpoints are able to prolong S- or delay M-phases, 
respectively, they are not fully functional, as embryos with abnormal DNA content or damaged DNA can 
still escape and divide. Fully functional checkpoints are reported only to act from the morula stage 
onwards (Adiga et al., 2007b; Shimura et al., 2002a; Yukawa et al., 2007).  
As described in 3.2., we observed a 2-cell arrest of matRnf1/Rnf2 dm embryos. A closer glance at these 
arrested embryos revealed that they never enter M-phase, as we failed to observe any mitotic figures. 
Moreover, matRnf1/Rnf2 dm embryos failed to acquire chromatin-wide H3S10 phosphorylation (H3S10P), 
an early marker of mitotic chromatin. H3S10P is first observed in wild type embryos at late G2-phase 
chromatin, where it weakly labels heterochromatic foci. Only upon M-phase entry does H3S10P label the 
entire chromatin. Interestingly, we found that few matRnf1/Rnf2 dm embryos show very weak 
heterochromatic H3S10P labeling at the time control embryos are already at the 4-cell stage. This 
indicated that the most advanced matRnf1/Rnf2 dm embryo developed was to the G2-phase of the 
second cell cycle.  
We set out to dissect cell cycle events in matRnf1/Rnf2 dm embryos to gain better understanding of the 
cause of the 2-cell arrest phenotype in these embryos. Although we still lack a direct molecular link to 
Polycomb deficiency, we characterized cell cycle progression in matRnf1/Rnf2 dm embryos and found 
that the second S-phase was severely affected. We show that S-phase in matRnf1/Rnf2 dm embryos was 
prolonged and the rate of DNA synthesis was reduced compared to controls. Moreover our results 
suggest that most embryos never exit from S-phase which is also accompanied by activation of an intra-
S-phase checkpoint. 
 
4.1.2.  Materials and Methods 
 
Mice  
The generation of Rnf1/Rnf2 double mutant (dm) oocytes and maternally (mat) Rnf1/Rnf2 dm embryos 
was described in 3.2.2. 
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Collection, in vitro fertilization and culture of mouse oocytes and embryos 
Collection of oocytes or embryos, in vitro fertilization (IVF) procedure and embryo culture was performed 
as described in 3.2.2. For a simplistic overview, time points for harvesting 2-cell embryos for RT-PCR and 
immunofluorescent (IF) staining purposes is shown in Supplementary Figure S1. 
 
 
 
 
Supplementary Figure S1 │Time course of the second cell cycle in control embryos. Cell cycle 
phases for control embryos are indicated in different colors based on replication timing and BrdU 
incorporation experiments. Black bars show time points for embryo harvesting. 
 
 
Immunofluorescence, microscopy and image analysis  
Immunofluorescense analysis was performed as described in 3.2.2. Antibodies used in this study are: 
anti-BrdU (Sigma B8434), anti-Cdkn1c (RB-1637), anti-CyclinB1 (Sc-245), anti-Cdt1 (gift from H. 
Nishitani), anti-Geminin (gift from H. Nishitani), anti-γH2AX (Upstate 05-636), anti-Phospho-(Ser/Thr) 
ATM/ATR Substrate (Cell Signaling 2851), anti-Phospho-Ser345 Chk1 (Cell Signaling 133D3; 2348) and 
anti-Phospho-Thr68 Chk2 (Cell Signaling 2661).   
Immunofluorescense stainings were analyzed using a laser scanning confocal microscope LSM510 
META (Zeiss) and LSM510 software. For embryos, either a z-series 1.3 µm slices was recorded or one 
confocal slice through the maximal radius of each (pro)nucleus was scanned. Images were analysed 
using Imaris (Bitplane) software and exported as TIFF files.  
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DNA replication analysis by BrdU or EdU incorporation 
Embryos were produced by IVF to minimalise developmental heterogeneity. Time intervals for culture in 
presence of BrdU (500µM; Sigma) and EdU (100nM; Invitrogen Click-iT™ Alexa Fluor® 488) are 
indicated in Figure2. Embryos were fixed (15 min in 4% paraformaldehyde in PBS) at the end of each 
indicated interval. For immunofluorescent analysis of BrdU standard IF protocol was used with the 
addition of a denaturing step (25 min, RT, 4M HCl in PBS-0.1% Triton-X 100) and a neutralizing step 
(0.1M Tris-HCl pH 8.5) after standard permeabilization. EdU was detected according to manufacturer‟s 
instructions (Invitrogen Click-iT™ Alexa Fluor® 488). Both BrdU and EdU was fluorescently detected 
using a laser scanning confocal microscope LSM510 META (Zeiss) and LSM510 software. Quantification 
of BrdU signals was performed by eye (+ for strong, +/- for weak and – for no BrdU incorporation), while 
EdU treated embryos were scanned using a laser scanning confocal microscope LSM510 META (Zeiss). 
The 10x objective was used with the pinhole opened to maximum to obtain one image of each embryo 
containing the entire depth of nuclei. Total nuclear area and total fluorescent intensity was quantified 
using ImageJ software. Nuclear fluorescent signal was corrected for background levels (cytoplasmic 
signal). 
Quantitative real-time RT-PCR 
RNA isolation, reverse transcription and quantitative real-time PCR was performed as described in 
chapter… All real time PCR measurements were normalized against endogenous LnmB1 and to 
exogenous bacterial spike gene Thr. All real time PCR experiments were performed on one or two 
biological replicates form independent isolations. 
Primers used: 
Cdk2 (F: 5‟-CATTCCTCTTCCCCTCATCA, R: 5‟-TAAGCAGGTTCTGGGGCTTA), 
 
Cdkn1c (F: 5‟-AATCTCCGCGAGGAAAGC, R: 5‟-GTCTGCAGCGGACTCCAT), 
 
Cdkn2a (F:5‟-TAGAGGCTAACGGCCAGAGA, R: 5‟-CCCAGAGTTCTTCCATCGTC), 
 
CcnE1 (F: 5‟-TGCTAGGTGTTTTAACTATAGGGTCA, R:5‟-TCTGGAGCACTCAGTGGTGT), 
 
CcnE2 (F: 5‟-CGAGCTGTGGAGGGTCTG, R: 5‟-AAACGGCTACTGCGTCTTGA), 
 
Cdt1 (F: 5‟-TAGTACCCCAGATGCCAAGG, R: 5‟-GCGGAACATCTCAACTAGCA), 
 
Geminin (F: 5‟-GGAGCCCAAGAGAATGTGAA, R: 5‟-CTAGCTGGTCATCCCAAAGC), 
 
LnmB1 (F: 5‟-GCCCTGGACATGGAGATCAGC, R: 5‟-CGACTGGAGGACGCTCTGGA). 
 
 
Expression profiling of GV oocytes and data analysis 
Expression profiling and data analysis was performed as described in 3.2.2. 
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4.1.3.  Results 
 
Cell cycle regulators are misexpressed in Rnf1/Rnf2 dm GV oocytes 
As previously described we performed genome-wide expression profiling of Rnf1/Rnf2 dm GV oocytes 
and found massive misregulation of gene expression compared to control oocytes (2662 genes 
misregulated > 1.5-fold compared to wild type; p<0.05). Although Gene Ontology analyses did not pick up 
significant cell cycle-related categories among misregulated genes, we still found a number of cell cycle 
regulators up- or down-regulated in Rnf1/Rnf2 dm GV oocytes (Fig 1a).  Interestingly, a number of 
positive cell cycle regulators, like cyclins and Cdk-s were up regulated, as well as two cell cycle inhibitors, 
such as Cdkn2a (Ink4a, p16) and Cdkn1c (p57).  Remarkably, the only misregulated cell cycle genes 
listed in Figure 1a that are Polycomb targets in ES cells (based on Mohn et al. and Ku et al.) are Cdk6 
and the two inhibitors, Cdkn1c and Cdkn2a. Other up-regulated genes may be oocyte specific Polycomb 
targets or mere secondary effects arising from the loss of Rnf1/Rnf2. We confirmed up-regulation of some 
cell-cycle genes by quantitative RT-PCR in GV oocytes and further examined the fate of transcript levels 
after fertilization in zygotes and 2-cell embryos (Fig 1b). While all five examined genes were up-regulated 
in Rnf1/Rnf2 dm GV ooctytes compared to wild type, transcript levels dropped close to wild type levels by 
1-cell (Cdk2) or early 2-cell stage (CcnE1, CcnE2, Cdkn1c, Cdkn2a). 
 
DNA replication analyses in matRnf1/Rnf2 dm zygotes and 2-cell embryos 
To determine whether matRnf1/Rnf2 dm embryos undergo DNA replication, we cultured IVF, therefore 
synchronized embryos in the presence or absence of BrdU during the first (4-16 hpf) or second cell cycle 
(19-34 hpf) (Fig 2a, right panels). Time of treatment was chosen to broadly cover the estimated S-phase 
of each cell cycle. Embryos were harvested at the end of each time point and BrdU incorporation was 
quantified by immunofluorescent staining. All control and all matRnf1/Rnf2 dm zygotes and 2-cell 
embryos examined underwent DNA replication, while control groups without BrdU did not show any signal 
(Fig 2a, right panels). To further dissect the dynamics of DNA replication, we performed a time course 
analysis of BrdU incorporation starting from 4 hpf (G1 of 1-cell stage) to 46 hpf (G2 of 4-cell stage in wild 
type embryos) broken down to 3 or 6 hour intervals of BrdU treatment (Fig 2a, left panels). While control 
zygotes replicated rather synchronously between 7-13 hpf, matRnf1/Rnf2 dm zygotes started DNA 
replication with a delay and in a less synchronous fashion (replication detected between 10-25 hpf). This 
delay in S-phase onset is consistent with the previously described delay of PN development in 
matRnf1/Rnf2 dm 1-cell embryos. Control embryos started the second round of DNA replication shortly 
after cleavage to 2-cell stage. Notably, “early cleaving” matRnf1/Rnf2 dm embryos (matRnf1/Rnf2 dm  
117 
 
 
Figure 1 │ Cell cycle regulators are misexpressed in Rnf1/Rnf2 double mutant GV oocytes. a, Cell 
cycle regulators found to be down- (green) or up-regulated (red) more then 1.5-fold in Rnf1/Rnf2 dm GV 
oocytes compared to wild-type in genome-wide expression profiling analyses b, Real-time PCR analysis 
of cell cycle regulator gene transcripts in wild-type (light blue), (mat)Rnf2 (dark blue), (mat)Rnf1 (pink) and 
(mat)Rnf1/Rnf2 dm (red) GV oocyets, zygotes and early 2-cell embryos. Transcript levels were 
normalized to LnmB1 control.  
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embryos that were already 2-cell at 22 hpf also readily started DNA replication, while delayed cleaving 
matRnf1/Rnf2 dm embryos presumably started replication accordingly, also with a delay. Strikingly 
however, majority of matRnf1/Rnf2 dm embryos did not seem to exit S-phase, as BrdU incorporation 
continued even up to the time when control embryos were engaged in the third round of DNA synthesis at 
the 4-cell stage (Fig 2a, left panels). 
Next, we precisely quantified the amount of DNA replication during the 2- and “4-“cell stages by culturing 
embryos in the presence of another nucleotide analog, EdU and quantifying EdU incorporation by 
fluorescent staining (Fig 2b). We found that quantification of one round of genome replication in control 
embryos either at the 2- or 4-cell stage is relatively consistent and that EdU incorporation signals during 
G2-phase are at background levels (Fig 2b, upper panel). Interestingly, matRnf1/Rnf2 dm 2-cell embryos 
showed on average markedly less EdU incorporation during the time of the 2-cell S-phase (Fig 2b, lower 
panel). Moreover, as expected from the previous experiment, EdU incorporation was not restricted to the 
normal interval of an S-phase, but continued at low levels at least up to the time point when control 
embryos finished DNA replication at the 4-cell stage.  
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Figure 2 │ DNA replication is abnormal in matRnf1/Rnf2 dm zygotes and 2-cell embryos. a, Time 
course analysis of BrdU incorporation. Following IVF, control (upper panel) and matRnf1/Rnf2 dm 
embryos (lower panel) were cultured in presence of BrdU at indicated intervals (top scale bar); hours post 
fertilization (hpf); embryos were fixed at the end of each BrdU treatment interval, stained with anti-BrdU 
antibody, and scored as BrdU- (light pink), BrdU+/- (dark pink) or BrdU+ (red). Each bar represents 100% 
of embryos analyzed at each interval, the actual number of embryos analyzed is indicated below each bar 
(n). Control groups of embryos incubated with no BrdU or with BrdU for the entire 1- or 2-cell stage are 
shown on the right side. Green dashed line shows time of cleavage divisions of control embryos. b, 
Quantification of DNA replication during the 2-cell and 4-cell stage. Control (upper panel) and 
matRnf1/Rnf2 dm embryos (lower panel) were cultured in the presence of EdU for indicated intervals, and 
fixed at the end of each interval. EdU was quantified by measuring total fluorescent signal (Y axis) in each 
nucleus of embryos. Two adjacent bars represent the two nuclei of a 2-cell embryo or randomly chosen 
two nuclei of a 4-cell embryo. 
 
 
Overexpression of Cdk inhibitors in Rnf1/Rnf2 dm GV oocytes is not likely the cause of the 2-cell 
arrest 
We observed that two cyclin dependent kinase (Cdk) inhibitors Cdkn2A and Cdkn1C were up-regulated in 
Rnf1/Rnf2 dm GV oocytes. Overexpression of Cdk inhibitors seemed like an attractive explanation for the 
cell cycle arrest phenotype in embryos. Cdkn2A however, is an inhibitor of the G1/S-phase cyclin 
dependent kinases Cdk4 and 6. As matRnf1/Rnf2 dm embryos enter S-phase, overexpression of this 
inhibitor is not a likely cause for the 2-cell arrest. This may be due to the observation that mouse pre-
implantation embryos lack a G1/S checkpoint. Cdkn1C on the other hand is an inducer of the G2/M 
checkpoint, through inhibition of the mitotic Cdk1. As our DNA replication analyses and H3S10P stainings 
indicate that some matRnf1/Rnf2 dm embryos may enter G2-phase, we examined whether Cdkn1C is 
responsible for the cell cycle arrest. Immunoflourescent stainings for Cdkn1C (Fig 3a) revealed that the 
inhibitor is present in matRnf1/Rnf2 dm zygotes (data not shown) and early 2-cell embryos, while absent 
or very low in control embryos. However, Cdkn1C protein levels in matRnf1/Rnf2 dm embryos decrease 
by mid 2-cell stage and remain at control-like levels up to 3.5 dpc (data not shown). Therefore, at the time 
of the arrest, Cdnk1C is not higher in matRnf1/Rnf2 dm embryos then in controls, arguing that it does not 
play a role in the 2-cell block. 
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Figure 3 │Expression of cell cycle inhibitor Cdkn1c and M-phase cyclin Cyclin B1 in control and 
matRnf1/Rnf2 dm 2-cell embryos. Control and matRnf1/Rnf2 dm 2-cell embryos stained for a, Cdkn1c 
or b, Cyclin B1 at different time points, as indicated on the left hand side. DNA was stained with DAPI.  
 
 
CyclinB1 does not localize to the nucleus in matRnf1/Rnf2 dm 2-cell embryos 
In eukaryotes, initiation of mitosis requires the activity of Cdk1 in complex with a B-type cyclin (Nurse, 
1990). In 2-cell mouse embryos cytoplasmic Cyclin B1 was shown to accumulate starting from S-phase 
into G2-phase and to rapidly localize to the nucleus upon Ckd1 activation at the G2/M transition (Ohashi 
et al., 2001). To address whether matRnf1/Rnf2 dm embryos produce Cyclin B1 and whether Cyclin B1 
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localization is effected, we performed immunoflourescent stainings for Cyclin B1 in embryos at the time of 
the G2/M transition (Fig 3b). Control embryos showed homogenous cytoplasmic and surprisingly nuclear 
Cyclin B1 staining at late G2 and a clear nuclear Cyclin B1 accumulation at M-phase. MatRnf1/Rnf2 dm 
embryos however showed overall less Cyclin B1 which failed to localize to the nucleus. As nuclear 
shuttling of Cyclin B1 is dependent on Cdk1 activation, these results suggest that Cdk1 remains inactive 
in matRnf1/Rnf2 dm embryos. 
 
De-novo replication licensing may participate in the prolonged S-phase of matRnf1/Rnf2 dm 2-cell 
embryos 
The prolonged S-phase in matRnf1/Rnf2 dm embryos in theory might be due to slowing or stalling 
replication forks and/or to re-firing of replication origins. Cdt1 is a component of the replication licensing 
complex (Bell and Stillman, 1992), while Geminin is an inhibitor of Cdt1, therefore an inhibitor of re-
licensing replication origins (Melixetian and Helin, 2004; Pitulescu et al., 2005). To test whether ectopic 
replication licensing would take place in matRnf1/Rnf2 dm embryos, we examined Cdt1 and Geminin 
expression. As reported for somatic cells, Cdt1 only localizes to the nucleus for a short time in early G1-
phase in control embryos to achieve one round of replication licensing and is then excluded from the 
nucleus for the rest of the cell cycle (Fig 4a, upper panel). Geminin on the other hand shows an opposite 
pattern in control embryos, staring to accumulate in the nucleus at late G1, reaching maximal expression 
at late G2 and being degraded at M-phase (Fig 4b, upper panel). Strikingly, matRnf1/Rnf2 dm embryos at 
late 2-cell stage do not show any nuclear Geminin staining (8 embryos out of 8) (Fig 4b, lower panel). 
While most (4 embryos out of 6) matRnf1/Rnf2 dm embryos showed control-like absence of Cdt1 at the 
late 2-cell stage, few (2 embryos out of 6) embryos did show nuclear staining of Cdt1, albeit much weaker 
then early G1 controls (Fig 4a, lower panel). The absence of Geminin and the low levels of nuclear Cdt1 
in some embryos suggests that re-licensing of replication origins may take place at the late 2-cell stage in 
matRnf1/Rnf2 dm embryos, although it may not happen genome-wide, like during normal licensing in G1. 
Examining transcript levels of Cdt1 (Fig 4c) and Geminin (Fig 4d) in wild type (light blue), matRnf2 mutant 
(dark blue), matRnf1 mutant (pink) and matRnf1/Rnf2 dm (red) GV oocytes, late zygotes, early 2-cell 
(G1/S) and late 2-cell (G2) embryos showed that in double mutants transcript levels at neither stage was 
convincingly altered. These results suggest that misregulation of Cdt1 and Geminin protein levels results 
from post-transcriptional misregulation in matRnf1/Rnf2 dm embryos. The mechanistic link of Cdt1 and 
Geminin misregulation to Polycomb deficiency remains elusive. 
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Figure 4 │Replication initiation inhibitor Geminin and replication initiation factor Cdt1 patterns in 
control and matRnf1/Rnf2 dm 2-cell embryos. Control (upper panel) and matRnf1/Rnf2 dm (lower 
panel) 2-cell embryos stained for a, Cdt1 or b, Geminin at different time points, as indicated on the left 
hand side. DNA was stained with DAPI. Real-time PCR analysis of c, Cdt1 and d, Geminin transcripts in 
wild-type (light blue), (mat)Rnf2 (dark blue), (mat)Rnf1 (pink) and (mat)Rnf1/Rnf2 dm (red) GV oocyets, 
zygotes, early 2-cell and late 2-cell embryos. Transcript levels were normalized to LnmB1 control.  
 
 
A novel γ-H2AX pattern during the 2-cell stage correlating with cell cycle phases 
To address whether the prolonged S-phase in matRnf1/Rnf2 dm embryos would be due to replication fork 
stalling, we stained embryos at different cell cycle phases during the 2-cell stage with anti-serine 139-
phospho H2AX (γH2AX) antibody, a well known marker of DNA damage and also known to accumulate in 
response to replication stress due to for stalling (Rao et al., 2007; Rogakou et al., 1999; Rogakou et al., 
1998; Ward and Chen, 2001). We observed an interesting pattern of γH2AX correlating with the cell cycle 
phase in control embryos. Early 2-cell embryos around G1/early S-phase exhibited only a few foci of 
γH2AX. The number of γH2AX foci increased drastically by mid/late S-phase, while in G2-phase were 
reduced again to only a few foci and disappeared completely by the end of G2. Mitotic chromatin was 
heavily labeled with γH2AX, as reported before (Ziegler-Birling et al., 2009). The increase of γH2AX 
labeling correlating with S-phase progression suggested that normal DNA replication in the embryo, 
without any exogenous DNA damage may be accompanied by activation of an intra-S-phase checkpoint. 
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Figure 5 │γ-H2AX patterns in control and matRnf1/Rnf2 dm 2-cell embryos. a, Control and b, 
matRnf1/Rnf2 dm 2-cell embryos stained for γ-H2AX at different time points, as indicated on the left hand 
side. DNA was stained with DAPI.  
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MatRnf1/Rnf2 dm embryos do not accumulate more γH2AX than S-phase controls, however unlike 
S-phase controls, they activate a checkpoint 
MatRnf1/Rnf2 dm embryos showed γH2AX patterns similar to control embryos at G1/early S- and mid S- 
phases (Fig 3b). However, during G2-phase almost 80% of matRnf1/Rnf2 dm embryos still showed an S-
phase-like γH2AX pattern (19 out of 25 embryos), while only 20% (6 out of 25 embryos) showed G2-like 
reduction of γH2AX foci. These results also support the notion that majority of matRnf1/Rnf2 dm embryos 
do not finish S-phase by the time control embryos are in G2. However, it also shows that matRnf1/Rnf2 
dm embryos do not accumulate more γH2AX then a control embryo during normal S-phase. 
To test whether elevated γH2AX levels during a normal S-phase or during “G2-phase” in matRnf1/Rnf2 
dm embryos would lead to checkpoint activation, we stained embryos for active forms of checkpoint 
components, such as ATR/ATM (Phospho-(Ser/Thr) ATM/ATR Substrate) (Fig 6a), Chk1 (Phospho-
Ser345) (Fig 6b) and Chk2 kinases (Phospho-Thr68) (Fig 6c). Surprisingly, although γH2AX was high in 
mid 2-cell (S-phase) control embryos, this did not trigger detectable checkpoint activation (top left row in 
each panel). As controls for checkpoint activation, we used γ-irradiated control embryos or control 
embryos treated with HU (second and third left rows in each panel). γ-irradiation triggered a strong 
checkpoint response in control embryos, while HU treatment resulted in a weaker activation of all three 
checkpoint proteins examined. γH2AX levels increased compared to non-treated embryos at the same 
cell cycle phase, the number of foci correlating with the strength of checkpoint activation. As expected, 
control embryos possessing only few γH2AX foci during late 2-cell stage (G2-phase) did not activate 
checkpoint components (top right row in each panel). Interestingly however, (16 out of 18) matRnf1/Rnf2 
dm embryos (+ Zp3-cre) at the late 2-cell stage had activated a checkpoint response, despite the fact that 
γH2AX levels visually did not exceed levels during a normal S-phase of a control embryo (second right 
row of each panel). These findings indicate that the prolonged S-phase in matRnf1/Rnf2 dm embryos is in 
part due to reduced rate of DNA synthesis triggering an intra-S phase checkpoint response. 
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Figure 6 │Analysis of checkpoint activation in 2-cell embryos in response to DNA damaging by γ–
irradiation, replication fork stalling by HU treatment or maternal deficiency for Rnf1/Rnf2. 
Checkpoint activation was examined by staining embryos for phosphorylated (activated) forms of a, 
ATM/ATR kinase substrates, b, phosphorylated Chk1 and c, phosphorylated Chk2 kinases. γ-H2AX 
patterns were also examined. Rnf1-/- RnfF/F were stained at mid 2-cell (left pnels) or at late 2-cell (right 
panels). Treatment or genetic addition of Zp3-cre is indicated on the left hand side of images. 
 
 
 
4.1.4.  Discussion 
 
Cell cycle characterization of matRnf1/Rnf2 dm embryos revealed that maternal Polycomb deficiency lead 
to a prolonged S-phase at the 2-cell stage. We found that most matRnf1/Rnf2 dm embryos remained in 
S-phase, only around 20% of embryos showed G2-like characteristics based on γH2AX patterns.  
Cell cycle arrest could be due to misregulated maternal factors directly interfering with cell cycle 
progression. We examined the possibility whether cell cycle arrest could be due to up-regulated maternal 
cell cycle inhibitors, such as Cdkn1C or Cdkn2A, which are known Polycomb targets in other cell types 
(Jacobs et al., 1999a; Mager et al., 2003; Sharpless and DePinho, 1999; Yang et al., 2009). Our results 
however, suggest that even though these Cdk inhibitors are up-regulated in Rnf1/Rnf2 dm GV oocytes, 
they are not the likely cause for the 2-cell block phenotype. 
Prolonged S-phase in matRnf1/Rnf2 dm 2-cell embryos correlated with reduced DNA synthesis rates, 
suggesting that a checkpoint may be activated. Indeed, delayed matRnf1/Rnf2 dm embryos with an S-
phase-like γH2AX pattern showed nuclear enrichment of activated checkpoint kinases ATM/ATR, Chk1 
and Chk2. However, literature suggests that checkpoint activation in early embryos results in cell cycle 
delay, but not full arrest (Shimura et al., 2002a; Yukawa et al., 2007). Therefore checkpoint activation 
does not explain why these embryos do not progress further. In line with this, the few matRnf1/Rnf2 dm 2-
cell embryos that show G2-like reduced γH2AX foci did not activate a checkpoint response, yet also did 
not divide further. 
PRC1 has been reported to directly regulate protein levels of the cell cycle regulator Geminin, by 
ubiquitinating it and therefore targeting it for proteosome-mediated degradation (Ohtsubo et al., 2008). 
Geminin plays a key role in inhibiting replication licensing: it associates with Cdt1, a component of the 
pre-replication complex (pre-RC), to prevent reinitiation of DNA replication (Saxena and Dutta, 2005). 
Based the observation of Ohtsubo et al., in matRnf1/Rnf2 dm embryos loss of PRC1 in theory may lead 
to accumulation of Geminin. Although overexpression of Geminin was shown to arrest cells in G1 
(Shreeram et al., 2002), which is not what we observe in matRnf1/Rnf2 dm embryos, we still decided to 
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investigate Geminin and Cdt1 levels in double mutant embryos. Surprisingly, we found that Geminin was 
absent in S-G2-phase matRnf1/Rnf2 dm 2-cell embryos. Although we cannot link absence of Geminin to 
PRC1 deficiency, it may have implications for the prolonged S-phase phenotype of these embryos. Loss 
of Geminin in Drosophila (Mihaylov et al., 2002; Quinn et al., 2001) or in human cells (Melixetian et al., 
2004; Tachibana et al., 2005; Zhu and Dutta, 2006b) causes partial over-replication of the genome. Re-
replication results in stalled replication forks and DNA damage that triggers the ATR-Chk1-Cdc25 DNA 
damage signaling pathway (Ullah et al., 2009). Moreover two studies have simultaneously shown that in 
mouse embryonic deficiency for Geminin also results in genome re-replication and DNA damage 
checkpoint activation starting at the 8-cell stage (Gonzalez et al., 2006; Hara et al., 2006). Maternal 
stores of Geminin before the 8-cell stage presumably mask any earlier effect in Geminin-/- embryos. 
Nevertheless, these studies demonstrate that Geminin-mediated replication control functions in early 
embryos. Therefore the extended S-phase in matRnf1/Rnf2 dm 2-cell embryos that is accompanied by 
checkpoint activation may be due to re-firing of replication origins caused by the absence of Geminin. The 
presence of weak nuclear Cdt1 in some matRnf1/Rnf2 dm 2-cell embryos further supports the notion of 
de-novo replication licensing. Further quantification of total DNA content of arrested matRnf1/Rnf2 dm 
embryos is needed to clarify this issue. 
Although reduced DNA synthesis rates and genome re-replication at first may seem contradicting, it can 
well be that re-initiation of replication origins cause replication fork stalling and checkpoint activation. The 
checkpoint will then actively reduce DNA synthesis, prolonging the replicative phase. 
We characterized a novel γH2AX pattern during the 2-cell stage of wild type embryos. Previous studies 
show either no γH2AX, even in response to DNA damage (Adiga et al., 2007b; Yukawa et al., 2007) or 
very few foci of γH2AX in non-damaged 2-cell embryos (Ziegler-Birling et al., 2009). These differences in 
γH2AX patterns may be attributed to different staining protocols, different antibodies used or simply that 
neither study examined the entire course of the second cell-cycle. Of note, with our staining protocol the 
anti-γH2AX antibody (Upstate 05-636) is extremely sensitive. Although the observed increase in γH2AX 
foci number during S-phase did not trigger detectable checkpoint activation in our experimental 
conditions, it is intriguing to speculate that weak checkpoint activation may take place during normal cell 
cycle progression in the embryo to regulate the length of the cycle. In Drosophila, the maternal to zygotic 
transition (MZT), which occurs by the 13
th
 mitosis and is equivalent to the ZGA in mouse, requires a 
functional DNA damage checkpoint. Removal of maternal ATR homolog Mei-41 or Chk1 homolog 
Grapes, results in developmental arrest at the 13
th
 mitosis with a failure to activate the zygotic genome 
(Fogarty et al., 1994; Su et al., 1999). In wild type fly embryos, lengthening of the 11
th
 and 12
th
 cycles that 
precede MZT was observed, while this was not the case in Mei-41 or Grapes mutants, suggesting that a 
checkpoint functions to slow cleavage speed and allow time for the initiation of the MZT. Involvement of 
checkpoint activation in murine ZGA by depleting maternal checkpoint components has not been 
examined so far.  
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Cell cycle regulation is taken over in the mouse embryo by embryonic gene products during ZGA at the 
late 2-cell stage. Proper ZGA is essential for progression beyond the 2-cell stage as demonstrated by 
inhibiting ZGA with the transcription inhibitor α-amanitin (Warner and Versteegh, 1974) or by a number of 
maternal effect genes, whose deletion results in incomplete ZGA and subsequent developmental arrest 
(Bultman et al., 2006; Tong et al., 2000; Wu et al., 2003). Maternal Polycomb deficiency may also effect 
ZGA directly, by failing to repress target genes during the activation of the embryonic genome, or 
indirectly, through the action of misregulated maternal factors inherited from the Rnf1/Rnf2 dm oocyte. 
Characterizing ZGA in matRnf1/Rnf2 dm embryos will provide further clues as to why these embryos 
cease development at the 2-cell stage.   
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5. General discussion and outlook 
 
5.1.  Polycomb proteins Rnf1 and Rnf2 are required during oogenesis for early embryonic 
development 
 
It is well established that early mammalian development is driven by factors that are prepared but 
dormant in the oocyte, inherited by the embryo, where they exert the program known as maternal to 
embryonic transition. However, the nature of this program as well as the mechanisms involved in 
establishing it still hold many unknowns. Polycomb proteins are evolutionarily conserved chromatin–
modifying factors that maintain cellular identity during many rounds of cell division by transcriptionally 
repressing developmental regulator genes that are inappropriate for the given cell lineage.  Previous 
studies from our lab have shown that Polycomb proteins are present in the mouse oocyte and are 
inherited by the embryo. Therefore in this study we aimed at dissecting the role of Polycomb proteins, 
with focus on PRC1 members Rnf1 and Rnf2, during oogenesis and early embryonic development.  
We demonstrate that maternal deficiency for Rnf1 and Rnf2, the two ubiquitin ligase members of the 
PRC1 complex, compromises embryonic development beyond the 2-cell stage. We observe defects in 
chromosome alignment during oocyte meiotic maturation and a developmental delay during the first two 
cell cycles of embryogenesis before development halts. We characterized cell cycle defects in 
matRnf1/Rnf2 dm embryos and found that majority of these embryos do not seem to enter the G2-phase 
of the second mitotic cell cycle. Although we do not understand the link to maternal Polycomb deficiency, 
we show that prolonged S-phase in these embryos may be due to re-initiation of replication origins and/or 
to activation of an intra-S-phase checkpoint.  
To gain better understanding of the mechanisms underlying of this phenotype, we performed expression 
profiling of fully grown oocytes, and revealed massive misregulation of transcription during oocyte growth 
in the absence of Rnf1 and Rnf2. Genes up-regulated in Rnf1/Rnf2 dm fully grown oocytes were enriched 
for key developmental regulator genes. Importantly, these developmental regulators represented several 
different lineages. Analyzing the fate of some of these up-regulated transcripts revealed that they are 
translationally repressed until fertilization. Upon fertilization, however, these differentiation specific 
transcripts are translated, resulting in the inappropriate presence of differentiation factors during the 
otherwise totipotent stage of early embryogenesis. 
Although we only show this type of message regulation for three examples (we were only able to test 
translational control of three messages due to limited availability of antibodies against proteins encoded 
by misregulated transcripts), it is intriguing to speculate that majority of de-repressed transcripts do not 
get translated in growing or fully grown oocytes, as we do not observe any developmental or phenotypical 
defect at these stages. We propose that up-regulated messages in Rnf1/Rnf2 dm oocytes only get 
recruited for translation during meiotic maturation or after fertilization, corresponding to the appearance of 
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developmental defects. Oocytes have a fine tuned translational regulation system that allows storage of 
maternal messages until the time they are needed for driving critical processes of early development. 
This storage system does not seem to be perturbed in Rnf1/Rnf2 dm oocytes and allows the oocyte to 
cope even with the presence of transcripts that normally would not be present at this stage of 
development.  
An exception to this translational repression may be oocyte specific messages that are normally 
expressed and translated in the growing or fully grown oocyte. Interestingly, although not a Polycomb 
target in other cell types, we observed up-regulation of Ddx6 transcripts in double mutant oocytes. Ddx6 
is a core member of P-bodies and the recently described P-body-like granules in mouse oocytes that 
were proposed to store dormant maternal messages until translational recruitment (Flemr et al., 2010). 
Other members of this oocyte granule, like Tnrc6 (GW182), Edc4 and Lsm14a are normally expressed in 
double mutant oocytes. Elevated levels of Ddx6 in double mutants may provide means for 
accommodating storage of de-repressed messages. Specific sequences in the 3‟UTRs of mRNAs control 
3‟-polyadenylation, which in turn regulates recruitment and stability of maternal messages (Dickson et al., 
1999; Hake and Richter, 1994; McGrew et al., 1989; Pique et al., 2008; Sheets et al., 1994). It would be 
interesting to examine 3‟UTR control elements in up-regulated transcripts and try to predict translational 
timing of these messages. 
We are quite confident that the up-regulation of developmental regulators we observe are a direct 
consequence of the loss of PRC1 in oocytes, as these lineage determiners are confirmed Polycomb 
targets in ES cells by numerous studies (Boyer et al., 2006; Endoh et al., 2008; Ku et al., 2008; Mohn et 
al., 2008). A question that remains unanswered is whether the up-regulated and translated differentiation 
inducing factors are the cause of the 2-cell arrest phenotype in the embryo? We also find many other 
genes up-regulated in PRC1 deficient oocytes, which are not Polycomb targets in ES cells. These may be 
oocyte specific Polycomb targets or up-regulated due to secondary effects. Clear secondary effects 
include the number of genes we find down-regulated upon loss of PRC1. We cannot exclude that lack of 
certain messages are not the cause of the arising phenotype. 
For example, we observed down-regulation of ATRX mRNA in double mutant oocytes and were able to 
show that this correlates with decreased ATRX protein levels in GV oocytes and during meiotic 
maturation. ATRX is a centromeric heterochromatin binding protein belonging to the chromatin 
remodeling SWI/SNF family of ATPases (Gibbons et al., 1997; Picketts et al., 1998). Depletion of ATRX in 
mouse oocytes was shown to cause meiotic maturation defects, namely chromosome condensation and 
alignment problems as well as spindle defects at the M-II stage (De La Fuente et al., 2004b). This 
phenotype is reminiscent of the defects we observe during meiotic maturation of Rnf1/Rnf2 dm oocytes, 
therefore down-regulation of ATRX transcripts may be in part responsible for the meiotic maturation 
phenotype. Moreover, ATRX was recently shown to act as an H3.3 histone variant chaperone at 
telomeres and specific sites in ES cells (Goldberg et al., 2010; Wong et al., 2010). Although ATRX 
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involvement has not been addressed in this process, H3.3 is specifically incorporated into the 
decondensing paternal genome following fertilization (Torres-Padilla et al., 2006; van der Heijden et al., 
2005). Given we observe a delay in PN formation in matRnf1/Rnf2 dm zygotes, decreased ATRX levels 
might be responsible for slowing H3.3 incorporation and PN formation. 
Another point we have to consider is whether the 2-cell block phenotype is only due to misregulated 
messages which are stored in the cytoplasm, or does PRC1-deficient chromatin also have an effect? 
Maternal PN transfer experiments between control and matRnf1/Rnf2 dm zygotes revealed that the 
developmental block is not only due to inappropriate cytoplasmic factors, but also to a defective 
chromatin setup inherited from the PRC1 deficient oocyte. Embryos reconstructed from control cytoplasm 
and Rnf1/Rnf2 dm chromatin reach blastocyts stage with only 16% (6/38) efficiency, compared to the 
77% (34/44) efficiency of control PN transferred embryos. Importantly, this experiment demonstrates that 
there is transgenerational inheritance of Polycomb-mediated epigenetic information from the oocyte to the 
embryo, which is functionally relevant for embryonic development. Although in 16% of cases wild type 
factors may re-program this defective chromatin to allow development to blastocyst, we did not test 
whether normal, viable mice could be produced from such embryos. It can well be, that “maternal PRC1-
deficient chromatin embryos” encounter defects during post-implantation development. For example, we 
know from somatic cell nuclear transfer experiments, that rates for producing blastocyst stage embryos 
are much higher than the efficiency of producing viable offspring (Ogura et al., 2000; Wakayama and 
Yanagimachi, 2001). It would be very interesting to further dissect the role of this PRC1-mediated 
transgenerational mark. We are planning to transplant PN transferred embryos back into surrogate 
mothers in the next round of PN transfer experiments. Unfortunately, due to technical difficulties to obtain 
sufficient numbers of such embryos, we are not able to investigate the role of maternally inherited H2AUb 
in more detail, for example its effect on embryonic genome activation. 
Rnf1 and Rnf2 have been reported to co-purify with nuclear factors such as E2F6 and Bcor (Gearhart et 
al., 2006; Ogawa et al., 2002; Sanchez et al., 2007). E2F6 mediates transcriptional silencing through 
H3K9 methylation while the Bcor complex is associated with an H3K36 and an H3K4 demethylase. 
Recently it was shown in mesenchymal stem cells that a mutantion in Bcor results in increase of H3K36 
and H3K4 methylation at target genes, concurrent with de-repression of target gene expression (Fan et 
al., 2009). To study possible contributions of deficiency in these complexes to the matRnf1/Rnf2 dm 
embryonic phenotype, we assessed H3K9me2, H3K9me3 and H3K36me3 levels in Rnf1/Rnf2 double 
deficient oocytes and early embryos. We failed to observe any global difference compared to controls 
(data not shown), supporting the notion that the phenotype likely results from a loss of PRC1 function 
during oogenesis.  
In certain scenarios PRC1 is known to be targeted to chromatin independently of PRC2 (Kalantry and 
Magnuson, 2006; Pasini et al., 2007; Puschendorf et al., 2008; Schoeftner et al., 2006; Terranova et al., 
2008), but in most cases PRC1 functions downstream of PRC2 in silencing target genes expression 
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(Boyer et al., 2006; Cao et al., 2005; Cao et al., 2002; Wang et al., 2004b). For instance in the zygote, 
PRC1 targeting is independent of PRC2 at PCH regions, but is PRC2 dependent at euchromatin 
(Puschendorf et al., 2008). Conversely, we examined expression of PRC2 members (Ezh2, Eed, Suz12) 
and H3K27me3 presence in Rnf1/Rnf2 dm growing oocytes and matRnf1/Rnf2 dm embryos. In oocytes 
we did not detect any difference in level or localization of these proteins and marks compared to control 
oocytes. In matRnf1/Rnf2 dm embryos PRC2 members show control-like patterns, while H3K27me3 
levels vary a little between embryos, but still show labeling of both maternal and paternal PN in majority of 
zygotes examined. These data show that the phenotype resulting from PRC1 deficiency in double 
mutants is independent of PRC2. It would be interesting to compare Rnf1/Rnf2 dm and PRC2 mutant 
oocyte gene expression profiles to determine the connection between these complexes for repression of 
target genes during oogenesis. On a side note, maternal Ezh2 deficiency does not result in a maternal 
effect phenotype. However, the homologous Ezh1 may act redundantly, just as Rnf1 can rescue loss of 
Rnf2 at this stage of development. 
The key accomplishment of maternal to embryonic transition (MET) is to activate the embryonic gene 
expression program on the newly formed embryonic genome. Proper zygotic (or embryonic) genome 
activation (ZGA) is essential for progression beyond the 2-cell stage as demonstrated by inhibiting ZGA 
with the transcription inhibitor α-amanitin (Warner and Versteegh, 1974) or by a number of maternal effect 
genes, whose deletion results in incomplete ZGA and subsequent developmental arrest (Bultman et al., 
2006; Tong et al., 2000; Wu et al., 2003). Major ZGA in mouse is known to take place mainly during the 
prolonged G2-phase of the second cell cycle (Flach et al., 1982). Therefore it is an important question 
whether matRnf1/Rnf2 dm embryos manage to activate the embryonic genome and if they do, to what 
extent? Preliminary data of RNAPII stainings of matRnf1/Rnf2 dm 2-cell embryos suggests that these 
embryos do activate transcription, although to a lesser extent then control 2-cell embryos. To answer this 
question more precisely, we are currently performing expression profiling of late G2 control and  
matRnf1/Rnf2 dm 2-cell embryos. To distinguish between maternal transcripts and de novo embryonic 
transcripts, we will include control and matRnf1/Rnf2 dm embryos treated with the RNAPII inhibitor α-
amanitin - therefore embryos only containing maternal transcripts-, in our expression profiling analysis. 
Characterizing ZGA in matRnf1/Rnf2 dm embryos will provide further clues as to why these embryos 
cease development at the 2-cell stage. 
 
Taken together, our findings demonstrate an essential function of Polycomb during oogenesis in keeping 
the developmental potential of oocytes under close guard, which is a prerequisite for proper initiation of 
embryonic development.  
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5.2.   Indications for germline function of Polycomb form other species 
 
PcG proteins are conserved from plants to humans. During evolution, a number of Polycomb genes are 
thought to have undergone expansion through multiple duplication events. For example, in the plant 
kingdom, the moss and fern genomes mostly have single copies of genes encoding for PcG proteins, 
while seed plants have multiple paralogs for most (Hennig and Derkacheva, 2009). A very similar 
example exists in the animal kingdom, where Drosophila has single copies of most PcG genes (except for 
Psc and Esc), while mammals have five Pc, three Ph, two Psc, two dRing and two E(Z) homologs (Ohno 
et al., 2008; Whitcomb et al., 2007). Interestingly, classical targets of Polycomb proteins, such as Hox 
genes, have also undergone expansion from fly to mammals. In plants, which lack Hox gene clusters 
Polycomb targets include other key developmental regulators (Katz et al., 2004; Schubert et al., 2005). 
These findings have led to the conclusion that Polycomb function may be conserved throughout 
evolution.  
In our study, we show an essential role for PcG proteins during mouse oogenesis. However, if we look 
around in other species, we find this is not the first evidence for Polycomb involvement in germline 
functions.  
Homologs of PRC2 components are well described in plants (Hennig and Derkacheva, 2009). 
Arabidopsis thaliana has three E(Z) homologs (CLF, MEA and SWN), three Su(Z)12 homologs (EMF2, 
FIS2 and VRN2), one Esc homolog (FIE) and five NURF55 homologs (MIS1-5). These proteins form at 
least three PRC2-like complexes (EMF, VRN and FIS) with different subunit composition. By catalyzing 
trimethylation of H3K27, all three complexes have been implicated in silencing target genes during 
different developmental stages. For example, the EMF complex was shown to silence targets during 
sporophytic development (Makarevich et al., 2006) with essential roles in suppressing precocious 
flowering through silencing flowering activators, such as the FT (Flowering Locus T) and AGL19 
(Agamous-like 19) genes (Jiang et al., 2008; Schonrock et al., 2006; Yoshida et al., 2001). The VRN 
Polycomb complex on the other hand is required for flowering after vernalization (exposure to cold) by 
repressing the flowering-repressor FLC (Flowering Locus C) (Gendall et al., 2001). The most exciting 
Polycomb complex in plants from our point of view is the FIS complex which is known to silence target 
genes during gametogenesis and early embryonic development. Maternal FIS function is needed for 
subsequent embryonic development, demonstrated by maternal fis mutants. These mutants are 
characterized by autonomous seed-like structure formation in absence of fertilization (Chaudhury et al., 
1997; Guitton et al., 2004; Kohler et al., 2003a; Ohad et al., 1996). Even when fertilized, maternal fis 
mutants give rise to embryos that fail to complete development (Kohler et al., 2003a; Kohler and 
Makarevich, 2006; Spillane et al., 2000; Yadegari et al., 2000). A direct target of the FIS complex is the 
PHERES1 (PHE1) transcription factor, which is silenced in the maternal germline as well as in the early 
embryo (Kohler et al., 2003b; Kohler et al., 2005).  
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Absence of H2AUb in plants and the fact that no PRC1 homologs could be found to date, could suggest 
that PRC2-mediated H3K27me3 may be responsible for silencing. However, this is probably not the case, 
because PRC1-analogs have been identified in plants that are required for PRC2-mediated silencing at 
certain target genes. These analogs include LHP1 (Like heterochromatin protein 1) and the RING finger 
containing AtRING1 proteins (Libault et al., 2005; Nakahigashi et al., 2005; Sanchez-Pulido et al., 2008; 
Xu and Shen, 2008). 
As in plants, PRC2 homologs have been identified and characterized in the nematode C. elegans. These 
include Mes2, the SET domain containing H3K27 HTMase, a homolog of the mammalian Ezh2 and 
Mes6, a homolog of mammalian Eed (Holdeman et al., 1998; Korf et al., 1998). Mes2, Mes6 and Mes3 (a 
protein with no known homology) were shown to function in a complex and to mediate di- and tri-
methylation at H3K27. Mes genes were originally identified in genetic screens for maternal-effect sterile 
or “grandchildless” mutants (Capowski et al., 1991). Mothers carrying Mes mutations produce viable 
offspring whose germline degenerates midway through larval development (Capowski et al., 1991; 
Paulsen et al., 1995). This effect is dependent on the number of X chromosomes: XX offspring are more 
severely effected than XO males (Garvin et al., 1998). Indeed, in wild type animals, H3K27me3 is 
concentrated on the X chromosome, which is silenced in the germline (Fong et al., 2002; Xu et al., 2001). 
The working model is that the Mes2/Mes3/Mes6 complex operates in the maternal germline and during 
early embryogenesis epigenetically marks the X chromosome and therefore represses gene expression 
from it during germline development of the embryo (Xu et al., 2001).  
Recently PRC1 homologs have also been identified in the worm: Mig32 and Spat3, homologs of Bmi1 
and Rnf2 respectively (Karakuzu et al., 2009). Consistent with being PRC1 analogs, mutants of either 
Mig32 or Spat3 show reduction or loss of H2AUb. Mig32 and Spat3 mutants display a similar somatic 
phenotype as Mes mutants and authors also show that at least for male tail development, worm PRC1-
like proteins and Mes factors function in the same pathway. These results suggest that Mig32 and Spat3 
may function in concert with the Mes2/Mes3/Mes6 complex, as PRC1 and PRC2 in fly and mammals. 
Surprisingly however, unlike Mes mutants, Mig32 and Spat3 mutants produce fertile offspring; therefore in 
the germline these PRC1-like proteins are not required for Mes2/Mes3/Mes6 function. It is possible that 
other redundant proteins may be responsible for H2A ubiqitination, or that H2AUb is simply not required 
for silencing in the germline (Karakuzu et al., 2009).  
Drosophila PRC1 and PRC2 components are perhaps even better described in literature than the 
mammalian homologs (Muller and Kassis, 2006; Ringrose and Paro, 2004). To our interest, genetic 
evidence indicates that the maternal contribution of the Eed homolog Esc is critical for early embryonic 
development (Margueron et al., 2009; Ohno et al., 2008; Struhl, 1981; Struhl and Brower, 1982). Embryos 
lacking maternal Esc display complete de-repression of all homeotic genes and conversion of all 
segments to the identity of the 14
th
 parasegment. Zygotic Esc was able to rescue the maternal Esc defect 
when overexpressed shortly after fertilization (Simon et al., 1995). These experiments show an essential 
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embryonic role of maternal Esc; however they do not address the function of Polycomb in the germline. In 
another study authors examine several different mutant alleles of E(Z) (Phillips and Shearn, 1990). While 
flies homozygous for E(Z) null alleles are lethal during larval development, weak mutant alleles, such as 
temperature-sensitive alleles cause adult homeotic phenotypes. Importantly, females homozygous for 
temperature-sensitive E(Z) alleles display a range of phenotypes from oogenesis defect to maternal-effect 
lethality, depending on the time and length of exposure to restrictive temperature (Phillips and Shearn, 
1990).  
Taken together, there are indications from other species for Polycomb functioning in the germline for 
proper embryonic development. In plants, there is a clear maternal effect phenotype due to the loss of the 
FIS complex in the germline. In the worm, the maternally provided PRC2-like complex is essential for 
germline development of the embryo. To our knowledge, Polycomb function in the germline has not been 
examined so far in other species. 
 
5.3.   Polycomb proteins Rnf1 and Rnf2 function during first linage specification events in   pre-
implantation embryos? 
 
Maternal PRC1 function in the female germline is essential for early embryonic development. But is this 
the only stage during early embryonic development where PcG proteins have an essential role? We know 
that zygotic (embryonic) Rnf2 mutants, that still have the maternal load of PRC1 proteins (Rnf2m+z-) are 
embryonic lethal around gastrulation (Voncken et al., 2003). Importantly, these mutant embryos still have 
Rnf1, which may be able to compensate for the loss of Rnf2 between the time when the embryo runs out 
of the maternal Polycomb supply and the time of gastrulation, where apparently Rnf1 redundancy is not 
sufficient to rescue development. A key process that takes place before implantation is the first lineage 
specification events in the embryo. The first two lineages, the ICM and the TE are established by the 
blastocyst stage; however, many studies have demonstrated that blastomeres are committed to either 
lineage already a few cleavages before the blastocyst stage (Johnson and Ziomek, 1983; Rossant and 
Vijh, 1980; Suwinska et al., 2008; Ziomek and Johnson, 1982). A significant change occurs in the 
developmental potential of blastomeres around the 5th cleavage, so that cell fates become fixed by the 
32-cell stage. Would Polycomb proteins that have been assigned key roles in regulating important 
developmental genes in ES cells, have a role in this change of developmental potential of blastomeres or 
during the establishment of the first lineages in the embryo? 
To address this question, we produced embryos that have the maternal contribution of Rnf1, but will be 
zygotically Rnf1/Rnf2 dm (Rnf1m+z- Rnf2m-z-). We achieved this by mating Rnf1+/- Rnf2F/F Zp3-cre 
females with Rnf1-/- Rnf2F/F Prm1-cre males. Half of the embryos from such crosses have the desired 
genotype, the other half of the litter has an embryonic Rnf1+ allele. Unfortunately, this approach does not 
allow us to pool embryos, but restricts us to single embryo-analysis techniques. Nevertheless, preliminary 
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observations on the developmental potential of Rnf1m+z- Rnf2m-z- embryos revealed that they cease 
development somewhere between the 16-cell to morula (32- or 64-cell stage).  More detailed analysis of 
these embryos is needed, but we can already draw two important conclusions. First, that the maternal 
presence of Rnf1 in Rnf1m+z- Rnf2m-z- embryos allows these embryos to overcome the 2-cell block. 
Second, that there is a developmental window around the time embryonic cells are undergoing important 
fate decisions where PRC1 plays an essential role. On a side note, we suspect that this role of PRC1 can 
be fulfilled by Rnf1, as Rnf2m+z- embryos only arrest at later stages of post-implantation embryonic 
development (Voncken et al., 2003). Another possibility - as Rnf2 is considered a stronger H2A ubiquitin 
ligase and it is maternally contributed in wild-type embryos - is that the maternal load of Rnf2 in Rnf2m+z- 
embryos is sufficient to overcome this “around 32-cell block”. We are currently generating mice to obtain 
embryos that will have the maternal contribution of Rnf2 but will be zygotically dm for Rnf1 and Rnf2 
(Rnf1m-z- Rnf2m+z-) to address the roles of Rnf1 vs Rnf2 at the time of first lineage determination 
events. 
Single-embryo protocols are currently being established in our lab, which will give us unique tools to 
address these roles of Polycomb proteins. It will be very interesting to dissect the role of PRC1 during this 
phase of development, where important fate decisions are made. 
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